data_2k1h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k1h _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 110.61 -0.144 . . . . 1.0 110.61 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -57.32 119.87 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.87 0.843 . . . . 1.0 111.553 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.01 -48.74 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.519 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.56 179.12 7.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.45 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 pt -131.05 125.4 57.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.253 -0.885 . . . . 1.0 110.421 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.8 t -89.0 110.35 21.06 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -86.84 99.56 11.91 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -84.63 159.66 57.79 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.678 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.41 31.17 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.632 2.221 . . . . 1.0 111.846 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 9' ' ' THR . 12.1 m120 -93.49 -165.94 1.42 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -108.57 -56.18 2.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.991 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 69' ' ' ALA . 2.6 m-20 -129.22 10.46 5.8 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.359 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.5 m -109.29 130.77 55.48 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.492 ' SD ' ' CE2' ' A' ' 71' ' ' TRP . 10.5 ptp -150.85 153.57 35.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -102.65 134.31 46.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.644 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.4 t -109.44 110.39 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.546 -0.539 . . . . 1.0 109.546 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m -90.38 134.42 34.34 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.462 -0.569 . . . . 1.0 109.462 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.8 pt? -167.38 151.92 6.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.453 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 m -84.09 84.06 7.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.937 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 179.395 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.521 -0.158 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 54.3 p90 -102.09 129.95 48.56 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.158 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 m -166.26 136.3 3.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.889 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.97 116.53 29.36 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.406 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -141.35 160.68 39.62 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.578 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -171.32 116.61 0.43 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.037 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 170.62 130.94 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.978 -0.379 . . . . 1.0 109.978 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.09 117.48 20.94 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.928 0.394 . . . . 1.0 110.039 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -147.17 150.85 35.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.319 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -68.93 141.77 54.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.691 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 -8.53 76.26 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 110.821 -0.911 . . . . 1.0 110.821 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -99.09 147.52 33.36 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 121.119 -0.232 . . . . 1.0 111.018 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.26 127.47 2.99 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.214 1.943 . . . . 1.0 112.728 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.44 -24.79 63.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.291 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 37.4 m-85 -65.3 -12.99 57.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.945 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -110.68 -37.86 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.977 0.418 . . . . 1.0 110.24 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -63.68 -39.14 93.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.153 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -61.32 -35.57 77.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.053 0.454 . . . . 1.0 110.899 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 9.8 mp -66.9 -37.41 84.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.829 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -66.3 -21.27 66.26 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.259 -0.576 . . . . 1.0 111.095 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -70.4 -4.5 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.602 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -117.95 134.29 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 110.08 -0.341 . . . . 1.0 110.08 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -72.63 133.39 44.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.965 -0.561 . . . . 1.0 109.794 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 139.07 -46.5 0.96 Allowed Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.23 134.81 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -118.95 -30.91 4.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.196 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.1 p -160.99 154.05 21.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.892 0.377 . . . . 1.0 110.023 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.1 mt -134.83 125.21 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.149 -0.685 . . . . 1.0 109.149 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.86 130.1 48.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 1.0 110.442 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -119.87 118.07 29.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.825 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.93 143.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.457 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.448 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.4 OUTLIER 62.35 -150.05 0.37 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.853 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.448 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 86.6 m-20 -97.35 16.82 18.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -141.99 157.13 45.3 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.9 pt -134.25 154.0 36.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.229 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -125.79 123.21 38.27 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.42 127.39 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.202 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -103.37 120.21 40.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.08 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HZ1' ' CD2' ' A' ' 74' ' ' LEU . 63.4 mttt -135.81 148.34 48.68 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.613 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 96.8 mt-10 -58.98 172.48 0.55 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.525 -0.761 . . . . 1.0 109.927 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.39 -13.67 61.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.29 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -90.84 12.23 20.04 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.628 -0.26 . . . . 1.0 111.009 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -100.96 147.8 25.75 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' ND2' ' CG ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -138.43 120.72 15.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.492 ' CE2' ' SD ' ' A' ' 15' ' ' MET . 95.9 m95 -64.81 -17.05 63.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.715 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -59.64 -20.83 58.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.874 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' CG ' ' ND2' ' A' ' 70' ' ' ASN . 81.0 mm-40 -98.0 -30.36 12.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.819 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.572 ' CD2' ' HZ1' ' A' ' 65' ' ' LYS . 9.3 mp -71.28 -38.83 71.8 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.473 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.8 mp -39.4 -63.16 0.68 Allowed Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 123.368 0.418 . . . . 1.0 110.735 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.95 -22.38 68.47 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.492 1.461 . . . . 1.0 111.927 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -75.43 -54.74 6.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.83 0.348 . . . . 1.0 111.415 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.7 pt -72.8 -40.82 61.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -51.17 -30.18 16.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.138 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -63.78 -41.07 98.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.16 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -62.2 -50.78 70.42 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.705 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 78.4 m-85 -67.96 -41.53 82.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.778 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.74 69.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.266 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.035 -179.766 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 120.37 0.129 . . . . 1.0 110.785 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 98.0 mt -58.68 120.01 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.161 0.505 . . . . 1.0 111.147 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.21 -45.83 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.887 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.68 179.08 4.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.94 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.2 mt -130.05 128.5 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.871 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.9 t -95.14 113.08 24.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.867 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.55 100.95 10.43 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.877 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -83.58 159.18 61.73 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.789 -0.641 . . . . 1.0 109.975 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.62 29.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.579 2.186 . . . . 1.0 111.861 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 9' ' ' THR . 9.2 m120 -96.72 -168.7 1.76 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -110.5 -60.13 1.85 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.482 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -116.82 5.1 13.0 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.298 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.8 m -107.53 127.53 53.7 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.2 mtt -142.32 150.5 40.88 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -106.11 131.0 53.9 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.738 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 t -107.39 113.74 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.0 m -92.09 128.38 37.92 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.811 -0.441 . . . . 1.0 109.811 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 19' ' ' LEU . 1.7 pt? -162.08 150.09 14.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.618 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.1 t -87.25 78.76 8.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.819 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 . . . . . 0 CA--C 1.538 0.495 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.164 179.762 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.541 ' HG ' ' N ' ' A' ' 28' ' ' PHE . 46.0 t . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.541 ' N ' ' HG ' ' A' ' 27' ' ' SER . 51.8 p90 -101.75 131.5 48.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.8 m -159.55 112.3 2.17 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.0 m -94.76 123.82 38.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.841 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.71 170.59 15.48 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.183 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.16 113.01 0.38 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.384 -0.826 . . . . 1.0 110.342 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 167.15 133.96 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.174 -0.306 . . . . 1.0 110.174 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.19 113.11 19.8 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.873 0.368 . . . . 1.0 110.205 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -146.04 149.63 34.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.345 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.35 138.54 53.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.824 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.31 -13.94 62.29 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -91.4 151.39 42.67 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 121.016 -0.274 . . . . 1.0 110.923 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -38.9 117.69 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.644 2.23 . . . . 1.0 112.708 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.2 mp0 -63.95 -23.33 67.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.939 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 41' ' ' PHE . 36.9 t80 -69.04 -8.57 46.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.758 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.64 -41.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -63.33 -40.17 96.57 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.254 -0.578 . . . . 1.0 111.122 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.42 ' CD ' ' OG1' ' A' ' 81' ' ' THR . 92.7 mtt-85 -61.11 -32.92 72.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.615 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 7.9 mp -65.56 -39.24 91.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.749 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -68.27 -20.23 64.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.065 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -59.7 -23.84 63.46 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.093 -0.243 . . . . 1.0 111.646 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.98 141.69 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 110.105 -0.332 . . . . 1.0 110.105 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.34 138.29 56.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.784 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.1 -55.7 0.57 Allowed Glycine 0 N--CA 1.465 0.6 0 N-CA-C 111.382 -0.687 . . . . 1.0 111.382 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.3 p -61.26 126.58 19.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.785 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -106.02 -30.1 9.51 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -167.03 161.29 14.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.468 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.56 131.85 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 116.135 -0.484 . . . . 1.0 109.709 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.42 121.98 46.65 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -122.13 112.32 18.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.716 -0.674 . . . . 1.0 109.47 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 60' ' ' PHE . 11.5 p -164.99 149.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.217 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.26 -156.27 0.28 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.006 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 19' ' ' LEU . 6.2 p30 -93.49 12.49 24.89 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.691 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' A' ' 57' ' ' VAL . 39.1 p90 -139.66 149.6 43.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 pt -132.22 157.58 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.454 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.3 t -134.26 122.92 23.42 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.584 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 63' ' ' ILE . 21.7 mm -104.85 128.46 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.045 0.45 . . . . 1.0 109.91 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -96.7 111.41 23.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.903 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -122.33 144.71 48.84 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.595 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' OE1' ' ND2' ' A' ' 68' ' ' ASN . 71.2 tt0 -58.88 165.61 2.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.024 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 68' ' ' ASN . 34.5 p30 -69.8 -19.93 63.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.214 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 42.3 p30 -89.67 15.67 9.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.627 -0.26 . . . . 1.0 111.206 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.44 162.6 18.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.897 0.379 . . . . 1.0 110.128 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.425 ' N ' ' ND2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -145.98 132.89 20.16 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.688 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -62.04 -17.69 58.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.334 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -56.78 -30.34 63.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.616 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -83.76 -38.5 21.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.784 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 7.2 mp -71.76 -40.31 69.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 121.1 -0.24 . . . . 1.0 111.417 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.415 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 1.9 mt -40.23 -63.22 0.75 Allowed Pre-proline 0 N--CA 1.467 0.382 0 O-C-N 123.477 0.486 . . . . 1.0 111.088 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 47.7 Cg_endo -63.35 -25.39 71.31 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.513 1.475 . . . . 1.0 111.953 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -78.18 -56.05 4.77 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.055 0.455 . . . . 1.0 111.967 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 79' ' ' GLU . 2.2 pp -69.08 -43.62 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.742 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.402 ' H ' HG13 ' A' ' 78' ' ' ILE . 6.9 tm-20 -50.25 -36.46 31.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.862 0.363 . . . . 1.0 110.35 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -66.77 -28.83 68.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.097 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.42 ' OG1' ' CD ' ' A' ' 44' ' ' ARG . 5.3 m -60.9 -47.14 87.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.785 0.326 . . . . 1.0 110.825 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -68.33 -37.2 80.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.661 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.81 -41.76 82.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.534 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 1.0 110.69 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 4' ' ' ILE . 76.9 mt-10 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.906 -0.035 . . . . 1.0 110.906 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.57 127.82 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.593 0.711 . . . . 1.0 111.882 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 2' ' ' GLU . 1.2 mp -90.82 -43.57 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 114.679 -1.146 . . . . 1.0 109.398 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.86 168.81 7.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.394 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.59 128.71 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.542 -0.754 . . . . 1.0 109.284 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 m -105.75 107.59 18.67 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.94 116.23 19.96 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.447 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -90.94 176.08 3.15 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.37 14.34 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.824 1.682 . . . . 1.0 112.019 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 9' ' ' THR . 18.9 m120 -95.82 -179.81 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.847 0.356 . . . . 1.0 110.608 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.449 ' O ' ' CZ2' ' A' ' 71' ' ' TRP . 78.1 t60 -110.15 -58.9 2.01 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.584 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 56.0 p30 -101.03 7.59 43.36 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.745 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -116.37 130.08 56.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -140.53 151.69 44.97 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.075 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -109.56 134.08 52.34 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.67 117.29 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.7 t -92.13 127.77 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.599 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -169.88 158.64 7.42 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 120.831 0.348 . . . . 1.0 111.104 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.5 t -96.01 95.24 8.06 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.633 0.254 . . . . 1.0 110.371 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 . . . . . 0 N--CA 1.471 0.606 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.888 179.702 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 121.13 0.49 . . . . 1.0 110.144 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.48 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 53.6 p90 -99.2 127.93 45.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.299 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.402 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 25.5 m -165.4 108.46 0.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.58 124.94 28.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.217 0.532 . . . . 1.0 110.7 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.416 ' OH ' ' CB ' ' A' ' 56' ' ' TYR . 1.2 p90 -139.86 163.83 31.61 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.337 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.16 116.34 0.73 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.189 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 171.3 133.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.467 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.68 120.39 26.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.104 0.478 . . . . 1.0 110.268 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -168.16 168.59 11.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.763 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -78.02 142.1 38.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.031 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.64 -27.05 19.28 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.703 -0.559 . . . . 1.0 111.703 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -90.89 147.94 37.06 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 117.163 0.482 . . . . 1.0 110.342 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -44.58 128.8 8.68 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.717 1.611 . . . . 1.0 113.317 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.81 -23.22 66.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.354 -0.839 . . . . 1.0 110.362 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -61.71 -48.53 80.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.114 0.483 . . . . 1.0 110.39 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.98 -40.38 80.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.782 -0.644 . . . . 1.0 110.52 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -58.48 -37.03 74.68 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.917 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -63.43 -40.13 96.34 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.321 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.504 ' C ' ' H ' ' A' ' 47' ' ' GLU . 18.4 mt -61.84 -41.32 97.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.723 -0.217 . . . . 1.0 111.239 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 71.1 t80 -72.05 13.12 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.895 0.378 . . . . 1.0 111.012 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' H ' ' C ' ' A' ' 45' ' ' LEU . 77.0 tt0 -89.76 -22.34 22.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.448 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.582 ' CG2' HE22 ' A' ' 77' ' ' GLN . 2.2 pp -121.77 141.25 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.09 0.471 . . . . 1.0 111.067 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.1 145.42 55.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.657 -0.702 . . . . 1.0 111.029 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.68 -32.78 3.95 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 111.588 -0.605 . . . . 1.0 111.588 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.4 t -63.75 113.57 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 120.19 -0.604 . . . . 1.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -87.51 -47.38 8.78 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.821 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p -164.42 167.06 20.04 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.074 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -133.36 151.11 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.568 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.63 130.42 52.64 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.347 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 39.4 t80 -123.22 112.81 18.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.63 149.83 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.711 0.291 . . . . 1.0 110.368 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.5 OUTLIER 59.2 -148.85 0.46 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.793 0.33 . . . . 1.0 110.619 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' LEU . 38.2 p30 -100.11 15.58 26.93 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.673 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -141.32 156.49 45.84 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 pt -132.59 154.09 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.399 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.4 m -126.96 124.39 39.36 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.53 ' CD1' ' N ' ' A' ' 63' ' ' ILE . 2.2 mp -106.76 118.26 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -104.81 112.34 25.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.719 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.481 ' NZ ' ' CD1' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -125.21 157.78 35.65 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -58.29 169.89 0.79 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.99 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.448 ' OD1' ' ND2' ' A' ' 13' ' ' ASN . 88.4 m-20 -70.17 -17.01 63.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.115 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -84.38 5.78 25.77 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.784 0.326 . . . . 1.0 110.677 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.21 151.16 19.76 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.252 0.549 . . . . 1.0 109.833 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.481 HD21 ' N ' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -136.26 123.15 21.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.115 -0.948 . . . . 1.0 110.226 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.481 ' CD1' ' NZ ' ' A' ' 65' ' ' LYS . 13.6 m0 -61.29 -23.97 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.608 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.455 ' H ' ' ND2' ' A' ' 70' ' ' ASN . 5.7 m120 -56.37 -33.31 65.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.163 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -77.97 -38.33 45.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.843 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 7.0 mp -67.72 -38.39 83.52 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.746 -0.206 . . . . 1.0 111.0 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mp -41.79 -64.6 0.63 Allowed Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.319 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -61.42 -25.44 79.96 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.095 1.863 . . . . 1.0 112.44 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.582 HE22 ' CG2' ' A' ' 48' ' ' ILE . 86.6 mt-30 -76.96 -54.28 6.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.98 0.419 . . . . 1.0 111.477 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 pt -68.78 -43.05 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.007 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.97 -32.26 61.41 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.308 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.93 -41.16 97.71 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.368 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.0 m -64.29 -49.95 69.79 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.188 0.518 . . . . 1.0 110.43 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -63.29 -47.48 82.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.474 -0.784 . . . . 1.0 110.189 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.55 68.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.535 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.466 179.768 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 120.657 0.265 . . . . 1.0 110.424 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.6 pt -48.05 155.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.56 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -130.93 -46.06 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 123.576 0.547 . . . . 1.0 111.041 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.71 153.24 5.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.66 118.57 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.174 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -95.91 113.16 24.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.433 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.13 117.73 21.2 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.068 -0.715 . . . . 1.0 109.068 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -91.59 176.32 2.87 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.198 -178.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.99 12.53 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.336 2.024 . . . . 1.0 111.933 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 9' ' ' THR . 86.7 m-20 -98.39 -179.68 4.43 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -112.05 -61.42 1.72 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.842 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.549 HD21 ' N ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -92.55 1.4 57.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.361 -179.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.549 ' N ' HD21 ' A' ' 13' ' ' ASN . 27.3 m -116.1 128.54 55.76 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.8 mmt -135.06 145.67 48.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.844 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -95.75 128.38 42.57 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.53 105.92 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.6 m -90.52 132.6 35.6 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.7 pt? -162.78 153.6 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.446 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -77.51 100.3 6.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.813 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 . . . . . 0 N--CA 1.468 0.467 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.414 178.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.449 0.642 . . . . 1.0 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.465 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 51.2 p90 -99.57 127.92 45.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.359 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.3 m -166.32 145.38 5.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.25 117.13 33.81 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.743 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -141.2 172.13 13.11 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.526 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.11 114.94 0.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.049 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 169.78 135.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.678 0.275 . . . . 1.0 110.352 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.89 129.08 34.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.245 0.545 . . . . 1.0 110.2 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -164.46 162.82 22.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.798 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -83.22 143.64 30.31 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.395 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.07 -28.38 15.93 Favored Glycine 0 N--CA 1.465 0.629 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -94.68 146.79 32.07 Favored Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.94 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -41.76 130.99 4.08 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.125 1.883 . . . . 1.0 112.727 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 42' ' ' ILE . 81.2 mm-40 -64.9 -25.83 68.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.203 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -57.8 -1.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.158 -0.217 . . . . 1.0 111.582 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.486 ' H ' ' C ' ' A' ' 40' ' ' GLU . 38.2 mm -114.57 -34.5 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.076 0.465 . . . . 1.0 110.747 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -63.12 -39.97 96.23 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.306 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -44.44 87.99 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 47' ' ' GLU . 10.1 mp -63.16 -40.89 98.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.988 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 81.4 t80 -78.11 12.37 1.87 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.996 0.427 . . . . 1.0 110.243 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' LEU . 38.2 tp10 -88.52 -29.76 19.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.897 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.72 140.58 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.427 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -67.42 142.09 56.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.748 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 137.04 -39.98 1.56 Allowed Glycine 0 N--CA 1.464 0.505 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.66 124.31 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.02 0.438 . . . . 1.0 110.935 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -94.71 -43.24 8.35 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.0 p -158.89 156.81 30.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.843 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.1 mt -129.15 123.38 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.136 -0.691 . . . . 1.0 109.136 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 47.0 m-85 -101.63 138.99 37.9 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.075 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -126.8 112.71 15.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.114 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' PHE . 10.1 p -165.94 155.39 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.646 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mt 54.75 -163.18 0.13 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.581 0.705 . . . . 1.0 111.127 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -87.62 13.07 11.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.047 -0.979 . . . . 1.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 57' ' ' VAL . 44.1 p90 -148.44 157.62 43.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.97 0.414 . . . . 1.0 110.004 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.7 pt -133.9 164.84 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.3 p -135.01 134.28 40.29 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.493 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.64 131.1 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.892 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -100.25 103.02 14.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.277 -0.874 . . . . 1.0 110.261 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.577 ' HZ1' ' CD2' ' A' ' 74' ' ' LEU . 16.3 mtpt -110.99 142.23 43.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.742 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -63.9 173.11 1.94 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.101 0.477 . . . . 1.0 110.106 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -70.2 -14.06 62.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.902 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -89.49 9.5 26.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.416 0.151 . . . . 1.0 110.597 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.47 150.65 23.16 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.505 ' CG ' HD22 ' A' ' 72' ' ' ASN . 0.1 OUTLIER -143.85 127.13 16.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.257 0.551 . . . . 1.0 109.566 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -64.44 -19.64 65.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.798 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.613 HD21 ' H ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -54.13 -19.77 5.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.95 0.405 . . . . 1.0 110.93 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.613 ' H ' HD21 ' A' ' 72' ' ' ASN . 54.8 mm-40 -95.83 -33.38 12.26 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.322 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.577 ' CD2' ' HZ1' ' A' ' 65' ' ' LYS . 9.3 mp -68.95 -42.07 77.15 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 120.519 -0.472 . . . . 1.0 111.334 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 mp -44.61 -61.65 2.04 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 120.905 0.383 . . . . 1.0 110.855 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.88 -28.34 42.73 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.398 1.399 . . . . 1.0 111.95 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -75.89 -51.45 12.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.493 0.663 . . . . 1.0 112.344 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.42 -40.32 88.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.191 -0.913 . . . . 1.0 110.764 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.95 -27.84 5.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.166 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -62.33 -45.81 91.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.742 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -64.8 -51.91 59.64 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.293 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -59.7 -48.33 82.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.207 0.527 . . . . 1.0 109.839 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.49 93.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.558 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.531 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 49.3 mp0 . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 120.739 0.304 . . . . 1.0 110.374 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.9 mt -47.26 156.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 1.0 109.693 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -129.19 -39.31 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.87 -0.605 . . . . 1.0 111.178 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.71 153.47 2.75 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.356 0.41 . . . . 1.0 110.093 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.7 mt -109.68 119.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 p -94.98 110.9 22.75 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.124 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 55.1 mp0 -83.34 108.72 16.73 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.341 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.554 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -87.27 157.49 53.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.134 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.86 23.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.571 2.181 . . . . 1.0 112.074 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.554 ' H ' ' C ' ' A' ' 9' ' ' THR . 96.4 m-20 -88.75 -168.56 2.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -110.71 -71.14 0.77 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.231 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 16.8 p30 -106.72 11.16 30.59 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.065 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.1 m -115.0 131.59 56.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' ' CD2' ' A' ' 71' ' ' TRP . 11.6 ptt? -142.33 149.35 39.34 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.119 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -105.32 131.39 52.82 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.019 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -108.87 111.3 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -90.69 128.84 36.78 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.4 pt? -170.47 162.47 8.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.87 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.9 p -80.14 109.14 14.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.556 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 N--CA 1.473 0.696 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.383 179.417 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 110.165 -0.309 . . . . 1.0 110.165 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -104.55 139.31 39.61 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.121 0.486 . . . . 1.0 110.461 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.3 m -165.25 107.24 0.8 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.23 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -105.41 131.64 52.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.348 0.594 . . . . 1.0 111.262 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.463 ' HH ' ' CB ' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -141.8 170.58 15.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.289 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.59 113.15 0.71 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.406 -0.816 . . . . 1.0 110.64 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 167.72 126.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.674 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.76 126.13 32.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.216 0.531 . . . . 1.0 110.371 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -167.41 170.29 11.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.68 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.87 142.98 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.581 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.99 -26.84 21.79 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -94.36 147.93 34.16 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 121.09 -0.244 . . . . 1.0 110.696 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -40.65 121.29 1.15 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.646 2.231 . . . . 1.0 112.505 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.99 -24.96 66.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.358 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -62.01 -18.45 60.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.624 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.1 mm -102.33 -33.1 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 123.321 0.388 . . . . 1.0 110.655 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -63.38 -38.34 90.76 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.207 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -60.06 -33.03 71.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.071 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 47' ' ' GLU . 9.4 mp -63.46 -38.77 92.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.667 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 70.0 t80 -76.3 14.89 0.66 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.989 0.424 . . . . 1.0 110.501 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 45' ' ' LEU . 82.1 tt0 -90.77 -23.66 20.58 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.689 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.627 ' CG2' HE22 ' A' ' 77' ' ' GLN . 1.9 pp -121.4 142.26 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.047 0.451 . . . . 1.0 110.544 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.46 143.95 54.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.344 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.77 -43.81 1.26 Allowed Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.246 -0.742 . . . . 1.0 111.246 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.86 115.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.454 0.645 . . . . 1.0 111.274 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -88.47 -42.76 11.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.3 p -170.2 168.94 8.04 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.288 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.41 137.71 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.07 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -110.64 136.27 49.99 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.423 0.452 . . . . 1.0 109.896 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.463 ' CB ' ' HH ' ' A' ' 31' ' ' TYR . 71.9 t80 -124.11 118.74 27.6 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.382 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -165.76 141.3 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.42 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.493 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.4 OUTLIER 64.05 -149.58 0.3 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.948 178.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.493 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 55.9 p-10 -97.68 18.56 15.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.785 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 28.9 p90 -141.58 156.82 45.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 pt -132.79 144.47 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.283 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 t -111.07 124.31 51.92 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.1 mt -112.2 125.58 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -116.5 133.27 56.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.215 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -144.19 156.12 44.18 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.558 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -51.27 162.83 0.29 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.688 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.496 ' OD1' ' ND2' ' A' ' 13' ' ' ASN . 92.3 m-20 -69.99 -14.26 62.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.76 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -88.27 9.98 21.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.775 -0.193 . . . . 1.0 110.598 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.92 164.92 11.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.325 0.583 . . . . 1.0 109.815 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.52 ' CG ' HD22 ' A' ' 72' ' ' ASN . 0.1 OUTLIER -150.04 134.01 16.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.477 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.461 ' CD2' ' SD ' ' A' ' 15' ' ' MET . 3.9 m0 -68.22 -18.09 64.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.256 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.642 HD21 ' H ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -57.78 -20.47 35.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.978 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.642 ' H ' HD21 ' A' ' 72' ' ' ASN . 80.7 mt-10 -95.24 -29.03 14.72 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.236 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 74' ' ' LEU . 8.8 mp -74.75 -39.41 61.85 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.976 -0.29 . . . . 1.0 111.298 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.417 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 2.2 mt -40.87 -62.35 1.02 Allowed Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 123.444 0.465 . . . . 1.0 111.917 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 36.8 Cg_endo -61.24 -27.84 84.1 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.878 1.718 . . . . 1.0 112.267 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.627 HE22 ' CG2' ' A' ' 48' ' ' ILE . 86.5 mt-30 -75.62 -49.97 16.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.288 0.566 . . . . 1.0 111.444 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 pt -70.28 -42.92 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.586 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -53.19 -35.13 59.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.263 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -63.47 -39.44 94.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.035 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.8 m -62.04 -48.08 81.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.013 0.435 . . . . 1.0 110.222 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.93 -44.59 80.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.987 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -45.17 -33.85 2.46 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.524 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.468 ' HZ1' ' CB ' ' A' ' 84' ' ' LYS . 9.3 mtpm? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.46 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 82' ' ' PHE . 38.6 tp10 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.7 mt -49.09 142.6 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.929 0.395 . . . . 1.0 110.421 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -120.05 -34.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.343 -0.844 . . . . 1.0 110.639 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.02 178.1 3.05 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.078 0.466 . . . . 1.0 110.177 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.1 pt -143.23 136.73 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.576 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.2 m -116.09 111.88 20.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.838 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.437 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 39.2 mp0 -84.16 113.87 21.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -82.88 177.18 3.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.304 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.86 21.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.216 1.944 . . . . 1.0 112.296 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.532 ' H ' ' C ' ' A' ' 9' ' ' THR . 94.3 m-20 -103.5 -178.25 3.61 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.55 -55.26 2.54 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.794 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -100.94 3.83 42.03 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.284 -178.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -116.22 131.36 56.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.6 mtt -146.23 153.54 40.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.816 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -106.8 135.99 47.4 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.805 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.46 120.68 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.748 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.2 t -96.06 127.57 42.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.327 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -164.33 154.42 14.44 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.419 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -92.71 99.07 11.83 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.464 ' N ' ' OE2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.699 0 CA-C-N 116.281 -0.418 . . . . 1.0 109.999 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 110.078 -0.341 . . . . 1.0 110.078 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 54.1 p90 -99.08 132.94 44.02 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 m -166.95 107.01 0.62 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.618 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.8 m -81.11 120.78 25.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.358 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -141.65 164.72 29.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.671 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.407 ' O ' ' CG2' ' A' ' 32' ' ' THR . 9.7 t -168.97 113.89 0.57 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.253 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 167.93 132.68 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.51 -0.313 . . . . 1.0 110.357 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.439 ' O ' ' NE2' ' A' ' 35' ' ' GLN . . . -81.29 122.69 27.75 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 1.0 110.068 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 34' ' ' ALA . 99.1 mm-40 -143.34 155.7 44.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.317 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.71 142.38 46.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.837 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.67 -3.55 55.0 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -98.71 155.61 36.52 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 122.889 -0.183 . . . . 1.0 110.583 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -36.34 109.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.866 2.378 . . . . 1.0 112.453 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.62 -36.59 74.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.936 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -55.83 -51.7 66.57 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.641 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.09 -41.22 91.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.957 0.408 . . . . 1.0 110.364 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -59.86 -38.92 83.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.01 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -61.02 -39.52 90.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.869 0.366 . . . . 1.0 110.421 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.63 -41.8 98.23 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.996 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -65.07 -29.09 69.95 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.911 -0.715 . . . . 1.0 111.14 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.79 -10.08 59.24 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.097 -0.241 . . . . 1.0 111.347 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -105.89 134.55 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.844 0.355 . . . . 1.0 110.301 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -73.26 128.84 36.63 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.32 -37.78 1.88 Allowed Glycine 0 N--CA 1.461 0.357 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.74 128.39 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.581 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.473 ' NZ ' ' OD1' ' A' ' 64' ' ' ASP . 27.7 mtmm -99.87 -40.8 7.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.421 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.6 m -165.71 171.19 13.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.362 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.4 137.35 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.04 -0.527 . . . . 1.0 109.998 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -111.46 133.4 53.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.698 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -122.88 108.16 12.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.221 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 60' ' ' PHE . 11.1 p -164.43 147.51 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.104 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 64.68 -160.54 0.29 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.897 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 19' ' ' LEU . 81.7 m-20 -89.3 15.03 9.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 57' ' ' VAL . 40.9 p90 -147.88 158.98 44.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.442 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 pt -129.44 152.19 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.411 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.0 m -113.91 118.96 35.65 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.9 mt -104.88 114.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.076 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.473 ' OD1' ' NZ ' ' A' ' 52' ' ' LYS . 60.2 t0 -98.04 126.24 43.38 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.419 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.418 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 4.8 mtmp? -139.15 143.91 38.38 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.45 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -55.71 167.66 0.52 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.351 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 68' ' ' ASN . 50.5 p-10 -68.62 -23.79 64.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.827 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 2.0 p-10 -77.93 -7.2 56.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.785 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.04 142.49 41.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.9 119.95 28.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.297 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -60.28 -28.81 68.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.739 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -57.53 -16.61 10.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.572 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -97.92 -34.63 10.76 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.33 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.27 -39.83 62.73 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.33 -0.231 . . . . 1.0 110.948 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mp -41.92 -62.55 1.11 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.025 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.56 -27.5 84.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.768 1.645 . . . . 1.0 112.124 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.56 -53.72 7.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.985 0.421 . . . . 1.0 111.491 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 pt -70.6 -44.1 77.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.031 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -52.07 -32.81 36.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.327 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -64.54 -39.43 93.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.227 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.5 m -62.99 -50.49 70.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.899 0.381 . . . . 1.0 110.71 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.448 ' CE1' ' OE2' ' A' ' 2' ' ' GLU . 3.0 t80 -62.06 -48.56 79.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.011 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.88 97.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.793 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp . . . . . 0 CA--C 1.516 -0.328 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.92 -179.587 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.521 0.2 . . . . 1.0 110.605 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 tt -50.86 118.47 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.495 0.664 . . . . 1.0 111.082 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mm -92.25 -48.33 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.2 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.91 178.76 9.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.213 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 tt -132.49 135.64 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.264 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 t -100.61 111.26 23.47 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.047 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.29 110.45 16.76 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -87.32 177.63 2.64 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 -178.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.25 7.95 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.988 1.792 . . . . 1.0 112.229 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' THR . 22.6 m120 -93.25 171.69 8.76 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.421 ' O ' ' CZ2' ' A' ' 71' ' ' TRP . 80.0 m80 -111.59 -38.29 4.95 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.169 -0.468 . . . . 1.0 111.352 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -110.42 -2.33 16.64 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.795 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -113.81 130.87 56.41 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.472 ' SD ' ' CG ' ' A' ' 71' ' ' TRP . 11.7 ptt? -142.74 151.81 41.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 1.0 109.767 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -113.89 138.34 50.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.947 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.8 t -100.44 127.6 53.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 t -104.22 132.32 50.6 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -169.64 158.04 7.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.91 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -102.75 86.19 2.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 -179.676 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.518 -0.253 0 CA-C-O 120.985 0.422 . . . . 1.0 110.112 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 51.9 p90 -100.09 127.65 46.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.346 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.8 m -161.42 132.54 5.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.416 ' CB ' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -101.8 120.15 39.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.259 0.552 . . . . 1.0 111.038 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -140.14 133.49 29.9 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.817 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.4 t -138.24 116.44 11.82 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.037 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 170.07 137.63 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.957 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.16 122.37 32.39 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -154.16 154.36 33.42 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.11 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -71.16 128.87 37.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.797 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.51 -19.82 52.5 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.437 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 38.9 mm-40 -82.18 152.0 67.31 Favored Pre-proline 0 CA--C 1.543 0.709 0 O-C-N 122.746 -0.267 . . . . 1.0 110.602 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.17 119.74 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.606 2.204 . . . . 1.0 112.923 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -68.77 -23.32 64.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.539 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.511 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 56.7 m-85 -69.26 -10.2 56.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.961 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.07 -33.71 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 123.3 0.375 . . . . 1.0 110.312 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 38' ' ' GLN . 67.3 m-20 -63.18 -39.87 95.89 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.211 -0.595 . . . . 1.0 110.71 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.454 ' NH1' ' OG1' ' A' ' 81' ' ' THR . 25.0 mmt85 -64.51 -34.67 78.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.49 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 8.7 mp -63.21 -41.05 99.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.005 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -69.8 -5.2 23.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.861 -0.336 . . . . 1.0 111.034 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.47 ' OE1' ' NE2' ' A' ' 77' ' ' GLN . 82.2 tt0 -68.12 -24.3 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.634 -0.257 . . . . 1.0 111.364 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.76 142.99 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.899 0.381 . . . . 1.0 110.816 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -67.14 143.85 56.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.847 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.93 -40.42 1.59 Allowed Glycine 0 N--CA 1.465 0.601 0 N-CA-C 111.452 -0.659 . . . . 1.0 111.452 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.11 112.38 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.543 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -82.02 -50.86 8.63 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.042 0.448 . . . . 1.0 110.176 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.8 p -160.96 160.54 30.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 30' ' ' THR . 49.5 mm -121.73 151.57 25.23 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.921 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.37 120.93 20.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -114.7 118.41 33.55 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.689 -0.485 . . . . 1.0 109.689 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -164.57 148.39 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.413 . . . . 1.0 110.192 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.85 -138.94 0.32 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.774 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -110.25 23.79 13.83 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 122.619 0.367 . . . . 1.0 110.865 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -147.42 157.56 43.63 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 mp -126.52 132.84 69.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 1.0 109.844 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t -103.11 123.58 46.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.433 ' CG2' ' NZ ' ' A' ' 65' ' ' LYS . 65.4 mt -112.05 127.52 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.673 -0.492 . . . . 1.0 109.673 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.04 111.72 23.03 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.579 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.433 ' NZ ' ' CG2' ' A' ' 63' ' ' ILE . 47.3 mttp -115.78 155.75 27.26 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.388 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 67' ' ' ASP . 7.3 tp10 -67.09 175.25 2.66 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.442 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 90.8 m-20 -70.12 -20.32 63.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.032 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -85.74 3.03 43.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.71 0.291 . . . . 1.0 111.098 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.21 153.36 17.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.423 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.448 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -141.32 121.82 14.13 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.032 0.444 . . . . 1.0 110.362 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.472 ' CG ' ' SD ' ' A' ' 15' ' ' MET . 5.6 m0 -58.16 -26.47 62.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.539 . . . . 1.0 111.266 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -56.48 -36.61 69.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.749 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -74.56 -40.29 61.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.646 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.484 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 3.9 mm? -70.7 -38.43 73.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mp -39.55 -62.49 0.82 Allowed Pre-proline 0 CA--C 1.541 0.599 0 O-C-N 123.441 0.463 . . . . 1.0 110.89 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.38 -22.61 59.54 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.783 1.656 . . . . 1.0 112.11 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.47 ' NE2' ' OE1' ' A' ' 47' ' ' GLU . 40.4 tt0 -76.47 -53.47 8.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.975 0.417 . . . . 1.0 111.621 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 pt -71.33 -40.32 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.824 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -50.91 -31.05 16.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.347 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -63.95 -39.67 94.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.326 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.454 ' OG1' ' NH1' ' A' ' 44' ' ' ARG . 21.6 m -60.1 -48.7 80.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.823 0.344 . . . . 1.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.511 ' CZ ' ' CD1' ' A' ' 41' ' ' PHE . 98.0 m-85 -69.51 -37.29 77.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.572 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.28 -43.07 92.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.662 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.75 -179.726 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.892 0.377 . . . . 1.0 110.417 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 85.0 mt -49.37 155.64 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-O 120.776 0.322 . . . . 1.0 110.267 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.1 mm -127.25 -37.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.434 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -171.65 158.69 5.13 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.127 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.466 ' CG2' ' SD ' ' A' ' 15' ' ' MET . 74.9 mt -104.23 131.83 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 m -114.56 104.85 12.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.105 0.479 . . . . 1.0 110.007 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -76.86 144.78 38.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.085 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -122.71 161.76 42.24 Favored Pre-proline 0 N--CA 1.472 0.655 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.0 21.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.529 2.153 . . . . 1.0 112.215 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.559 ' H ' ' C ' ' A' ' 9' ' ' THR . 14.9 m120 -96.42 -174.23 2.99 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.457 ' O ' ' CH2' ' A' ' 71' ' ' TRP . 59.3 t-80 -110.72 -51.27 2.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.825 0.345 . . . . 1.0 111.652 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.482 HD21 ' N ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -116.22 7.57 14.11 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.875 -0.602 . . . . 1.0 112.103 -178.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.482 ' N ' HD21 ' A' ' 13' ' ' ASN . 24.1 m -111.72 130.06 55.91 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.466 ' SD ' ' CG2' ' A' ' 6' ' ' ILE . 38.8 ttm -139.7 150.9 45.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -107.29 131.4 54.25 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.94 -0.573 . . . . 1.0 109.579 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.7 t -108.61 109.98 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -90.48 133.19 35.22 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.475 ' CD2' ' N ' ' A' ' 19' ' ' LEU . 1.6 pt? -166.05 155.55 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.063 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -88.25 83.79 6.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 -179.729 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.155 0.503 . . . . 1.0 110.21 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 46.2 p90 -102.79 131.21 49.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.217 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.41 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.1 m -160.81 108.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -79.64 117.79 20.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.668 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 29' ' ' THR . 9.5 p90 -142.27 162.38 35.63 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.252 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.34 114.08 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.562 . . . . 1.0 109.972 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 169.29 139.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.296 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.8 120.97 25.35 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.799 -0.445 . . . . 1.0 109.799 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.478 ' OE1' ' NE2' ' A' ' 38' ' ' GLN . 81.9 mt-30 -148.07 146.91 29.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.029 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -70.5 142.75 51.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.828 -0.624 . . . . 1.0 111.122 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.22 -13.03 62.73 Favored Glycine 0 N--CA 1.46 0.286 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.478 ' NE2' ' OE1' ' A' ' 35' ' ' GLN . 75.6 mt-30 -97.3 147.42 32.94 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 122.837 -0.214 . . . . 1.0 110.932 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -41.92 128.06 3.88 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.136 1.891 . . . . 1.0 112.896 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.452 ' OE2' ' NZ ' ' A' ' 84' ' ' LYS . 95.9 mt-10 -66.89 -26.28 66.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.023 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -60.26 -11.98 7.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.903 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -110.32 -39.65 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 110.105 -0.331 . . . . 1.0 110.105 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -66.23 -38.15 87.22 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.863 -0.335 . . . . 1.0 111.281 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -60.23 -34.09 73.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.19 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 8.2 mp -66.02 -36.86 84.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.21 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 75.7 t80 -74.11 13.41 0.55 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.818 0.342 . . . . 1.0 111.193 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 45' ' ' LEU . 80.8 mm-40 -87.51 -20.92 25.84 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.611 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.15 142.2 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 1.3 pm0 -68.71 148.96 49.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.095 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.61 -36.0 3.01 Favored Glycine 0 N--CA 1.468 0.779 0 N-CA-C 111.366 -0.693 . . . . 1.0 111.366 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.82 114.88 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.3 0.571 . . . . 1.0 110.656 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.87 -42.81 8.89 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 p -165.04 161.74 19.96 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.508 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.8 mt -130.98 136.2 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -111.34 129.63 55.94 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.156 -0.474 . . . . 1.0 109.866 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -124.17 118.46 26.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.632 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 p -164.79 146.92 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.997 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 tp 62.4 -131.25 0.57 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.83 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 19' ' ' LEU . 48.3 p-10 -115.25 23.56 12.36 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.156 0.582 . . . . 1.0 110.971 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.35 159.63 43.11 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.7 pt -132.09 149.44 32.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.147 -0.479 . . . . 1.0 109.808 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.2 t -114.96 122.49 46.43 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.31 115.42 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -100.37 114.95 28.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.1 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -125.47 153.12 44.0 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.674 0.273 . . . . 1.0 110.793 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -61.79 167.58 3.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.854 -0.424 . . . . 1.0 109.854 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.08 -18.62 65.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.649 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -85.95 4.5 37.34 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.862 0.363 . . . . 1.0 110.768 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.33 149.54 21.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.281 0.562 . . . . 1.0 110.502 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.564 HD21 ' N ' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -138.31 126.86 23.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.142 -0.935 . . . . 1.0 110.654 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.564 ' N ' HD21 ' A' ' 70' ' ' ASN . 4.5 m-90 -57.72 -27.43 62.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.978 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.417 ' H ' ' ND2' ' A' ' 70' ' ' ASN . 5.7 m120 -55.49 -29.61 59.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.331 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.53 -35.6 30.14 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.132 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 3.7 mm? -70.51 -38.78 74.34 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 121.078 -0.249 . . . . 1.0 111.601 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mt -39.92 -62.62 0.83 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.165 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -62.74 -24.21 74.64 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.895 1.73 . . . . 1.0 112.315 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -75.95 -54.05 7.47 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.465 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.3 pt -67.5 -41.24 85.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.524 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.32 -28.37 7.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.255 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -58.73 -33.38 70.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.142 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.7 p -64.44 -44.35 91.42 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.139 0.495 . . . . 1.0 110.245 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.13 -36.13 83.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.576 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -46.19 -46.87 17.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.908 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.452 ' NZ ' ' OE2' ' A' ' 40' ' ' GLU . 98.9 mttt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.399 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.772 0.32 . . . . 1.0 110.506 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 99.1 mt -51.65 118.23 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-O 121.05 0.452 . . . . 1.0 110.804 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 67.8 mt -92.81 -35.24 6.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.038 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.5 151.63 1.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.226 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.6 mt -107.42 125.91 63.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -107.25 116.9 32.74 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.99 0.424 . . . . 1.0 110.437 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -72.67 145.93 46.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.434 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -121.68 168.72 10.64 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.293 -179.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.69 -7.8 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.47 2.113 . . . . 1.0 112.159 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 9' ' ' THR . 98.4 m-20 -92.83 173.95 7.49 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.071 0.462 . . . . 1.0 110.05 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.566 ' CG ' ' H ' ' A' ' 13' ' ' ASN . 46.0 p-80 -113.7 -55.1 2.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.34 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.566 ' H ' ' CG ' ' A' ' 12' ' ' HIS . 51.0 p30 -82.62 3.7 27.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.866 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -124.23 145.66 49.22 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.27 0.557 . . . . 1.0 109.98 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.3 tpp -144.8 153.78 42.0 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.703 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -101.65 123.94 46.49 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.058 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.5 t -104.07 106.52 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.932 0.396 . . . . 1.0 110.007 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -88.85 134.44 33.94 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.746 0.308 . . . . 1.0 110.445 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.536 ' CD2' ' N ' ' A' ' 19' ' ' LEU . 1.5 pt? -170.17 160.77 8.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.056 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -81.06 99.02 8.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.995 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 121.088 0.47 . . . . 1.0 110.191 178.809 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 CA--C 1.517 -0.309 0 CA-C-O 120.799 0.333 . . . . 1.0 110.123 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.453 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 54.4 p90 -102.77 127.44 49.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.136 0.493 . . . . 1.0 110.515 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.2 m -161.72 149.28 14.66 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.041 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.67 130.14 52.18 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.18 -0.463 . . . . 1.0 111.013 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.74 170.26 16.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.41 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.407 ' O ' ' CG2' ' A' ' 32' ' ' THR . 8.9 t -167.43 116.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.669 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 32' ' ' THR . . . 168.15 134.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.095 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.59 120.83 31.99 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.119 0.485 . . . . 1.0 110.413 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -147.94 153.15 38.67 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.712 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -68.14 131.42 45.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.283 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.37 -16.35 57.81 Favored Glycine 0 N--CA 1.466 0.677 0 N-CA-C 110.743 -0.943 . . . . 1.0 110.743 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -88.24 151.7 49.23 Favored Pre-proline 0 N--CA 1.455 -0.18 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.64 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -36.86 114.23 0.12 Allowed 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.81 2.34 . . . . 1.0 112.879 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.81 -27.2 66.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.394 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.519 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 39.1 m-85 -60.8 -23.71 65.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.384 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 42' ' ' ILE . 36.9 mm -100.36 -31.34 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.75 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -63.57 -40.53 97.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.037 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -59.75 -32.74 70.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.068 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.482 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 8.6 mp -66.65 -39.35 88.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.874 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.3 -22.82 65.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.852 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.56 -15.29 63.58 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.874 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.45 140.4 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.413 0.625 . . . . 1.0 110.31 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.63 136.37 41.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.135 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.54 -43.28 1.19 Allowed Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.22 119.69 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.158 0.504 . . . . 1.0 111.104 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -96.76 -42.71 7.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 1.0 109.99 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.4 p -166.19 165.99 17.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.301 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.34 152.84 32.64 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.889 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.447 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -127.4 129.73 48.08 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.421 0.451 . . . . 1.0 109.981 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -121.76 122.66 40.01 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.194 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -164.89 149.02 2.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.506 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.0 tp 57.39 -128.5 1.7 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.127 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -118.97 24.31 10.9 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 123.302 0.376 . . . . 1.0 110.822 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -144.42 155.69 43.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 pt -129.68 147.58 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.329 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.7 m -120.29 119.92 34.57 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.411 -0.588 . . . . 1.0 109.411 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.2 mt -105.25 124.41 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.549 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -101.32 124.78 47.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.443 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -135.66 154.17 51.38 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.267 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.428 ' CG ' ' H ' ' A' ' 67' ' ' ASP . 71.0 tt0 -61.52 169.89 2.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.48 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.428 ' H ' ' CG ' ' A' ' 66' ' ' GLU . 50.9 t0 -67.8 -21.86 65.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.118 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -82.96 -5.41 59.06 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.773 0.32 . . . . 1.0 110.568 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.5 152.49 26.03 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.074 0.464 . . . . 1.0 110.51 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.457 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -141.69 118.68 11.24 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.299 0.571 . . . . 1.0 109.787 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -57.64 -21.24 38.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.988 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -57.92 -35.18 70.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.561 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -75.95 -35.89 59.53 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 121.11 0.481 . . . . 1.0 110.607 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 9.2 mp -69.12 -37.81 78.53 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.212 -0.305 . . . . 1.0 111.3 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.456 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 3.6 mp -38.4 -63.67 0.54 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.021 0.378 . . . . 1.0 112.021 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 40.0 Cg_endo -62.26 -26.51 77.45 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.428 2.086 . . . . 1.0 112.551 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -76.15 -54.38 6.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.301 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.5 pt -69.77 -42.95 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.916 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -51.34 -35.73 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.145 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -66.59 -36.69 83.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.472 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.1 m -57.25 -47.21 81.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.02 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.519 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 95.3 m-85 -70.72 -33.14 70.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 1.0 111.028 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.91 -48.12 81.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.749 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 84' ' ' LYS . 4.5 mptp? . . . . . 0 N--CA 1.466 0.368 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.755 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.908 0.385 . . . . 1.0 110.956 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.7 pt -51.7 146.62 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.542 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 mm -123.31 -43.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.356 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.05 140.73 7.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.43 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.19 123.53 60.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.622 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.1 m -106.09 103.25 12.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.205 -0.452 . . . . 1.0 109.87 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -70.21 155.63 40.37 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.499 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -132.35 158.36 75.83 Favored Pre-proline 0 N--CA 1.474 0.763 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 -178.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.85 32.62 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.436 2.091 . . . . 1.0 112.023 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 9' ' ' THR . 13.5 m120 -90.62 -169.57 2.43 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -109.98 -39.57 5.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.521 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.565 HD21 ' N ' ' A' ' 67' ' ' ASP . 12.5 p30 -145.29 15.3 1.48 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.993 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -116.32 125.5 52.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.541 -0.3 . . . . 1.0 110.276 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.24 148.39 46.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.178 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -100.6 137.98 38.27 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.229 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.64 108.4 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -92.4 131.44 37.56 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.2 pt? -169.11 165.09 11.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.955 0.407 . . . . 1.0 110.515 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.8 t -84.38 119.48 25.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.969 0.414 . . . . 1.0 110.754 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 N--CA 1.475 0.817 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.73 178.602 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 C--O 1.223 -0.295 0 CA-C-O 120.812 0.339 . . . . 1.0 110.455 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -123.07 145.15 48.79 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.427 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 m -167.07 107.11 0.61 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.119 -0.697 . . . . 1.0 109.119 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.2 m -84.27 115.64 22.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.273 0.559 . . . . 1.0 110.331 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.432 ' O ' ' OG1' ' A' ' 32' ' ' THR . 22.2 p90 -141.41 167.16 22.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.651 -0.704 . . . . 1.0 110.198 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 31' ' ' TYR . 98.1 m -170.21 112.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.96 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 167.57 137.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.309 . . . . 1.0 110.807 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.8 112.37 8.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.157 0.504 . . . . 1.0 110.659 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -150.77 147.51 27.39 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.71 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.49 143.97 53.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.71 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.84 -25.47 20.68 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -102.65 146.76 32.96 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 116.949 0.374 . . . . 1.0 110.493 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -41.98 123.95 2.64 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.08 1.853 . . . . 1.0 112.627 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -45.33 -23.7 0.22 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.769 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.483 ' CE2' ' OG1' ' A' ' 81' ' ' THR . 89.3 m-85 -56.4 -43.05 78.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.49 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.5 mm -62.29 -47.05 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.676 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -62.02 -39.64 92.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.746 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -57.52 -49.08 77.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 47' ' ' GLU . 5.1 mt -55.63 -39.1 70.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.132 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 73.6 t80 -77.37 16.18 0.65 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.84 0.352 . . . . 1.0 110.756 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 45' ' ' LEU . 36.4 tp10 -95.7 -35.95 11.38 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.567 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -115.17 139.72 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.855 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -62.04 136.11 57.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.782 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.98 -42.85 0.98 Allowed Glycine 0 C--O 1.228 -0.256 0 N-CA-C 111.28 -0.728 . . . . 1.0 111.28 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.02 113.18 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.136 0.493 . . . . 1.0 111.205 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -83.68 -49.38 9.2 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -158.81 153.74 25.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.411 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 mm -121.12 136.43 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.673 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -112.49 142.93 44.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.826 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -135.41 117.0 14.88 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.859 -0.422 . . . . 1.0 109.859 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' PHE . 8.8 p -165.79 145.18 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.226 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.33 -156.17 0.33 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.195 0.522 . . . . 1.0 110.966 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 19' ' ' LEU . 82.8 m-20 -91.51 13.42 17.78 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' A' ' 57' ' ' VAL . 36.4 p90 -140.71 149.11 41.77 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.703 0.287 . . . . 1.0 110.235 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 pt -128.17 159.66 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.9 p -122.85 130.24 52.63 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.6 mt -115.36 110.47 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.524 -0.546 . . . . 1.0 109.524 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.54 109.75 21.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.331 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.612 ' NZ ' ' HE1' ' A' ' 71' ' ' TRP . 24.3 mtmm -122.14 153.66 38.44 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.222 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.31 164.91 17.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.203 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.565 ' N ' HD21 ' A' ' 13' ' ' ASN . 42.6 p-10 -58.48 -28.74 65.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.736 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 14.3 m120 -70.32 3.29 3.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.583 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 67' ' ' ASP . . . -94.53 145.43 24.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.274 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.482 HD22 ' CD ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -140.88 123.4 15.98 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.26 -0.427 . . . . 1.0 109.991 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.612 ' HE1' ' NZ ' ' A' ' 65' ' ' LYS . 3.1 m0 -64.78 -27.23 68.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.237 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -57.57 -16.25 9.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.583 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.482 ' CD ' HD22 ' A' ' 70' ' ' ASN . 97.0 mt-10 -96.01 -33.5 12.11 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.588 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 4.0 mm? -74.86 -31.3 61.59 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.066 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -41.17 -61.94 1.19 Allowed Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 123.022 0.201 . . . . 1.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.97 -24.81 67.01 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.06 1.84 . . . . 1.0 112.718 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -79.06 -55.75 4.89 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.108 0.48 . . . . 1.0 111.56 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.461 ' O ' ' OG1' ' A' ' 81' ' ' THR . 2.3 pp -65.23 -39.01 84.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.044 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -49.11 -29.42 5.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.906 0.384 . . . . 1.0 110.606 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -70.69 -25.95 63.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.615 -0.266 . . . . 1.0 111.307 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.483 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 81.9 p -60.62 -48.78 80.25 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.916 0.389 . . . . 1.0 111.921 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -35.65 58.29 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.221 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.85 69.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.396 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.49 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -141.18 131.33 24.81 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.61 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -57.32 119.87 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.87 0.843 . . . . 1.0 111.553 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.01 -48.74 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.519 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.56 179.12 7.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.45 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 pt -131.05 125.4 57.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.253 -0.885 . . . . 1.0 110.421 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.8 t -89.0 110.35 21.06 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -86.84 99.56 11.91 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -84.63 159.66 57.79 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.678 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.41 31.17 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.632 2.221 . . . . 1.0 111.846 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 9' ' ' THR . 12.1 m120 -93.49 -165.94 1.42 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -108.57 -56.18 2.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.991 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 69' ' ' ALA . 2.6 m-20 -129.22 10.46 5.8 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.359 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.5 m -109.29 130.77 55.48 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.492 ' SD ' ' CE2' ' A' ' 71' ' ' TRP . 10.5 ptp -150.85 153.57 35.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -102.65 134.31 46.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.644 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.4 t -109.44 110.39 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.546 -0.539 . . . . 1.0 109.546 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m -90.38 134.42 34.34 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.462 -0.569 . . . . 1.0 109.462 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.8 pt? -167.38 151.92 6.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.453 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 m -84.09 84.06 7.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.937 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -93.55 155.73 40.41 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.25 141.21 81.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.19 1.927 . . . . 1.0 111.27 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HE ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -97.67 8.28 44.94 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.52 -0.763 . . . . 1.0 109.742 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -52.96 -49.6 65.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.61 -0.436 . . . . 1.0 110.304 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -127.26 60.13 1.4 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.628 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.36 50.77 0.17 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.299 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.6 t -84.72 152.45 23.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 54.3 p90 -102.09 129.95 48.56 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.158 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 m -166.26 136.3 3.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.889 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.97 116.53 29.36 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.406 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -141.35 160.68 39.62 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.578 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -171.32 116.61 0.43 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.037 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 170.62 130.94 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.978 -0.379 . . . . 1.0 109.978 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.09 117.48 20.94 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.928 0.394 . . . . 1.0 110.039 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -147.17 150.85 35.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.319 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -68.93 141.77 54.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.691 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 -8.53 76.26 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 110.821 -0.911 . . . . 1.0 110.821 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -99.09 147.52 33.36 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 121.119 -0.232 . . . . 1.0 111.018 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.26 127.47 2.99 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.214 1.943 . . . . 1.0 112.728 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.44 -24.79 63.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.291 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 37.4 m-85 -65.3 -12.99 57.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.945 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -110.68 -37.86 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.977 0.418 . . . . 1.0 110.24 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -63.68 -39.14 93.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.153 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -61.32 -35.57 77.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.053 0.454 . . . . 1.0 110.899 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 9.8 mp -66.9 -37.41 84.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.829 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -66.3 -21.27 66.26 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.259 -0.576 . . . . 1.0 111.095 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -70.4 -4.5 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.602 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -117.95 134.29 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 110.08 -0.341 . . . . 1.0 110.08 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -72.63 133.39 44.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.965 -0.561 . . . . 1.0 109.794 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 139.07 -46.5 0.96 Allowed Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.23 134.81 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -118.95 -30.91 4.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.196 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.1 p -160.99 154.05 21.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.892 0.377 . . . . 1.0 110.023 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.1 mt -134.83 125.21 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.149 -0.685 . . . . 1.0 109.149 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.86 130.1 48.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 1.0 110.442 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -119.87 118.07 29.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.825 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.93 143.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.457 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.448 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.4 OUTLIER 62.35 -150.05 0.37 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.853 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.448 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 86.6 m-20 -97.35 16.82 18.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -141.99 157.13 45.3 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.9 pt -134.25 154.0 36.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.229 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -125.79 123.21 38.27 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.42 127.39 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.202 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -103.37 120.21 40.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.08 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HZ1' ' CD2' ' A' ' 74' ' ' LEU . 63.4 mttt -135.81 148.34 48.68 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.613 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 96.8 mt-10 -58.98 172.48 0.55 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.525 -0.761 . . . . 1.0 109.927 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.39 -13.67 61.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.29 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -90.84 12.23 20.04 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.628 -0.26 . . . . 1.0 111.009 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -100.96 147.8 25.75 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' ND2' ' CG ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -138.43 120.72 15.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.492 ' CE2' ' SD ' ' A' ' 15' ' ' MET . 95.9 m95 -64.81 -17.05 63.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.715 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -59.64 -20.83 58.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.874 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' CG ' ' ND2' ' A' ' 70' ' ' ASN . 81.0 mm-40 -98.0 -30.36 12.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.819 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.572 ' CD2' ' HZ1' ' A' ' 65' ' ' LYS . 9.3 mp -71.28 -38.83 71.8 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.473 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.8 mp -39.4 -63.16 0.68 Allowed Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 123.368 0.418 . . . . 1.0 110.735 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.95 -22.38 68.47 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.492 1.461 . . . . 1.0 111.927 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -75.43 -54.74 6.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.83 0.348 . . . . 1.0 111.415 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.7 pt -72.8 -40.82 61.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -51.17 -30.18 16.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.138 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -63.78 -41.07 98.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.16 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -62.2 -50.78 70.42 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.705 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 78.4 m-85 -67.96 -41.53 82.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.778 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.74 69.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.266 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -62.21 -62.11 2.0 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.035 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.0 p -58.79 -46.24 88.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.357 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.93 -1.033 . . . . 1.0 110.357 179.86 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.0 mmm . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.46 141.39 22.9 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.785 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 98.0 mt -58.68 120.01 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.161 0.505 . . . . 1.0 111.147 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.21 -45.83 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.887 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.68 179.08 4.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.94 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.2 mt -130.05 128.5 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.871 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.9 t -95.14 113.08 24.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.867 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.55 100.95 10.43 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.877 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -83.58 159.18 61.73 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.789 -0.641 . . . . 1.0 109.975 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.62 29.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.579 2.186 . . . . 1.0 111.861 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 9' ' ' THR . 9.2 m120 -96.72 -168.7 1.76 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -110.5 -60.13 1.85 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.482 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -116.82 5.1 13.0 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.298 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.8 m -107.53 127.53 53.7 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.2 mtt -142.32 150.5 40.88 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -106.11 131.0 53.9 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.738 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 t -107.39 113.74 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.0 m -92.09 128.38 37.92 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.811 -0.441 . . . . 1.0 109.811 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.493 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.7 pt? -162.08 150.09 14.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.618 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.1 t -87.25 78.76 8.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.819 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -77.27 156.24 81.64 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.164 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.44 141.55 81.39 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.38 2.053 . . . . 1.0 111.364 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.488 ' HE ' ' N ' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -92.94 12.64 23.16 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -57.27 -51.11 70.66 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.273 -0.571 . . . . 1.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 27' ' ' SER . 93.9 m-20 -138.93 60.76 1.59 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.609 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -71.99 45.72 0.12 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.495 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.541 ' HG ' ' N ' ' A' ' 28' ' ' PHE . 46.0 t -83.15 166.39 18.7 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.541 ' N ' ' HG ' ' A' ' 27' ' ' SER . 51.8 p90 -101.75 131.5 48.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.8 m -159.55 112.3 2.17 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.0 m -94.76 123.82 38.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.841 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.71 170.59 15.48 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.183 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.16 113.01 0.38 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.384 -0.826 . . . . 1.0 110.342 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 167.15 133.96 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.174 -0.306 . . . . 1.0 110.174 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.19 113.11 19.8 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.873 0.368 . . . . 1.0 110.205 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -146.04 149.63 34.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.345 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.35 138.54 53.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.824 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.31 -13.94 62.29 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -91.4 151.39 42.67 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 121.016 -0.274 . . . . 1.0 110.923 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -38.9 117.69 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.644 2.23 . . . . 1.0 112.708 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.2 mp0 -63.95 -23.33 67.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.939 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.458 ' CG ' ' O ' ' A' ' 41' ' ' PHE . 36.9 t80 -69.04 -8.57 46.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.758 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.64 -41.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -63.33 -40.17 96.57 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.254 -0.578 . . . . 1.0 111.122 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.42 ' CD ' ' OG1' ' A' ' 81' ' ' THR . 92.7 mtt-85 -61.11 -32.92 72.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.615 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 7.9 mp -65.56 -39.24 91.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.749 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -68.27 -20.23 64.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.065 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -59.7 -23.84 63.46 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.093 -0.243 . . . . 1.0 111.646 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.98 141.69 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 110.105 -0.332 . . . . 1.0 110.105 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.34 138.29 56.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.784 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.1 -55.7 0.57 Allowed Glycine 0 N--CA 1.465 0.6 0 N-CA-C 111.382 -0.687 . . . . 1.0 111.382 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.3 p -61.26 126.58 19.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.785 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -106.02 -30.1 9.51 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -167.03 161.29 14.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.468 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.56 131.85 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 116.135 -0.484 . . . . 1.0 109.709 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.42 121.98 46.65 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -122.13 112.32 18.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.716 -0.674 . . . . 1.0 109.47 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 60' ' ' PHE . 11.5 p -164.99 149.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.217 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.26 -156.27 0.28 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.006 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 19' ' ' LEU . 6.2 p30 -93.49 12.49 24.89 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.691 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' A' ' 57' ' ' VAL . 39.1 p90 -139.66 149.6 43.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 pt -132.22 157.58 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.454 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.3 t -134.26 122.92 23.42 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.584 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 63' ' ' ILE . 21.7 mm -104.85 128.46 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.045 0.45 . . . . 1.0 109.91 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -96.7 111.41 23.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.903 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -122.33 144.71 48.84 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.595 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' OE1' ' ND2' ' A' ' 68' ' ' ASN . 71.2 tt0 -58.88 165.61 2.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.024 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 68' ' ' ASN . 34.5 p30 -69.8 -19.93 63.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.214 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 42.3 p30 -89.67 15.67 9.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.627 -0.26 . . . . 1.0 111.206 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.44 162.6 18.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.897 0.379 . . . . 1.0 110.128 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.425 ' N ' ' ND2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -145.98 132.89 20.16 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.688 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -62.04 -17.69 58.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.334 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -56.78 -30.34 63.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.616 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -83.76 -38.5 21.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.784 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.51 ' CD1' ' N ' ' A' ' 74' ' ' LEU . 7.2 mp -71.76 -40.31 69.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 121.1 -0.24 . . . . 1.0 111.417 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.415 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 1.9 mt -40.23 -63.22 0.75 Allowed Pre-proline 0 N--CA 1.467 0.382 0 O-C-N 123.477 0.486 . . . . 1.0 111.088 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 47.7 Cg_endo -63.35 -25.39 71.31 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.513 1.475 . . . . 1.0 111.953 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -78.18 -56.05 4.77 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.055 0.455 . . . . 1.0 111.967 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 79' ' ' GLU . 2.2 pp -69.08 -43.62 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.742 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.402 ' H ' HG13 ' A' ' 78' ' ' ILE . 6.9 tm-20 -50.25 -36.46 31.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.862 0.363 . . . . 1.0 110.35 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -66.77 -28.83 68.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.097 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.42 ' OG1' ' CD ' ' A' ' 44' ' ' ARG . 5.3 m -60.9 -47.14 87.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.785 0.326 . . . . 1.0 110.825 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -68.33 -37.2 80.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.661 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.81 -41.76 82.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.534 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.01 -15.71 56.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 1.0 110.69 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.0 p -85.55 40.29 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.429 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.4 p30 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.964 -1.017 . . . . 1.0 110.569 179.848 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 4' ' ' ILE . 76.9 mt-10 -119.16 115.88 25.17 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 116.603 -0.272 . . . . 1.0 110.906 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.57 127.82 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.593 0.711 . . . . 1.0 111.882 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 2' ' ' GLU . 1.2 mp -90.82 -43.57 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 114.679 -1.146 . . . . 1.0 109.398 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.86 168.81 7.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.394 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.59 128.71 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.542 -0.754 . . . . 1.0 109.284 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 m -105.75 107.59 18.67 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.94 116.23 19.96 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.447 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -90.94 176.08 3.15 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.37 14.34 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.824 1.682 . . . . 1.0 112.019 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 9' ' ' THR . 18.9 m120 -95.82 -179.81 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.847 0.356 . . . . 1.0 110.608 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.449 ' O ' ' CZ2' ' A' ' 71' ' ' TRP . 78.1 t60 -110.15 -58.9 2.01 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.584 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 56.0 p30 -101.03 7.59 43.36 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.745 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -116.37 130.08 56.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -140.53 151.69 44.97 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.075 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -109.56 134.08 52.34 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.67 117.29 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.7 t -92.13 127.77 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.599 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.478 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.4 pt? -169.88 158.64 7.42 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 120.831 0.348 . . . . 1.0 111.104 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.5 t -96.01 95.24 8.06 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.633 0.254 . . . . 1.0 110.371 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 21.0 pt-20 -126.61 46.13 1.81 Allowed Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.888 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 73.6 Cg_endo -68.31 155.54 68.92 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.207 1.938 . . . . 1.0 111.683 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -151.76 -156.22 0.69 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.081 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.494 ' CD ' ' H ' ' A' ' 24' ' ' GLN . 27.8 mp0 -46.86 -72.73 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.857 0.36 . . . . 1.0 111.152 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' A' ' 27' ' ' SER . 80.0 m-20 -142.8 57.6 1.42 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.209 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 52.71 -72.48 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.721 0.296 . . . . 1.0 111.61 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.623 ' N ' ' O ' ' A' ' 25' ' ' ASP . 2.6 t 67.03 109.84 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.144 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.48 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 53.6 p90 -99.2 127.93 45.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.299 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.402 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 25.5 m -165.4 108.46 0.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.58 124.94 28.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.217 0.532 . . . . 1.0 110.7 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.416 ' OH ' ' CB ' ' A' ' 56' ' ' TYR . 1.2 p90 -139.86 163.83 31.61 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.337 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.16 116.34 0.73 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.189 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 171.3 133.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.467 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.68 120.39 26.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.104 0.478 . . . . 1.0 110.268 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -168.16 168.59 11.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.763 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -78.02 142.1 38.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.031 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.64 -27.05 19.28 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.703 -0.559 . . . . 1.0 111.703 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -90.89 147.94 37.06 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 117.163 0.482 . . . . 1.0 110.342 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -44.58 128.8 8.68 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.717 1.611 . . . . 1.0 113.317 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.81 -23.22 66.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.354 -0.839 . . . . 1.0 110.362 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -61.71 -48.53 80.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.114 0.483 . . . . 1.0 110.39 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.98 -40.38 80.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.782 -0.644 . . . . 1.0 110.52 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -58.48 -37.03 74.68 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.917 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -63.43 -40.13 96.34 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.321 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.504 ' C ' ' H ' ' A' ' 47' ' ' GLU . 18.4 mt -61.84 -41.32 97.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.723 -0.217 . . . . 1.0 111.239 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 71.1 t80 -72.05 13.12 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.895 0.378 . . . . 1.0 111.012 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' H ' ' C ' ' A' ' 45' ' ' LEU . 77.0 tt0 -89.76 -22.34 22.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.448 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.582 ' CG2' HE22 ' A' ' 77' ' ' GLN . 2.2 pp -121.77 141.25 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.09 0.471 . . . . 1.0 111.067 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.1 145.42 55.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.657 -0.702 . . . . 1.0 111.029 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.68 -32.78 3.95 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 111.588 -0.605 . . . . 1.0 111.588 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.4 t -63.75 113.57 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 120.19 -0.604 . . . . 1.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -87.51 -47.38 8.78 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.821 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p -164.42 167.06 20.04 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.074 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -133.36 151.11 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.568 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.63 130.42 52.64 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.347 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 39.4 t80 -123.22 112.81 18.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.63 149.83 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.711 0.291 . . . . 1.0 110.368 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.5 OUTLIER 59.2 -148.85 0.46 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.793 0.33 . . . . 1.0 110.619 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' LEU . 38.2 p30 -100.11 15.58 26.93 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.673 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -141.32 156.49 45.84 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 pt -132.59 154.09 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.399 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.4 m -126.96 124.39 39.36 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 2.2 mp -106.76 118.26 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -104.81 112.34 25.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.719 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.481 ' NZ ' ' CD1' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -125.21 157.78 35.65 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -58.29 169.89 0.79 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.99 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.448 ' OD1' ' ND2' ' A' ' 13' ' ' ASN . 88.4 m-20 -70.17 -17.01 63.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.115 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -84.38 5.78 25.77 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.784 0.326 . . . . 1.0 110.677 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.21 151.16 19.76 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.252 0.549 . . . . 1.0 109.833 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.481 HD21 ' N ' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -136.26 123.15 21.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.115 -0.948 . . . . 1.0 110.226 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.481 ' CD1' ' NZ ' ' A' ' 65' ' ' LYS . 13.6 m0 -61.29 -23.97 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.608 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.455 ' H ' ' ND2' ' A' ' 70' ' ' ASN . 5.7 m120 -56.37 -33.31 65.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.163 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -77.97 -38.33 45.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.843 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 74' ' ' LEU . 7.0 mp -67.72 -38.39 83.52 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.746 -0.206 . . . . 1.0 111.0 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mp -41.79 -64.6 0.63 Allowed Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.319 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -61.42 -25.44 79.96 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.095 1.863 . . . . 1.0 112.44 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.582 HE22 ' CG2' ' A' ' 48' ' ' ILE . 86.6 mt-30 -76.96 -54.28 6.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.98 0.419 . . . . 1.0 111.477 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 pt -68.78 -43.05 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.007 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.97 -32.26 61.41 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.308 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.93 -41.16 97.71 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.368 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.0 m -64.29 -49.95 69.79 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.188 0.518 . . . . 1.0 110.43 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -63.29 -47.48 82.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.474 -0.784 . . . . 1.0 110.189 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.55 68.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.535 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -65.38 -55.45 18.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.466 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -58.29 -43.83 88.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.323 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.0 t30 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.373 179.697 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ptt? . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.94 139.44 26.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.424 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.6 pt -48.05 155.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.56 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -130.93 -46.06 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 123.576 0.547 . . . . 1.0 111.041 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.71 153.24 5.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.66 118.57 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.174 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -95.91 113.16 24.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.433 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.13 117.73 21.2 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.068 -0.715 . . . . 1.0 109.068 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -91.59 176.32 2.87 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.198 -178.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.99 12.53 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.336 2.024 . . . . 1.0 111.933 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 9' ' ' THR . 86.7 m-20 -98.39 -179.68 4.43 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -112.05 -61.42 1.72 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.842 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.549 HD21 ' N ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -92.55 1.4 57.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.361 -179.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.549 ' N ' HD21 ' A' ' 13' ' ' ASN . 27.3 m -116.1 128.54 55.76 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.8 mmt -135.06 145.67 48.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.844 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -95.75 128.38 42.57 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.53 105.92 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.6 m -90.52 132.6 35.6 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.7 pt? -162.78 153.6 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.446 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -77.51 100.3 6.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.813 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -146.29 69.88 12.87 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.414 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 23' ' ' ARG . 29.3 Cg_exo -60.9 -72.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.277 1.984 . . . . 1.0 111.597 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.542 ' C ' ' H ' ' A' ' 25' ' ' ASP . 85.1 mtp180 47.46 105.66 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 O-C-N 123.539 0.524 . . . . 1.0 111.09 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -57.52 -2.32 0.12 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.947 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 23' ' ' ARG . 8.9 p-10 -116.77 35.73 4.47 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.968 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 27' ' ' SER . 8.7 p30 -42.24 -56.41 2.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.672 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 26' ' ' ASN . 27.4 t 55.1 123.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 O-C-N 123.85 0.719 . . . . 1.0 110.238 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 51.2 p90 -99.57 127.92 45.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.359 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.3 m -166.32 145.38 5.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.25 117.13 33.81 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.743 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -141.2 172.13 13.11 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.526 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.11 114.94 0.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.049 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 169.78 135.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.678 0.275 . . . . 1.0 110.352 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.89 129.08 34.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.245 0.545 . . . . 1.0 110.2 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -164.46 162.82 22.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.798 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -83.22 143.64 30.31 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.395 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.07 -28.38 15.93 Favored Glycine 0 N--CA 1.465 0.629 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -94.68 146.79 32.07 Favored Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.94 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -41.76 130.99 4.08 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.125 1.883 . . . . 1.0 112.727 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 42' ' ' ILE . 81.2 mm-40 -64.9 -25.83 68.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.203 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -57.8 -1.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.158 -0.217 . . . . 1.0 111.582 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.486 ' H ' ' C ' ' A' ' 40' ' ' GLU . 38.2 mm -114.57 -34.5 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.076 0.465 . . . . 1.0 110.747 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -63.12 -39.97 96.23 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.306 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -44.44 87.99 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 47' ' ' GLU . 10.1 mp -63.16 -40.89 98.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.988 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 81.4 t80 -78.11 12.37 1.87 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.996 0.427 . . . . 1.0 110.243 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' LEU . 38.2 tp10 -88.52 -29.76 19.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.897 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.72 140.58 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.427 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -67.42 142.09 56.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.748 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 137.04 -39.98 1.56 Allowed Glycine 0 N--CA 1.464 0.505 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.66 124.31 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.02 0.438 . . . . 1.0 110.935 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -94.71 -43.24 8.35 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.0 p -158.89 156.81 30.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.843 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.1 mt -129.15 123.38 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.136 -0.691 . . . . 1.0 109.136 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 47.0 m-85 -101.63 138.99 37.9 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.075 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -126.8 112.71 15.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.114 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' PHE . 10.1 p -165.94 155.39 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.646 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mt 54.75 -163.18 0.13 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.581 0.705 . . . . 1.0 111.127 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -87.62 13.07 11.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.047 -0.979 . . . . 1.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 57' ' ' VAL . 44.1 p90 -148.44 157.62 43.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.97 0.414 . . . . 1.0 110.004 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.7 pt -133.9 164.84 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.3 p -135.01 134.28 40.29 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.493 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.64 131.1 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.892 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -100.25 103.02 14.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.277 -0.874 . . . . 1.0 110.261 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.577 ' HZ1' ' CD2' ' A' ' 74' ' ' LEU . 16.3 mtpt -110.99 142.23 43.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.742 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -63.9 173.11 1.94 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.101 0.477 . . . . 1.0 110.106 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -70.2 -14.06 62.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.902 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -89.49 9.5 26.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.416 0.151 . . . . 1.0 110.597 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.47 150.65 23.16 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.505 ' CG ' HD22 ' A' ' 72' ' ' ASN . 0.1 OUTLIER -143.85 127.13 16.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.257 0.551 . . . . 1.0 109.566 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -64.44 -19.64 65.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.798 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.613 HD21 ' H ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -54.13 -19.77 5.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.95 0.405 . . . . 1.0 110.93 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.613 ' H ' HD21 ' A' ' 72' ' ' ASN . 54.8 mm-40 -95.83 -33.38 12.26 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.322 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.577 ' CD2' ' HZ1' ' A' ' 65' ' ' LYS . 9.3 mp -68.95 -42.07 77.15 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 120.519 -0.472 . . . . 1.0 111.334 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 mp -44.61 -61.65 2.04 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 120.905 0.383 . . . . 1.0 110.855 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.88 -28.34 42.73 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.398 1.399 . . . . 1.0 111.95 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -75.89 -51.45 12.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.493 0.663 . . . . 1.0 112.344 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.42 -40.32 88.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.191 -0.913 . . . . 1.0 110.764 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.95 -27.84 5.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.166 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -62.33 -45.81 91.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.742 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -64.8 -51.91 59.64 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.293 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -59.7 -48.33 82.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.207 0.527 . . . . 1.0 109.839 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.49 93.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.558 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -70.63 -7.69 46.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.531 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 p -60.73 -44.6 96.44 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.382 -0.527 . . . . 1.0 110.656 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.755 -179.819 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 20' ' ' SER . 89.0 mmm . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 49.3 mp0 -122.81 116.75 24.22 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.442 0.464 . . . . 1.0 110.374 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 89.9 mt -47.26 156.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 1.0 109.693 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -129.19 -39.31 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.87 -0.605 . . . . 1.0 111.178 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.71 153.47 2.75 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.356 0.41 . . . . 1.0 110.093 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.7 mt -109.68 119.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 p -94.98 110.9 22.75 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.124 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 55.1 mp0 -83.34 108.72 16.73 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.341 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.554 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -87.27 157.49 53.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.134 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.86 23.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.571 2.181 . . . . 1.0 112.074 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.554 ' H ' ' C ' ' A' ' 9' ' ' THR . 96.4 m-20 -88.75 -168.56 2.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -110.71 -71.14 0.77 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.231 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 16.8 p30 -106.72 11.16 30.59 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.065 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.1 m -115.0 131.59 56.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' ' CD2' ' A' ' 71' ' ' TRP . 11.6 ptt? -142.33 149.35 39.34 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.119 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -105.32 131.39 52.82 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.019 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -108.87 111.3 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -90.69 128.84 36.78 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.4 pt? -170.47 162.47 8.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.87 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 1' ' ' MET . 77.9 p -80.14 109.14 14.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.556 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 4.8 mm-40 -136.56 54.71 9.62 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.383 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 41.0 Cg_endo -66.62 144.36 72.04 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 C-N-CA 122.14 1.893 . . . . 1.0 111.486 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.449 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 66.1 ttt180 -156.52 146.54 21.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.442 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.11 -2.64 16.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.48 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -142.0 59.26 1.48 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.685 0.279 . . . . 1.0 110.56 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 23' ' ' ARG . 56.4 m-80 -59.71 -86.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.283 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.9 t 45.09 -163.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.165 -0.309 . . . . 1.0 110.165 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -104.55 139.31 39.61 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.121 0.486 . . . . 1.0 110.461 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.3 m -165.25 107.24 0.8 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.23 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -105.41 131.64 52.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.348 0.594 . . . . 1.0 111.262 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.463 ' HH ' ' CB ' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -141.8 170.58 15.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.289 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.59 113.15 0.71 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.406 -0.816 . . . . 1.0 110.64 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 167.72 126.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.674 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.76 126.13 32.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.216 0.531 . . . . 1.0 110.371 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -167.41 170.29 11.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.68 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.87 142.98 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.581 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.99 -26.84 21.79 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -94.36 147.93 34.16 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 121.09 -0.244 . . . . 1.0 110.696 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -40.65 121.29 1.15 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.646 2.231 . . . . 1.0 112.505 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.99 -24.96 66.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.358 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -62.01 -18.45 60.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.624 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.1 mm -102.33 -33.1 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 123.321 0.388 . . . . 1.0 110.655 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -63.38 -38.34 90.76 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.207 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -60.06 -33.03 71.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.071 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 47' ' ' GLU . 9.4 mp -63.46 -38.77 92.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.667 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 70.0 t80 -76.3 14.89 0.66 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.989 0.424 . . . . 1.0 110.501 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 45' ' ' LEU . 82.1 tt0 -90.77 -23.66 20.58 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.689 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.627 ' CG2' HE22 ' A' ' 77' ' ' GLN . 1.9 pp -121.4 142.26 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.047 0.451 . . . . 1.0 110.544 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.46 143.95 54.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.344 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.77 -43.81 1.26 Allowed Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.246 -0.742 . . . . 1.0 111.246 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.1 m -54.86 115.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.454 0.645 . . . . 1.0 111.274 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -88.47 -42.76 11.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.3 p -170.2 168.94 8.04 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.288 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.41 137.71 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.07 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -110.64 136.27 49.99 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.423 0.452 . . . . 1.0 109.896 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.463 ' CB ' ' HH ' ' A' ' 31' ' ' TYR . 71.9 t80 -124.11 118.74 27.6 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.382 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -165.76 141.3 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.42 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.493 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.4 OUTLIER 64.05 -149.58 0.3 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.948 178.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.493 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 55.9 p-10 -97.68 18.56 15.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.785 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 28.9 p90 -141.58 156.82 45.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.5 pt -132.79 144.47 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.283 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 t -111.07 124.31 51.92 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.1 mt -112.2 125.58 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -116.5 133.27 56.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.215 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -144.19 156.12 44.18 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.558 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -51.27 162.83 0.29 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.688 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.496 ' OD1' ' ND2' ' A' ' 13' ' ' ASN . 92.3 m-20 -69.99 -14.26 62.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.76 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -88.27 9.98 21.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.775 -0.193 . . . . 1.0 110.598 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.92 164.92 11.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.325 0.583 . . . . 1.0 109.815 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.52 ' CG ' HD22 ' A' ' 72' ' ' ASN . 0.1 OUTLIER -150.04 134.01 16.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.477 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.461 ' CD2' ' SD ' ' A' ' 15' ' ' MET . 3.9 m0 -68.22 -18.09 64.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.256 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.642 HD21 ' H ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -57.78 -20.47 35.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.978 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.642 ' H ' HD21 ' A' ' 72' ' ' ASN . 80.7 mt-10 -95.24 -29.03 14.72 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.236 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 74' ' ' LEU . 8.8 mp -74.75 -39.41 61.85 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.976 -0.29 . . . . 1.0 111.298 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.417 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 2.2 mt -40.87 -62.35 1.02 Allowed Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 123.444 0.465 . . . . 1.0 111.917 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 36.8 Cg_endo -61.24 -27.84 84.1 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.878 1.718 . . . . 1.0 112.267 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.627 HE22 ' CG2' ' A' ' 48' ' ' ILE . 86.5 mt-30 -75.62 -49.97 16.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.288 0.566 . . . . 1.0 111.444 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 pt -70.28 -42.92 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.586 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -53.19 -35.13 59.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.263 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -63.47 -39.44 94.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.035 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.8 m -62.04 -48.08 81.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.013 0.435 . . . . 1.0 110.222 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.93 -44.59 80.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.987 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -45.17 -33.85 2.46 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.524 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 86' ' ' ASN . 9.3 mtpm? -67.04 -51.73 51.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.46 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.0 m -76.67 34.46 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.404 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 84' ' ' LYS . 24.6 m120 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.628 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.9 mtt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 82' ' ' PHE . 38.6 tp10 -109.49 106.55 16.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.053 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.7 mt -49.09 142.6 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.929 0.395 . . . . 1.0 110.421 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -120.05 -34.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.343 -0.844 . . . . 1.0 110.639 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.02 178.1 3.05 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.078 0.466 . . . . 1.0 110.177 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.1 pt -143.23 136.73 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.576 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.2 m -116.09 111.88 20.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.838 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.437 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 39.2 mp0 -84.16 113.87 21.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -82.88 177.18 3.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.304 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.86 21.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.216 1.944 . . . . 1.0 112.296 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.532 ' H ' ' C ' ' A' ' 9' ' ' THR . 94.3 m-20 -103.5 -178.25 3.61 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.55 -55.26 2.54 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.794 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -100.94 3.83 42.03 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.284 -178.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -116.22 131.36 56.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.6 mtt -146.23 153.54 40.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.816 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -106.8 135.99 47.4 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.805 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.46 120.68 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.748 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.2 t -96.06 127.57 42.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.327 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -164.33 154.42 14.44 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.419 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -92.71 99.07 11.83 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' N ' ' OE2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -82.91 151.39 63.86 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.281 -0.418 . . . . 1.0 109.999 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.74 -18.83 32.1 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.535 2.156 . . . . 1.0 112.038 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -67.48 91.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.963 0.411 . . . . 1.0 110.961 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -88.44 26.54 1.43 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.165 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -128.3 8.33 6.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.665 -0.243 . . . . 1.0 110.438 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 38.06 80.81 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.485 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.2 t -103.64 126.3 50.7 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.078 -0.341 . . . . 1.0 110.078 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 54.1 p90 -99.08 132.94 44.02 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 m -166.95 107.01 0.62 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.618 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.8 m -81.11 120.78 25.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.358 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -141.65 164.72 29.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.671 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.407 ' O ' ' CG2' ' A' ' 32' ' ' THR . 9.7 t -168.97 113.89 0.57 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.253 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 167.93 132.68 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.51 -0.313 . . . . 1.0 110.357 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.439 ' O ' ' NE2' ' A' ' 35' ' ' GLN . . . -81.29 122.69 27.75 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 1.0 110.068 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 34' ' ' ALA . 99.1 mm-40 -143.34 155.7 44.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.317 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.71 142.38 46.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.837 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.67 -3.55 55.0 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -98.71 155.61 36.52 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 122.889 -0.183 . . . . 1.0 110.583 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -36.34 109.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.866 2.378 . . . . 1.0 112.453 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.62 -36.59 74.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.936 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -55.83 -51.7 66.57 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.641 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.09 -41.22 91.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.957 0.408 . . . . 1.0 110.364 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -59.86 -38.92 83.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.01 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -61.02 -39.52 90.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.869 0.366 . . . . 1.0 110.421 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.63 -41.8 98.23 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.996 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -65.07 -29.09 69.95 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.911 -0.715 . . . . 1.0 111.14 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.79 -10.08 59.24 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.097 -0.241 . . . . 1.0 111.347 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -105.89 134.55 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.844 0.355 . . . . 1.0 110.301 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -73.26 128.84 36.63 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.32 -37.78 1.88 Allowed Glycine 0 N--CA 1.461 0.357 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.74 128.39 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.581 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.473 ' NZ ' ' OD1' ' A' ' 64' ' ' ASP . 27.7 mtmm -99.87 -40.8 7.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.421 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.6 m -165.71 171.19 13.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.362 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.4 137.35 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.04 -0.527 . . . . 1.0 109.998 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -111.46 133.4 53.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.698 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -122.88 108.16 12.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.221 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 60' ' ' PHE . 11.1 p -164.43 147.51 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.104 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 64.68 -160.54 0.29 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.897 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 19' ' ' LEU . 81.7 m-20 -89.3 15.03 9.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 57' ' ' VAL . 40.9 p90 -147.88 158.98 44.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.442 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 pt -129.44 152.19 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.411 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.0 m -113.91 118.96 35.65 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.9 mt -104.88 114.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.076 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.473 ' OD1' ' NZ ' ' A' ' 52' ' ' LYS . 60.2 t0 -98.04 126.24 43.38 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.419 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.418 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 4.8 mtmp? -139.15 143.91 38.38 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.45 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -55.71 167.66 0.52 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.351 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 68' ' ' ASN . 50.5 p-10 -68.62 -23.79 64.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.827 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 2.0 p-10 -77.93 -7.2 56.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.785 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.04 142.49 41.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.9 119.95 28.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.297 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -60.28 -28.81 68.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.739 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -57.53 -16.61 10.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.572 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -97.92 -34.63 10.76 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.33 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mp -74.27 -39.83 62.73 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.33 -0.231 . . . . 1.0 110.948 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 mp -41.92 -62.55 1.11 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.025 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.56 -27.5 84.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.768 1.645 . . . . 1.0 112.124 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.56 -53.72 7.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.985 0.421 . . . . 1.0 111.491 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 pt -70.6 -44.1 77.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.031 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -52.07 -32.81 36.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.327 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -64.54 -39.43 93.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.227 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.5 m -62.99 -50.49 70.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.899 0.381 . . . . 1.0 110.71 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.448 ' CE1' ' OE2' ' A' ' 2' ' ' GLU . 3.0 t80 -62.06 -48.56 79.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.011 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.88 97.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.793 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -78.35 5.0 11.47 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.92 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m -57.26 -41.83 80.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.477 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.691 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -157.5 149.81 22.68 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.605 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 tt -50.86 118.47 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.495 0.664 . . . . 1.0 111.082 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mm -92.25 -48.33 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.2 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.91 178.76 9.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.213 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 tt -132.49 135.64 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.264 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 t -100.61 111.26 23.47 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.047 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.29 110.45 16.76 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -87.32 177.63 2.64 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 -178.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.25 7.95 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.988 1.792 . . . . 1.0 112.229 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' THR . 22.6 m120 -93.25 171.69 8.76 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.421 ' O ' ' CZ2' ' A' ' 71' ' ' TRP . 80.0 m80 -111.59 -38.29 4.95 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.169 -0.468 . . . . 1.0 111.352 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -110.42 -2.33 16.64 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.795 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -113.81 130.87 56.41 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.472 ' SD ' ' CG ' ' A' ' 71' ' ' TRP . 11.7 ptt? -142.74 151.81 41.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 1.0 109.767 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -113.89 138.34 50.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.947 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.8 t -100.44 127.6 53.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 t -104.22 132.32 50.6 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.453 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.8 pt? -169.64 158.04 7.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.91 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -102.75 86.19 2.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -98.22 146.16 31.05 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.37 86.14 0.83 Allowed 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.144 1.896 . . . . 1.0 111.924 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.565 ' HE ' ' HH ' ' A' ' 56' ' ' TYR . 37.6 mmt180 -133.85 89.68 2.61 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.109 0.48 . . . . 1.0 110.341 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -94.91 20.6 8.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.378 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 27' ' ' SER . 94.6 m-20 -129.6 -6.92 4.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.78 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.7 m120 54.7 -84.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.607 -0.27 . . . . 1.0 110.396 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 25' ' ' ASP . 14.4 p 56.77 107.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.985 0.422 . . . . 1.0 110.112 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 51.9 p90 -100.09 127.65 46.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.346 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.8 m -161.42 132.54 5.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.416 ' CB ' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -101.8 120.15 39.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.259 0.552 . . . . 1.0 111.038 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -140.14 133.49 29.9 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.817 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.4 t -138.24 116.44 11.82 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.037 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 170.07 137.63 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.957 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.16 122.37 32.39 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -154.16 154.36 33.42 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.11 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -71.16 128.87 37.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.797 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.51 -19.82 52.5 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.437 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 38.9 mm-40 -82.18 152.0 67.31 Favored Pre-proline 0 CA--C 1.543 0.709 0 O-C-N 122.746 -0.267 . . . . 1.0 110.602 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.17 119.74 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.606 2.204 . . . . 1.0 112.923 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -68.77 -23.32 64.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.539 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.511 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 56.7 m-85 -69.26 -10.2 56.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.961 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.07 -33.71 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 123.3 0.375 . . . . 1.0 110.312 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 38' ' ' GLN . 67.3 m-20 -63.18 -39.87 95.89 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.211 -0.595 . . . . 1.0 110.71 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.454 ' NH1' ' OG1' ' A' ' 81' ' ' THR . 25.0 mmt85 -64.51 -34.67 78.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.49 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 8.7 mp -63.21 -41.05 99.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.005 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -69.8 -5.2 23.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.861 -0.336 . . . . 1.0 111.034 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' OE1' ' NE2' ' A' ' 77' ' ' GLN . 82.2 tt0 -68.12 -24.3 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.634 -0.257 . . . . 1.0 111.364 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.76 142.99 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.899 0.381 . . . . 1.0 110.816 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -67.14 143.85 56.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.847 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.93 -40.42 1.59 Allowed Glycine 0 N--CA 1.465 0.601 0 N-CA-C 111.452 -0.659 . . . . 1.0 111.452 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.11 112.38 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.543 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -82.02 -50.86 8.63 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.042 0.448 . . . . 1.0 110.176 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.8 p -160.96 160.54 30.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 30' ' ' THR . 49.5 mm -121.73 151.57 25.23 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.921 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.37 120.93 20.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.565 ' HH ' ' HE ' ' A' ' 23' ' ' ARG . 53.1 t80 -114.7 118.41 33.55 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.689 -0.485 . . . . 1.0 109.689 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -164.57 148.39 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.413 . . . . 1.0 110.192 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 63.85 -138.94 0.32 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.774 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -110.25 23.79 13.83 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 122.619 0.367 . . . . 1.0 110.865 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -147.42 157.56 43.63 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 mp -126.52 132.84 69.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 1.0 109.844 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t -103.11 123.58 46.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.433 ' CG2' ' NZ ' ' A' ' 65' ' ' LYS . 65.4 mt -112.05 127.52 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.673 -0.492 . . . . 1.0 109.673 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.04 111.72 23.03 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.579 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' NZ ' ' CG2' ' A' ' 63' ' ' ILE . 47.3 mttp -115.78 155.75 27.26 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.388 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 67' ' ' ASP . 7.3 tp10 -67.09 175.25 2.66 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.442 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 90.8 m-20 -70.12 -20.32 63.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.032 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -85.74 3.03 43.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.71 0.291 . . . . 1.0 111.098 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.21 153.36 17.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.423 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.448 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -141.32 121.82 14.13 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.032 0.444 . . . . 1.0 110.362 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.472 ' CG ' ' SD ' ' A' ' 15' ' ' MET . 5.6 m0 -58.16 -26.47 62.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.539 . . . . 1.0 111.266 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -56.48 -36.61 69.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.749 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -74.56 -40.29 61.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.646 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 3.9 mm? -70.7 -38.43 73.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mp -39.55 -62.49 0.82 Allowed Pre-proline 0 CA--C 1.541 0.599 0 O-C-N 123.441 0.463 . . . . 1.0 110.89 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.38 -22.61 59.54 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.783 1.656 . . . . 1.0 112.11 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.47 ' NE2' ' OE1' ' A' ' 47' ' ' GLU . 40.4 tt0 -76.47 -53.47 8.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.975 0.417 . . . . 1.0 111.621 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 pt -71.33 -40.32 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.824 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -50.91 -31.05 16.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.347 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -63.95 -39.67 94.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.326 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.454 ' OG1' ' NH1' ' A' ' 44' ' ' ARG . 21.6 m -60.1 -48.7 80.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.823 0.344 . . . . 1.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.511 ' CZ ' ' CD1' ' A' ' 41' ' ' PHE . 98.0 m-85 -69.51 -37.29 77.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.572 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.28 -43.07 92.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.662 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -62.46 -61.41 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.75 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.8 t -60.12 -45.73 92.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.459 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.696 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 66.7 mtt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.449 -0.574 . . . . 1.0 109.449 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.41 ' H ' ' H3 ' ' A' ' 1' ' ' MET . 7.1 pt-20 -125.78 125.04 42.28 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.417 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 85.0 mt -49.37 155.64 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-O 120.776 0.322 . . . . 1.0 110.267 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.1 mm -127.25 -37.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.434 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -171.65 158.69 5.13 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.127 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.466 ' CG2' ' SD ' ' A' ' 15' ' ' MET . 74.9 mt -104.23 131.83 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 m -114.56 104.85 12.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.105 0.479 . . . . 1.0 110.007 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -76.86 144.78 38.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.085 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -122.71 161.76 42.24 Favored Pre-proline 0 N--CA 1.472 0.655 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.0 21.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.529 2.153 . . . . 1.0 112.215 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.559 ' H ' ' C ' ' A' ' 9' ' ' THR . 14.9 m120 -96.42 -174.23 2.99 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.457 ' O ' ' CH2' ' A' ' 71' ' ' TRP . 59.3 t-80 -110.72 -51.27 2.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.825 0.345 . . . . 1.0 111.652 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.482 HD21 ' N ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -116.22 7.57 14.11 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.875 -0.602 . . . . 1.0 112.103 -178.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.482 ' N ' HD21 ' A' ' 13' ' ' ASN . 24.1 m -111.72 130.06 55.91 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.466 ' SD ' ' CG2' ' A' ' 6' ' ' ILE . 38.8 ttm -139.7 150.9 45.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -107.29 131.4 54.25 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.94 -0.573 . . . . 1.0 109.579 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.7 t -108.61 109.98 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -90.48 133.19 35.22 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.6 pt? -166.05 155.55 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.063 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -88.25 83.79 6.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 23' ' ' ARG . 20.8 pt-20 -107.16 147.36 35.02 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -38.66 86.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 122.456 2.104 . . . . 1.0 112.85 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 21' ' ' GLU . 49.2 ptt85 -78.49 -18.66 54.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.706 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -43.48 -27.41 0.28 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.122 0.487 . . . . 1.0 110.502 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -70.84 -42.59 69.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.432 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 23' ' ' ARG . 11.5 p30 38.82 49.55 1.54 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.765 0.317 . . . . 1.0 111.41 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.5 t -120.02 142.59 48.67 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.21 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 46.2 p90 -102.79 131.21 49.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.217 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.41 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.1 m -160.81 108.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -79.64 117.79 20.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.668 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 29' ' ' THR . 9.5 p90 -142.27 162.38 35.63 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.252 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.34 114.08 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.562 . . . . 1.0 109.972 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 169.29 139.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.296 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.8 120.97 25.35 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.799 -0.445 . . . . 1.0 109.799 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.478 ' OE1' ' NE2' ' A' ' 38' ' ' GLN . 81.9 mt-30 -148.07 146.91 29.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.029 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -70.5 142.75 51.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.828 -0.624 . . . . 1.0 111.122 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.22 -13.03 62.73 Favored Glycine 0 N--CA 1.46 0.286 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.478 ' NE2' ' OE1' ' A' ' 35' ' ' GLN . 75.6 mt-30 -97.3 147.42 32.94 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 122.837 -0.214 . . . . 1.0 110.932 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -41.92 128.06 3.88 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.136 1.891 . . . . 1.0 112.896 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.452 ' OE2' ' NZ ' ' A' ' 84' ' ' LYS . 95.9 mt-10 -66.89 -26.28 66.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.023 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.45 ' CE2' ' O ' ' A' ' 1' ' ' MET . 99.3 m-85 -60.26 -11.98 7.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.903 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -110.32 -39.65 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 110.105 -0.331 . . . . 1.0 110.105 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -66.23 -38.15 87.22 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.863 -0.335 . . . . 1.0 111.281 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -60.23 -34.09 73.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.19 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 8.2 mp -66.02 -36.86 84.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.21 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 75.7 t80 -74.11 13.41 0.55 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.818 0.342 . . . . 1.0 111.193 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 45' ' ' LEU . 80.8 mm-40 -87.51 -20.92 25.84 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.611 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.15 142.2 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 1.3 pm0 -68.71 148.96 49.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.095 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.61 -36.0 3.01 Favored Glycine 0 N--CA 1.468 0.779 0 N-CA-C 111.366 -0.693 . . . . 1.0 111.366 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.82 114.88 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.3 0.571 . . . . 1.0 110.656 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.87 -42.81 8.89 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 p -165.04 161.74 19.96 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.508 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.8 mt -130.98 136.2 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -111.34 129.63 55.94 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.156 -0.474 . . . . 1.0 109.866 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -124.17 118.46 26.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.632 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 p -164.79 146.92 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.997 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 tp 62.4 -131.25 0.57 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.83 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 19' ' ' LEU . 48.3 p-10 -115.25 23.56 12.36 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.156 0.582 . . . . 1.0 110.971 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.35 159.63 43.11 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.7 pt -132.09 149.44 32.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.147 -0.479 . . . . 1.0 109.808 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.2 t -114.96 122.49 46.43 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.31 115.42 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -100.37 114.95 28.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.1 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -125.47 153.12 44.0 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.674 0.273 . . . . 1.0 110.793 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -61.79 167.58 3.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.854 -0.424 . . . . 1.0 109.854 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.08 -18.62 65.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.649 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -85.95 4.5 37.34 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.862 0.363 . . . . 1.0 110.768 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.33 149.54 21.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.281 0.562 . . . . 1.0 110.502 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.564 HD21 ' N ' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -138.31 126.86 23.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.142 -0.935 . . . . 1.0 110.654 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.564 ' N ' HD21 ' A' ' 70' ' ' ASN . 4.5 m-90 -57.72 -27.43 62.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.978 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.417 ' H ' ' ND2' ' A' ' 70' ' ' ASN . 5.7 m120 -55.49 -29.61 59.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.331 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.53 -35.6 30.14 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.132 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.481 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 3.7 mm? -70.51 -38.78 74.34 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 121.078 -0.249 . . . . 1.0 111.601 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mt -39.92 -62.62 0.83 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.165 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -62.74 -24.21 74.64 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.895 1.73 . . . . 1.0 112.315 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -75.95 -54.05 7.47 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.465 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.3 pt -67.5 -41.24 85.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.524 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.32 -28.37 7.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.255 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -58.73 -33.38 70.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.142 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.7 p -64.44 -44.35 91.42 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.139 0.495 . . . . 1.0 110.245 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.13 -36.13 83.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.576 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -46.19 -46.87 17.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.908 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.452 ' NZ ' ' OE2' ' A' ' 40' ' ' GLU . 98.9 mttt -62.66 -49.35 75.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.399 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.1 p -60.12 -51.4 69.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.582 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.0 t30 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.941 -1.028 . . . . 1.0 110.502 179.862 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ptp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -149.86 139.95 22.07 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.506 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 99.1 mt -51.65 118.23 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-O 121.05 0.452 . . . . 1.0 110.804 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 67.8 mt -92.81 -35.24 6.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.038 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.5 151.63 1.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.226 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.6 mt -107.42 125.91 63.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -107.25 116.9 32.74 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.99 0.424 . . . . 1.0 110.437 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -72.67 145.93 46.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.434 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -121.68 168.72 10.64 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.293 -179.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.69 -7.8 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.47 2.113 . . . . 1.0 112.159 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.481 ' H ' ' C ' ' A' ' 9' ' ' THR . 98.4 m-20 -92.83 173.95 7.49 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.071 0.462 . . . . 1.0 110.05 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.566 ' CG ' ' H ' ' A' ' 13' ' ' ASN . 46.0 p-80 -113.7 -55.1 2.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.34 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.566 ' H ' ' CG ' ' A' ' 12' ' ' HIS . 51.0 p30 -82.62 3.7 27.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.866 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -124.23 145.66 49.22 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.27 0.557 . . . . 1.0 109.98 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.3 tpp -144.8 153.78 42.0 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.703 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -101.65 123.94 46.49 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.058 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.5 t -104.07 106.52 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.932 0.396 . . . . 1.0 110.007 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -88.85 134.44 33.94 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.746 0.308 . . . . 1.0 110.445 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.5 pt? -170.17 160.77 8.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.056 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -81.06 99.02 8.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.995 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 14.0 mm-40 -131.04 52.46 9.53 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 121.088 0.47 . . . . 1.0 110.191 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 43.1 Cg_endo -66.56 145.67 77.09 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.065 1.843 . . . . 1.0 111.819 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.525 ' C ' ' H ' ' A' ' 25' ' ' ASP . 72.9 ttt180 -155.84 140.7 17.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.361 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.585 ' CD ' ' H ' ' A' ' 24' ' ' GLN . 2.2 pm0 -60.99 0.46 0.22 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.41 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 23' ' ' ARG . 66.7 t0 -138.33 52.53 1.83 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.62 -0.263 . . . . 1.0 110.497 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -69.65 54.16 0.12 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.392 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.0 t -79.12 169.49 18.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.123 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.453 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 54.4 p90 -102.77 127.44 49.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.136 0.493 . . . . 1.0 110.515 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.2 m -161.72 149.28 14.66 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.041 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.67 130.14 52.18 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.18 -0.463 . . . . 1.0 111.013 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.74 170.26 16.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.41 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.407 ' O ' ' CG2' ' A' ' 32' ' ' THR . 8.9 t -167.43 116.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.669 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 32' ' ' THR . . . 168.15 134.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.095 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.59 120.83 31.99 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.119 0.485 . . . . 1.0 110.413 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -147.94 153.15 38.67 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.712 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -68.14 131.42 45.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.283 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.37 -16.35 57.81 Favored Glycine 0 N--CA 1.466 0.677 0 N-CA-C 110.743 -0.943 . . . . 1.0 110.743 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -88.24 151.7 49.23 Favored Pre-proline 0 N--CA 1.455 -0.18 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.64 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -36.86 114.23 0.12 Allowed 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.81 2.34 . . . . 1.0 112.879 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.81 -27.2 66.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.394 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.519 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 39.1 m-85 -60.8 -23.71 65.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.384 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 42' ' ' ILE . 36.9 mm -100.36 -31.34 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.75 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -63.57 -40.53 97.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.037 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -59.75 -32.74 70.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.068 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 8.6 mp -66.65 -39.35 88.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.874 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.3 -22.82 65.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.852 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.56 -15.29 63.58 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.874 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.45 140.4 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.413 0.625 . . . . 1.0 110.31 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.63 136.37 41.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.135 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.54 -43.28 1.19 Allowed Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.22 119.69 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.158 0.504 . . . . 1.0 111.104 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -96.76 -42.71 7.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 1.0 109.99 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.4 p -166.19 165.99 17.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.301 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.5 mp -135.34 152.84 32.64 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.889 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.447 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -127.4 129.73 48.08 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.421 0.451 . . . . 1.0 109.981 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -121.76 122.66 40.01 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.194 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -164.89 149.02 2.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.506 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.0 tp 57.39 -128.5 1.7 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.127 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -118.97 24.31 10.9 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 123.302 0.376 . . . . 1.0 110.822 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -144.42 155.69 43.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 pt -129.68 147.58 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.329 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.7 m -120.29 119.92 34.57 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.411 -0.588 . . . . 1.0 109.411 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.2 mt -105.25 124.41 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.549 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -101.32 124.78 47.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.443 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -135.66 154.17 51.38 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.267 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.428 ' CG ' ' H ' ' A' ' 67' ' ' ASP . 71.0 tt0 -61.52 169.89 2.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.48 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.428 ' H ' ' CG ' ' A' ' 66' ' ' GLU . 50.9 t0 -67.8 -21.86 65.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.118 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -82.96 -5.41 59.06 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.773 0.32 . . . . 1.0 110.568 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.5 152.49 26.03 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.074 0.464 . . . . 1.0 110.51 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.457 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -141.69 118.68 11.24 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.299 0.571 . . . . 1.0 109.787 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -57.64 -21.24 38.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.988 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -57.92 -35.18 70.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.561 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -75.95 -35.89 59.53 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 121.11 0.481 . . . . 1.0 110.607 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' A' ' 74' ' ' LEU . 9.2 mp -69.12 -37.81 78.53 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.212 -0.305 . . . . 1.0 111.3 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.456 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 3.6 mp -38.4 -63.67 0.54 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.021 0.378 . . . . 1.0 112.021 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 40.0 Cg_endo -62.26 -26.51 77.45 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.428 2.086 . . . . 1.0 112.551 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -76.15 -54.38 6.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.301 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.5 pt -69.77 -42.95 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.916 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -51.34 -35.73 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.145 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -66.59 -36.69 83.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.472 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.1 m -57.25 -47.21 81.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.02 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.519 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 95.3 m-85 -70.72 -33.14 70.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 1.0 111.028 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.91 -48.12 81.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.749 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 84' ' ' LYS . 4.5 mptp? -83.22 -10.58 58.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.755 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.1 t -61.06 -46.63 89.9 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.619 0.574 . . . . 1.0 110.568 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.3 t30 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.848 -1.072 . . . . 1.0 110.53 -179.794 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -142.83 139.23 30.82 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.956 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.7 pt -51.7 146.62 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.542 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 mm -123.31 -43.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.356 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.05 140.73 7.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.43 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.19 123.53 60.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.622 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.1 m -106.09 103.25 12.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.205 -0.452 . . . . 1.0 109.87 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -70.21 155.63 40.37 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.499 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -132.35 158.36 75.83 Favored Pre-proline 0 N--CA 1.474 0.763 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 -178.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.85 32.62 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.436 2.091 . . . . 1.0 112.023 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 9' ' ' THR . 13.5 m120 -90.62 -169.57 2.43 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -109.98 -39.57 5.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.521 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.565 HD21 ' N ' ' A' ' 67' ' ' ASP . 12.5 p30 -145.29 15.3 1.48 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.993 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -116.32 125.5 52.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.541 -0.3 . . . . 1.0 110.276 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.24 148.39 46.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.178 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -100.6 137.98 38.27 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.229 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.64 108.4 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -92.4 131.44 37.56 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 1.2 pt? -169.11 165.09 11.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.955 0.407 . . . . 1.0 110.515 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.8 t -84.38 119.48 25.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.969 0.414 . . . . 1.0 110.754 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -131.12 75.16 78.6 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.73 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.52 143.43 99.45 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.284 1.99 . . . . 1.0 111.977 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -166.97 155.7 10.18 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -43.0 -59.7 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 1.0 111.092 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' SER . 52.8 p-10 -143.29 60.47 1.4 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 119.235 -0.412 . . . . 1.0 111.869 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 25' ' ' ASP . 22.2 m-80 -23.08 83.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.392 0.615 . . . . 1.0 112.26 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' ASP . 13.9 m -93.31 -151.99 0.32 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.455 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -123.07 145.15 48.79 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.427 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 m -167.07 107.11 0.61 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.119 -0.697 . . . . 1.0 109.119 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.2 m -84.27 115.64 22.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.273 0.559 . . . . 1.0 110.331 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.432 ' O ' ' OG1' ' A' ' 32' ' ' THR . 22.2 p90 -141.41 167.16 22.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.651 -0.704 . . . . 1.0 110.198 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 31' ' ' TYR . 98.1 m -170.21 112.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.96 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 167.57 137.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.309 . . . . 1.0 110.807 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.8 112.37 8.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.157 0.504 . . . . 1.0 110.659 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -150.77 147.51 27.39 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.71 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.49 143.97 53.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.71 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.84 -25.47 20.68 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -102.65 146.76 32.96 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 116.949 0.374 . . . . 1.0 110.493 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -41.98 123.95 2.64 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.08 1.853 . . . . 1.0 112.627 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -45.33 -23.7 0.22 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.769 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.483 ' CE2' ' OG1' ' A' ' 81' ' ' THR . 89.3 m-85 -56.4 -43.05 78.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.49 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.5 mm -62.29 -47.05 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.676 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -62.02 -39.64 92.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.746 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -57.52 -49.08 77.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 47' ' ' GLU . 5.1 mt -55.63 -39.1 70.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.132 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 73.6 t80 -77.37 16.18 0.65 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.84 0.352 . . . . 1.0 110.756 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 45' ' ' LEU . 36.4 tp10 -95.7 -35.95 11.38 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.567 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -115.17 139.72 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.855 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -62.04 136.11 57.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.782 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.98 -42.85 0.98 Allowed Glycine 0 C--O 1.228 -0.256 0 N-CA-C 111.28 -0.728 . . . . 1.0 111.28 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.02 113.18 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.136 0.493 . . . . 1.0 111.205 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -83.68 -49.38 9.2 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -158.81 153.74 25.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.411 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.9 mm -121.12 136.43 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.673 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -112.49 142.93 44.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.826 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -135.41 117.0 14.88 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.859 -0.422 . . . . 1.0 109.859 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' PHE . 8.8 p -165.79 145.18 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.226 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.33 -156.17 0.33 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.195 0.522 . . . . 1.0 110.966 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 19' ' ' LEU . 82.8 m-20 -91.51 13.42 17.78 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' A' ' 57' ' ' VAL . 36.4 p90 -140.71 149.11 41.77 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.703 0.287 . . . . 1.0 110.235 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 pt -128.17 159.66 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.9 p -122.85 130.24 52.63 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.6 mt -115.36 110.47 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.524 -0.546 . . . . 1.0 109.524 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.54 109.75 21.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.331 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.612 ' NZ ' ' HE1' ' A' ' 71' ' ' TRP . 24.3 mtmm -122.14 153.66 38.44 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.222 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.31 164.91 17.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.203 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.565 ' N ' HD21 ' A' ' 13' ' ' ASN . 42.6 p-10 -58.48 -28.74 65.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.736 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 14.3 m120 -70.32 3.29 3.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.583 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 67' ' ' ASP . . . -94.53 145.43 24.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.274 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.482 HD22 ' CD ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -140.88 123.4 15.98 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.26 -0.427 . . . . 1.0 109.991 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.612 ' HE1' ' NZ ' ' A' ' 65' ' ' LYS . 3.1 m0 -64.78 -27.23 68.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.237 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -57.57 -16.25 9.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.583 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.482 ' CD ' HD22 ' A' ' 70' ' ' ASN . 97.0 mt-10 -96.01 -33.5 12.11 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.588 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 4.0 mm? -74.86 -31.3 61.59 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.066 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -41.17 -61.94 1.19 Allowed Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 123.022 0.201 . . . . 1.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.97 -24.81 67.01 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.06 1.84 . . . . 1.0 112.718 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -79.06 -55.75 4.89 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.108 0.48 . . . . 1.0 111.56 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.461 ' O ' ' OG1' ' A' ' 81' ' ' THR . 2.3 pp -65.23 -39.01 84.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.044 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -49.11 -29.42 5.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.906 0.384 . . . . 1.0 110.606 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -70.69 -25.95 63.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.615 -0.266 . . . . 1.0 111.307 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.483 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 81.9 p -60.62 -48.78 80.25 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.916 0.389 . . . . 1.0 111.921 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -35.65 58.29 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.221 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.85 69.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.396 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -67.63 -1.62 5.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.49 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.3 p -60.78 -33.1 72.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.517 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.5 p30 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.545 179.761 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 110.61 -0.144 . . . . 1.0 110.61 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -57.32 119.87 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.87 0.843 . . . . 1.0 111.553 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.01 -48.74 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.519 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.56 179.12 7.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.45 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 pt -131.05 125.4 57.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.253 -0.885 . . . . 1.0 110.421 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.8 t -89.0 110.35 21.06 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -86.84 99.56 11.91 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.489 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -84.63 159.66 57.79 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.678 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.41 31.17 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.632 2.221 . . . . 1.0 111.846 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 9' ' ' THR . 12.1 m120 -93.49 -165.94 1.42 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -108.57 -56.18 2.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.991 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 69' ' ' ALA . 2.6 m-20 -129.22 10.46 5.8 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.359 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.5 m -109.29 130.77 55.48 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.492 ' SD ' ' CE2' ' A' ' 71' ' ' TRP . 10.5 ptp -150.85 153.57 35.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -102.65 134.31 46.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.644 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.4 t -109.44 110.39 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.546 -0.539 . . . . 1.0 109.546 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m -90.38 134.42 34.34 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.462 -0.569 . . . . 1.0 109.462 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.649 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -167.38 151.92 6.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.453 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 m -84.09 84.06 7.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.937 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 179.395 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.521 -0.158 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 54.3 p90 -102.09 129.95 48.56 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.158 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 m -166.26 136.3 3.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.889 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.97 116.53 29.36 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.406 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -141.35 160.68 39.62 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.578 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 32' ' ' THR . 9.9 t -171.32 116.61 0.43 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.037 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 170.62 130.94 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.978 -0.379 . . . . 1.0 109.978 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.09 117.48 20.94 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.928 0.394 . . . . 1.0 110.039 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -147.17 150.85 35.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.319 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -68.93 141.77 54.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.691 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 -8.53 76.26 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 110.821 -0.911 . . . . 1.0 110.821 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -99.09 147.52 33.36 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 121.119 -0.232 . . . . 1.0 111.018 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.26 127.47 2.99 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.214 1.943 . . . . 1.0 112.728 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.44 -24.79 63.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.291 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 37.4 m-85 -65.3 -12.99 57.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.945 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -110.68 -37.86 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.977 0.418 . . . . 1.0 110.24 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -63.68 -39.14 93.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.153 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -61.32 -35.57 77.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.053 0.454 . . . . 1.0 110.899 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 45' ' ' LEU . 9.8 mp -66.9 -37.41 84.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.829 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -66.3 -21.27 66.26 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.259 -0.576 . . . . 1.0 111.095 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -70.4 -4.5 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.602 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -117.95 134.29 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 110.08 -0.341 . . . . 1.0 110.08 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.621 ' N ' HD13 ' A' ' 48' ' ' ILE . 19.3 pt-20 -72.63 133.39 44.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.965 -0.561 . . . . 1.0 109.794 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 139.07 -46.5 0.96 Allowed Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.23 134.81 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -118.95 -30.91 4.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.196 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.1 p -160.99 154.05 21.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.892 0.377 . . . . 1.0 110.023 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.1 mt -134.83 125.21 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.149 -0.685 . . . . 1.0 109.149 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.86 130.1 48.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 1.0 110.442 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -119.87 118.07 29.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.825 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.93 143.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.457 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.455 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.4 OUTLIER 62.35 -150.05 0.37 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.853 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 86.6 m-20 -97.35 16.82 18.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -141.99 157.13 45.3 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.9 pt -134.25 154.0 36.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.229 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -125.79 123.21 38.27 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.42 127.39 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.202 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -103.37 120.21 40.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.08 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.746 ' HZ3' ' CD2' ' A' ' 74' ' ' LEU . 63.4 mttt -135.81 148.34 48.68 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.613 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 96.8 mt-10 -58.98 172.48 0.55 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.525 -0.761 . . . . 1.0 109.927 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.39 -13.67 61.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.29 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -90.84 12.23 20.04 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.628 -0.26 . . . . 1.0 111.009 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -100.96 147.8 25.75 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -138.43 120.72 15.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.492 ' CE2' ' SD ' ' A' ' 15' ' ' MET . 95.9 m95 -64.81 -17.05 63.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.715 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -59.64 -20.83 58.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.874 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -98.0 -30.36 12.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.746 ' CD2' ' HZ3' ' A' ' 65' ' ' LYS . 9.3 mp -71.28 -38.83 71.8 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.473 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.8 mp -39.4 -63.16 0.68 Allowed Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 123.368 0.418 . . . . 1.0 110.735 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.95 -22.38 68.47 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.492 1.461 . . . . 1.0 111.927 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -75.43 -54.74 6.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.83 0.348 . . . . 1.0 111.415 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.7 pt -72.8 -40.82 61.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -51.17 -30.18 16.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.138 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -63.78 -41.07 98.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.16 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -62.2 -50.78 70.42 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.705 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 78.4 m-85 -67.96 -41.53 82.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.778 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.74 69.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.266 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.035 -179.766 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 120.37 0.129 . . . . 1.0 110.785 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 98.0 mt -58.68 120.01 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.161 0.505 . . . . 1.0 111.147 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.21 -45.83 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.887 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.68 179.08 4.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.94 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.2 mt -130.05 128.5 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.871 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.9 t -95.14 113.08 24.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.867 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.55 100.95 10.43 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.877 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -83.58 159.18 61.73 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.789 -0.641 . . . . 1.0 109.975 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.62 29.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.579 2.186 . . . . 1.0 111.861 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 9' ' ' THR . 9.2 m120 -96.72 -168.7 1.76 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -110.5 -60.13 1.85 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.482 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -116.82 5.1 13.0 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.298 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.8 m -107.53 127.53 53.7 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.2 mtt -142.32 150.5 40.88 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -106.11 131.0 53.9 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.738 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 t -107.39 113.74 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.0 m -92.09 128.38 37.92 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.811 -0.441 . . . . 1.0 109.811 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.704 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.7 pt? -162.08 150.09 14.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.618 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.1 t -87.25 78.76 8.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.819 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 . . . . . 0 CA--C 1.538 0.495 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.164 179.762 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.439 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 51.8 p90 -101.75 131.5 48.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.8 m -159.55 112.3 2.17 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.0 m -94.76 123.82 38.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.841 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.71 170.59 15.48 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.183 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -171.16 113.01 0.38 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.384 -0.826 . . . . 1.0 110.342 178.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.15 133.96 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.174 -0.306 . . . . 1.0 110.174 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.19 113.11 19.8 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.873 0.368 . . . . 1.0 110.205 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -146.04 149.63 34.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.345 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.35 138.54 53.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.824 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.31 -13.94 62.29 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -91.4 151.39 42.67 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 121.016 -0.274 . . . . 1.0 110.923 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -38.9 117.69 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.644 2.23 . . . . 1.0 112.708 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.2 mp0 -63.95 -23.33 67.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.939 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.508 ' O ' HD13 ' A' ' 45' ' ' LEU . 36.9 t80 -69.04 -8.57 46.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.758 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 41' ' ' PHE . 1.6 mp -111.64 -41.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -63.33 -40.17 96.57 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.254 -0.578 . . . . 1.0 111.122 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.42 ' CD ' ' OG1' ' A' ' 81' ' ' THR . 92.7 mtt-85 -61.11 -32.92 72.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.615 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.556 HD12 ' N ' ' A' ' 45' ' ' LEU . 7.9 mp -65.56 -39.24 91.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.749 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -68.27 -20.23 64.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.065 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -59.7 -23.84 63.46 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.093 -0.243 . . . . 1.0 111.646 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.98 141.69 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 110.105 -0.332 . . . . 1.0 110.105 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.34 138.29 56.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.784 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.1 -55.7 0.57 Allowed Glycine 0 N--CA 1.465 0.6 0 N-CA-C 111.382 -0.687 . . . . 1.0 111.382 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 51' ' ' VAL . 12.3 p -61.26 126.58 19.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.785 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -106.02 -30.1 9.51 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -167.03 161.29 14.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.468 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.56 131.85 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 116.135 -0.484 . . . . 1.0 109.709 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.42 121.98 46.65 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -122.13 112.32 18.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.716 -0.674 . . . . 1.0 109.47 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 60' ' ' PHE . 11.5 p -164.99 149.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.217 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.26 -156.27 0.28 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.006 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 19' ' ' LEU . 6.2 p30 -93.49 12.49 24.89 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.691 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' A' ' 57' ' ' VAL . 39.1 p90 -139.66 149.6 43.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 pt -132.22 157.58 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.454 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.3 t -134.26 122.92 23.42 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.584 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.85 128.46 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.045 0.45 . . . . 1.0 109.91 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -96.7 111.41 23.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.903 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -122.33 144.71 48.84 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.595 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' OE1' ' ND2' ' A' ' 68' ' ' ASN . 71.2 tt0 -58.88 165.61 2.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.024 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 68' ' ' ASN . 34.5 p30 -69.8 -19.93 63.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.214 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 42.3 p30 -89.67 15.67 9.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.627 -0.26 . . . . 1.0 111.206 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.44 162.6 18.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.897 0.379 . . . . 1.0 110.128 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -145.98 132.89 20.16 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.688 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -62.04 -17.69 58.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.334 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -56.78 -30.34 63.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.616 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -83.76 -38.5 21.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.784 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 74' ' ' LEU . 7.2 mp -71.76 -40.31 69.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 121.1 -0.24 . . . . 1.0 111.417 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.415 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 1.9 mt -40.23 -63.22 0.75 Allowed Pre-proline 0 N--CA 1.467 0.382 0 O-C-N 123.477 0.486 . . . . 1.0 111.088 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 47.7 Cg_endo -63.35 -25.39 71.31 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.513 1.475 . . . . 1.0 111.953 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -78.18 -56.05 4.77 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.055 0.455 . . . . 1.0 111.967 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.08 -43.62 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.742 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -50.25 -36.46 31.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.862 0.363 . . . . 1.0 110.35 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -66.77 -28.83 68.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.097 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.42 ' OG1' ' CD ' ' A' ' 44' ' ' ARG . 5.3 m -60.9 -47.14 87.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.785 0.326 . . . . 1.0 110.825 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -68.33 -37.2 80.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.661 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.81 -41.76 82.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.534 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 1.0 110.69 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 4' ' ' ILE . 76.9 mt-10 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.906 -0.035 . . . . 1.0 110.906 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.57 127.82 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.593 0.711 . . . . 1.0 111.882 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 2' ' ' GLU . 1.2 mp -90.82 -43.57 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 114.679 -1.146 . . . . 1.0 109.398 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.86 168.81 7.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.394 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.59 128.71 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.542 -0.754 . . . . 1.0 109.284 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 m -105.75 107.59 18.67 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.94 116.23 19.96 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -90.94 176.08 3.15 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.37 14.34 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.824 1.682 . . . . 1.0 112.019 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' THR . 18.9 m120 -95.82 -179.81 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.847 0.356 . . . . 1.0 110.608 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.449 ' O ' ' CZ2' ' A' ' 71' ' ' TRP . 78.1 t60 -110.15 -58.9 2.01 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.584 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 56.0 p30 -101.03 7.59 43.36 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.745 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -116.37 130.08 56.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -140.53 151.69 44.97 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.075 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -109.56 134.08 52.34 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.67 117.29 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.7 t -92.13 127.77 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.599 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -169.88 158.64 7.42 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 120.831 0.348 . . . . 1.0 111.104 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.5 t -96.01 95.24 8.06 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.633 0.254 . . . . 1.0 110.371 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 . . . . . 0 N--CA 1.471 0.606 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.888 179.702 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 121.13 0.49 . . . . 1.0 110.144 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 53.6 p90 -99.2 127.93 45.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.299 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.402 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 25.5 m -165.4 108.46 0.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.58 124.94 28.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.217 0.532 . . . . 1.0 110.7 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.416 ' OH ' ' CB ' ' A' ' 56' ' ' TYR . 1.2 p90 -139.86 163.83 31.61 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.337 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -168.16 116.34 0.73 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.189 178.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 171.3 133.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.467 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.68 120.39 26.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.104 0.478 . . . . 1.0 110.268 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -168.16 168.59 11.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.763 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -78.02 142.1 38.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.031 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.64 -27.05 19.28 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.703 -0.559 . . . . 1.0 111.703 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -90.89 147.94 37.06 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 117.163 0.482 . . . . 1.0 110.342 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -44.58 128.8 8.68 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.717 1.611 . . . . 1.0 113.317 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.81 -23.22 66.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.354 -0.839 . . . . 1.0 110.362 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -61.71 -48.53 80.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.114 0.483 . . . . 1.0 110.39 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.98 -40.38 80.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.782 -0.644 . . . . 1.0 110.52 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -58.48 -37.03 74.68 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.917 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -63.43 -40.13 96.34 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.321 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 47' ' ' GLU . 18.4 mt -61.84 -41.32 97.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.723 -0.217 . . . . 1.0 111.239 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 71.1 t80 -72.05 13.12 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.895 0.378 . . . . 1.0 111.012 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 45' ' ' LEU . 77.0 tt0 -89.76 -22.34 22.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.448 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 pp -121.77 141.25 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.09 0.471 . . . . 1.0 111.067 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.1 145.42 55.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.657 -0.702 . . . . 1.0 111.029 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.68 -32.78 3.95 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 111.588 -0.605 . . . . 1.0 111.588 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.4 t -63.75 113.57 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 120.19 -0.604 . . . . 1.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -87.51 -47.38 8.78 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.821 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p -164.42 167.06 20.04 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.074 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -133.36 151.11 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.568 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.63 130.42 52.64 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.347 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 39.4 t80 -123.22 112.81 18.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.63 149.83 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.711 0.291 . . . . 1.0 110.368 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.5 OUTLIER 59.2 -148.85 0.46 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.793 0.33 . . . . 1.0 110.619 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.458 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 38.2 p30 -100.11 15.58 26.93 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.673 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -141.32 156.49 45.84 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 pt -132.59 154.09 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.399 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.4 m -126.96 124.39 39.36 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.778 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.2 mp -106.76 118.26 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -104.81 112.34 25.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.719 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.446 ' NZ ' ' CD1' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -125.21 157.78 35.65 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -58.29 169.89 0.79 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.99 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.448 ' OD1' ' ND2' ' A' ' 13' ' ' ASN . 88.4 m-20 -70.17 -17.01 63.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.115 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -84.38 5.78 25.77 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.784 0.326 . . . . 1.0 110.677 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.21 151.16 19.76 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.252 0.549 . . . . 1.0 109.833 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -136.26 123.15 21.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.115 -0.948 . . . . 1.0 110.226 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.477 ' N ' ' CD1' ' A' ' 71' ' ' TRP . 13.6 m0 -61.29 -23.97 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.608 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -56.37 -33.31 65.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.163 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -77.97 -38.33 45.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.843 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 74' ' ' LEU . 7.0 mp -67.72 -38.39 83.52 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.746 -0.206 . . . . 1.0 111.0 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mp -41.79 -64.6 0.63 Allowed Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.319 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -61.42 -25.44 79.96 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.095 1.863 . . . . 1.0 112.44 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -76.96 -54.28 6.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.98 0.419 . . . . 1.0 111.477 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 pt -68.78 -43.05 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.007 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.97 -32.26 61.41 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.308 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.93 -41.16 97.71 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.368 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.0 m -64.29 -49.95 69.79 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.188 0.518 . . . . 1.0 110.43 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -63.29 -47.48 82.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.474 -0.784 . . . . 1.0 110.189 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.55 68.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.535 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.466 179.768 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 120.657 0.265 . . . . 1.0 110.424 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.6 pt -48.05 155.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.56 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -130.93 -46.06 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 123.576 0.547 . . . . 1.0 111.041 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.71 153.24 5.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -108.66 118.57 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.174 -179.104 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -95.91 113.16 24.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.433 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.13 117.73 21.2 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.068 -0.715 . . . . 1.0 109.068 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -91.59 176.32 2.87 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.198 -178.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.99 12.53 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.336 2.024 . . . . 1.0 111.933 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' THR . 22.5 m120 -98.39 -179.68 4.43 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -112.05 -61.42 1.72 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.842 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 65' ' ' LYS . 42.8 p30 -92.55 1.4 57.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.361 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -116.1 128.54 55.76 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.8 mmt -135.06 145.67 48.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.844 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -95.75 128.38 42.57 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.53 105.92 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.6 m -90.52 132.6 35.6 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.7 pt? -162.78 153.6 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.446 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -77.51 100.3 6.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.813 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 . . . . . 0 N--CA 1.468 0.467 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.414 178.907 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.449 0.642 . . . . 1.0 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 51.2 p90 -99.57 127.92 45.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.359 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.3 m -166.32 145.38 5.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.25 117.13 33.81 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.743 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -141.2 172.13 13.11 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.526 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -172.11 114.94 0.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.049 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 169.78 135.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.678 0.275 . . . . 1.0 110.352 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.89 129.08 34.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.245 0.545 . . . . 1.0 110.2 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -164.46 162.82 22.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.798 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -83.22 143.64 30.31 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.395 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.07 -28.38 15.93 Favored Glycine 0 N--CA 1.465 0.629 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -94.68 146.79 32.07 Favored Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.94 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -41.76 130.99 4.08 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.125 1.883 . . . . 1.0 112.727 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 42' ' ' ILE . 81.2 mm-40 -64.9 -25.83 68.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.203 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -57.8 -1.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.158 -0.217 . . . . 1.0 111.582 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 40' ' ' GLU . 38.2 mm -114.57 -34.5 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.076 0.465 . . . . 1.0 110.747 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -63.12 -39.97 96.23 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.306 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -44.44 87.99 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.1 mp -63.16 -40.89 98.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.988 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 81.4 t80 -78.11 12.37 1.87 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.996 0.427 . . . . 1.0 110.243 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -88.52 -29.76 19.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.897 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.72 140.58 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.427 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -67.42 142.09 56.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.748 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 137.04 -39.98 1.56 Allowed Glycine 0 N--CA 1.464 0.505 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 51' ' ' VAL . 33.7 m -65.66 124.31 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.02 0.438 . . . . 1.0 110.935 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -94.71 -43.24 8.35 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.0 p -158.89 156.81 30.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.843 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.1 mt -129.15 123.38 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.136 -0.691 . . . . 1.0 109.136 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 47.0 m-85 -101.63 138.99 37.9 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.075 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -126.8 112.71 15.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.114 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' PHE . 10.1 p -165.94 155.39 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.646 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mt 54.75 -163.18 0.13 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.581 0.705 . . . . 1.0 111.127 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -87.62 13.07 11.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.047 -0.979 . . . . 1.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 57' ' ' VAL . 44.1 p90 -148.44 157.62 43.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.97 0.414 . . . . 1.0 110.004 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.7 pt -133.9 164.84 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.3 p -135.01 134.28 40.29 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.493 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.64 131.1 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.892 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -100.25 103.02 14.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.277 -0.874 . . . . 1.0 110.261 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 16.3 mtpt -110.99 142.23 43.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.742 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -63.9 173.11 1.94 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.101 0.477 . . . . 1.0 110.106 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -70.2 -14.06 62.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.902 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -89.49 9.5 26.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.416 0.151 . . . . 1.0 110.597 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.412 ' HB1' ' HZ3' ' A' ' 65' ' ' LYS . . . -102.47 150.65 23.16 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -143.85 127.13 16.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.257 0.551 . . . . 1.0 109.566 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.441 ' CE3' HD22 ' A' ' 74' ' ' LEU . 85.3 m95 -64.44 -19.64 65.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.798 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 42.8 p-10 -54.13 -19.77 5.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.95 0.405 . . . . 1.0 110.93 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 72' ' ' ASN . 54.8 mm-40 -95.83 -33.38 12.26 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.322 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 74' ' ' LEU . 9.3 mp -68.95 -42.07 77.15 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 120.519 -0.472 . . . . 1.0 111.334 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 mp -44.61 -61.65 2.04 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 120.905 0.383 . . . . 1.0 110.855 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.88 -28.34 42.73 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.398 1.399 . . . . 1.0 111.95 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -75.89 -51.45 12.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.493 0.663 . . . . 1.0 112.344 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.42 -40.32 88.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.191 -0.913 . . . . 1.0 110.764 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.95 -27.84 5.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.166 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -62.33 -45.81 91.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.742 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -64.8 -51.91 59.64 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.293 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -59.7 -48.33 82.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.207 0.527 . . . . 1.0 109.839 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.49 93.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.558 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.531 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 49.3 mp0 . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 120.739 0.304 . . . . 1.0 110.374 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 4' ' ' ILE . 89.9 mt -47.26 156.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 1.0 109.693 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.452 ' N ' HG22 ' A' ' 3' ' ' ILE . 43.5 mm -129.19 -39.31 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.87 -0.605 . . . . 1.0 111.178 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.71 153.47 2.75 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.356 0.41 . . . . 1.0 110.093 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.7 mt -109.68 119.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 p -94.98 110.9 22.75 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.124 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 8' ' ' GLU . 55.1 mp0 -83.34 108.72 16.73 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.341 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -87.27 157.49 53.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.134 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.86 23.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.571 2.181 . . . . 1.0 112.074 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' A' ' 9' ' ' THR . 96.4 m-20 -88.75 -168.56 2.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -110.71 -71.14 0.77 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.231 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 16.8 p30 -106.72 11.16 30.59 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.065 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.1 m -115.0 131.59 56.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' ' CD2' ' A' ' 71' ' ' TRP . 11.6 ptt? -142.33 149.35 39.34 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.119 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -105.32 131.39 52.82 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.019 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -108.87 111.3 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -90.69 128.84 36.78 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -170.47 162.47 8.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.87 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.9 p -80.14 109.14 14.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.556 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 N--CA 1.473 0.696 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.383 179.417 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 110.165 -0.309 . . . . 1.0 110.165 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -104.55 139.31 39.61 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.121 0.486 . . . . 1.0 110.461 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.3 m -165.25 107.24 0.8 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.23 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -105.41 131.64 52.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.348 0.594 . . . . 1.0 111.262 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.8 170.58 15.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.289 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -167.59 113.15 0.71 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.406 -0.816 . . . . 1.0 110.64 178.013 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.72 126.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.674 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.76 126.13 32.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.216 0.531 . . . . 1.0 110.371 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -167.41 170.29 11.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.68 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.87 142.98 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.581 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.99 -26.84 21.79 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -94.36 147.93 34.16 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 121.09 -0.244 . . . . 1.0 110.696 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -40.65 121.29 1.15 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.646 2.231 . . . . 1.0 112.505 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.99 -24.96 66.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.358 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.427 ' O ' HD13 ' A' ' 45' ' ' LEU . 92.4 m-85 -62.01 -18.45 60.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.624 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.1 mm -102.33 -33.1 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 123.321 0.388 . . . . 1.0 110.655 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -63.38 -38.34 90.76 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.207 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -60.06 -33.03 71.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.071 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 45' ' ' LEU . 9.4 mp -63.46 -38.77 92.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.667 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 70.0 t80 -76.3 14.89 0.66 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.989 0.424 . . . . 1.0 110.501 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 45' ' ' LEU . 82.1 tt0 -90.77 -23.66 20.58 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.689 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 pp -121.4 142.26 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.047 0.451 . . . . 1.0 110.544 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.46 143.95 54.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.344 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.77 -43.81 1.26 Allowed Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.246 -0.742 . . . . 1.0 111.246 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 51' ' ' VAL . 17.1 m -54.86 115.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.454 0.645 . . . . 1.0 111.274 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -88.47 -42.76 11.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.3 p -170.2 168.94 8.04 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.288 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.41 137.71 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.07 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -110.64 136.27 49.99 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.423 0.452 . . . . 1.0 109.896 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -124.11 118.74 27.6 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.382 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -165.76 141.3 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.42 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.51 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.4 OUTLIER 64.05 -149.58 0.3 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.948 178.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.51 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 55.9 p-10 -97.68 18.56 15.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.785 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 28.9 p90 -141.58 156.82 45.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 61' ' ' ILE . 28.5 pt -132.79 144.47 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.283 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 t -111.07 124.31 51.92 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.1 mt -112.2 125.58 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -116.5 133.27 56.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.215 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' HG3' ' HB3' ' A' ' 69' ' ' ALA . 4.0 ptpt -144.19 156.12 44.18 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.558 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -51.27 162.83 0.29 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.688 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.496 ' OD1' ' ND2' ' A' ' 13' ' ' ASN . 92.3 m-20 -69.99 -14.26 62.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.76 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -88.27 9.98 21.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.775 -0.193 . . . . 1.0 110.598 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.509 ' HB3' ' HG3' ' A' ' 65' ' ' LYS . . . -104.92 164.92 11.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.325 0.583 . . . . 1.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -150.04 134.01 16.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.477 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.461 ' CD2' ' SD ' ' A' ' 15' ' ' MET . 3.9 m0 -68.22 -18.09 64.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.256 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 39.3 p-10 -57.78 -20.47 35.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.978 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.435 ' N ' ' OD1' ' A' ' 72' ' ' ASN . 80.7 mt-10 -95.24 -29.03 14.72 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.236 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 74' ' ' LEU . 8.8 mp -74.75 -39.41 61.85 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.976 -0.29 . . . . 1.0 111.298 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.437 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 2.2 mt -40.87 -62.35 1.02 Allowed Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 123.444 0.465 . . . . 1.0 111.917 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 36.8 Cg_endo -61.24 -27.84 84.1 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.878 1.718 . . . . 1.0 112.267 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -75.62 -49.97 16.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.288 0.566 . . . . 1.0 111.444 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 pt -70.28 -42.92 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.586 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -53.19 -35.13 59.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.263 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -63.47 -39.44 94.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.035 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.8 m -62.04 -48.08 81.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.013 0.435 . . . . 1.0 110.222 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.93 -44.59 80.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.987 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -45.17 -33.85 2.46 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.524 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.46 179.392 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 82' ' ' PHE . 38.6 tp10 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.7 mt -49.09 142.6 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.929 0.395 . . . . 1.0 110.421 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -120.05 -34.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.343 -0.844 . . . . 1.0 110.639 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.02 178.1 3.05 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.078 0.466 . . . . 1.0 110.177 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.1 pt -143.23 136.73 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.576 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.2 m -116.09 111.88 20.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.838 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.437 ' OE1' ' N ' ' A' ' 8' ' ' GLU . 39.2 mp0 -84.16 113.87 21.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -82.88 177.18 3.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.304 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.86 21.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.216 1.944 . . . . 1.0 112.296 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 9' ' ' THR . 94.3 m-20 -103.5 -178.25 3.61 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.55 -55.26 2.54 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.794 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' A' ' 67' ' ' ASP . 20.3 p30 -100.94 3.83 42.03 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.284 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -116.22 131.36 56.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.6 mtt -146.23 153.54 40.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.816 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -106.8 135.99 47.4 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.805 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.46 120.68 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.748 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.2 t -96.06 127.57 42.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.327 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -164.33 154.42 14.44 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.419 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -92.71 99.07 11.83 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' OE2' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.699 0 CA-C-N 116.281 -0.418 . . . . 1.0 109.999 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 110.078 -0.341 . . . . 1.0 110.078 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 54.1 p90 -99.08 132.94 44.02 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 m -166.95 107.01 0.62 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.618 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.8 m -81.11 120.78 25.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.358 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -141.65 164.72 29.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.671 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 32' ' ' THR . 9.7 t -168.97 113.89 0.57 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.253 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.93 132.68 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.51 -0.313 . . . . 1.0 110.357 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.439 ' O ' ' NE2' ' A' ' 35' ' ' GLN . . . -81.29 122.69 27.75 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 1.0 110.068 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 34' ' ' ALA . 99.1 mm-40 -143.34 155.7 44.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.317 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.71 142.38 46.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.837 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.67 -3.55 55.0 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -98.71 155.61 36.52 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 122.889 -0.183 . . . . 1.0 110.583 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -36.34 109.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.866 2.378 . . . . 1.0 112.453 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.62 -36.59 74.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.936 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -55.83 -51.7 66.57 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.641 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.09 -41.22 91.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.957 0.408 . . . . 1.0 110.364 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -59.86 -38.92 83.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.01 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -61.02 -39.52 90.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.869 0.366 . . . . 1.0 110.421 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.44 ' O ' HG22 ' A' ' 48' ' ' ILE . 8.5 mp -63.63 -41.8 98.23 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.996 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -65.07 -29.09 69.95 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.911 -0.715 . . . . 1.0 111.14 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.79 -10.08 59.24 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.097 -0.241 . . . . 1.0 111.347 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -105.89 134.55 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.844 0.355 . . . . 1.0 110.301 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.624 ' N ' HD13 ' A' ' 48' ' ' ILE . 17.8 tp10 -73.26 128.84 36.63 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.32 -37.78 1.88 Allowed Glycine 0 N--CA 1.461 0.357 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.74 128.39 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.581 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.473 ' NZ ' ' OD1' ' A' ' 64' ' ' ASP . 27.7 mtmm -99.87 -40.8 7.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.421 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.6 m -165.71 171.19 13.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.362 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.4 137.35 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.04 -0.527 . . . . 1.0 109.998 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -111.46 133.4 53.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.698 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -122.88 108.16 12.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.221 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 60' ' ' PHE . 11.1 p -164.43 147.51 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.104 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 64.68 -160.54 0.29 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.897 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 19' ' ' LEU . 81.7 m-20 -89.3 15.03 9.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 57' ' ' VAL . 40.9 p90 -147.88 158.98 44.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.442 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 pt -129.44 152.19 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.411 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.0 m -113.91 118.96 35.65 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.9 mt -104.88 114.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.076 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.473 ' OD1' ' NZ ' ' A' ' 52' ' ' LYS . 60.2 t0 -98.04 126.24 43.38 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.419 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HZ3' ' HB1' ' A' ' 69' ' ' ALA . 4.8 mtmp? -139.15 143.91 38.38 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.45 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' OE1' ' ND2' ' A' ' 68' ' ' ASN . 95.6 mt-10 -55.71 167.66 0.52 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.351 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.438 ' HA ' HD21 ' A' ' 13' ' ' ASN . 50.5 p-10 -68.62 -23.79 64.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.827 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 9.9 p30 -77.93 -7.2 56.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.785 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.546 ' HB1' ' HZ3' ' A' ' 65' ' ' LYS . . . -76.04 142.49 41.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -126.9 119.95 28.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.297 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -60.28 -28.81 68.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.739 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -57.53 -16.61 10.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.572 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -97.92 -34.63 10.76 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.33 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 74' ' ' LEU . 8.7 mp -74.27 -39.83 62.73 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.33 -0.231 . . . . 1.0 110.948 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 3.9 mp -41.92 -62.55 1.11 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.025 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 37.4 Cg_endo -60.56 -27.5 84.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.768 1.645 . . . . 1.0 112.124 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.56 -53.72 7.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.985 0.421 . . . . 1.0 111.491 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 pt -70.6 -44.1 77.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.031 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -52.07 -32.81 36.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.327 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -64.54 -39.43 93.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.227 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.5 m -62.99 -50.49 70.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.899 0.381 . . . . 1.0 110.71 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.448 ' CE1' ' OE2' ' A' ' 2' ' ' GLU . 3.0 t80 -62.06 -48.56 79.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.011 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.88 97.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.793 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp . . . . . 0 CA--C 1.516 -0.328 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.92 -179.587 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.521 0.2 . . . . 1.0 110.605 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 3' ' ' ILE . 18.0 tt -50.86 118.47 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.495 0.664 . . . . 1.0 111.082 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mm -92.25 -48.33 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.2 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.91 178.76 9.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.213 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 tt -132.49 135.64 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.264 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 t -100.61 111.26 23.47 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.047 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.29 110.45 16.76 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -87.32 177.63 2.64 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 -178.403 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.25 7.95 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.988 1.792 . . . . 1.0 112.229 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 9' ' ' THR . 22.6 m120 -93.25 171.69 8.76 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.421 ' O ' ' CZ2' ' A' ' 71' ' ' TRP . 80.0 m80 -111.59 -38.29 4.95 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.169 -0.468 . . . . 1.0 111.352 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -110.42 -2.33 16.64 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.795 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -113.81 130.87 56.41 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.472 ' SD ' ' CG ' ' A' ' 71' ' ' TRP . 11.7 ptt? -142.74 151.81 41.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 1.0 109.767 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -113.89 138.34 50.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.947 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.8 t -100.44 127.6 53.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 t -104.22 132.32 50.6 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -169.64 158.04 7.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.91 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -102.75 86.19 2.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 -179.676 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.518 -0.253 0 CA-C-O 120.985 0.422 . . . . 1.0 110.112 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 51.9 p90 -100.09 127.65 46.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.346 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.8 m -161.42 132.54 5.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.416 ' CB ' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -101.8 120.15 39.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.259 0.552 . . . . 1.0 111.038 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -140.14 133.49 29.9 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.817 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 32' ' ' THR . 10.4 t -138.24 116.44 11.82 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.037 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 170.07 137.63 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.957 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.16 122.37 32.39 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -154.16 154.36 33.42 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.11 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -71.16 128.87 37.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.797 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.51 -19.82 52.5 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.437 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 38.9 mm-40 -82.18 152.0 67.31 Favored Pre-proline 0 CA--C 1.543 0.709 0 O-C-N 122.746 -0.267 . . . . 1.0 110.602 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.17 119.74 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.606 2.204 . . . . 1.0 112.923 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -68.77 -23.32 64.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.539 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.601 ' C ' HD12 ' A' ' 42' ' ' ILE . 56.7 m-85 -69.26 -10.2 56.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.961 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.601 HD12 ' C ' ' A' ' 41' ' ' PHE . 2.0 mp -118.07 -33.71 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 123.3 0.375 . . . . 1.0 110.312 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 38' ' ' GLN . 67.3 m-20 -63.18 -39.87 95.89 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.211 -0.595 . . . . 1.0 110.71 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.454 ' NH1' ' OG1' ' A' ' 81' ' ' THR . 25.0 mmt85 -64.51 -34.67 78.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.49 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.7 mp -63.21 -41.05 99.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.005 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -69.8 -5.2 23.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.861 -0.336 . . . . 1.0 111.034 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -68.12 -24.3 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.634 -0.257 . . . . 1.0 111.364 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.483 HG12 HD11 ' A' ' 74' ' ' LEU . 2.3 pp -121.76 142.99 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.899 0.381 . . . . 1.0 110.816 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -67.14 143.85 56.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.847 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.93 -40.42 1.59 Allowed Glycine 0 N--CA 1.465 0.601 0 N-CA-C 111.452 -0.659 . . . . 1.0 111.452 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.11 112.38 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.543 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -82.02 -50.86 8.63 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.042 0.448 . . . . 1.0 110.176 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.8 p -160.96 160.54 30.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 30' ' ' THR . 49.5 mm -121.73 151.57 25.23 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.921 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.37 120.93 20.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -114.7 118.41 33.55 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.689 -0.485 . . . . 1.0 109.689 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -164.57 148.39 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.413 . . . . 1.0 110.192 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER 63.85 -138.94 0.32 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.774 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.43 ' H ' HD12 ' A' ' 58' ' ' LEU . 56.0 p30 -110.25 23.79 13.83 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 122.619 0.367 . . . . 1.0 110.865 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -147.42 157.56 43.63 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 mp -126.52 132.84 69.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 1.0 109.844 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t -103.11 123.58 46.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.433 ' CG2' ' NZ ' ' A' ' 65' ' ' LYS . 65.4 mt -112.05 127.52 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.673 -0.492 . . . . 1.0 109.673 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.04 111.72 23.03 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.579 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.433 ' NZ ' ' CG2' ' A' ' 63' ' ' ILE . 47.3 mttp -115.78 155.75 27.26 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.388 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 67' ' ' ASP . 7.3 tp10 -67.09 175.25 2.66 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.412 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 90.8 m-20 -70.12 -20.32 63.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.032 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -85.74 3.03 43.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.71 0.291 . . . . 1.0 111.098 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.21 153.36 17.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.423 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.32 121.82 14.13 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.032 0.444 . . . . 1.0 110.362 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.472 ' CG ' ' SD ' ' A' ' 15' ' ' MET . 5.6 m0 -58.16 -26.47 62.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.539 . . . . 1.0 111.266 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -56.48 -36.61 69.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.749 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -74.56 -40.29 61.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.646 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.9 mm? -70.7 -38.43 73.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mp -39.55 -62.49 0.82 Allowed Pre-proline 0 CA--C 1.541 0.599 0 O-C-N 123.441 0.463 . . . . 1.0 110.89 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.38 -22.61 59.54 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.783 1.656 . . . . 1.0 112.11 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 44' ' ' ARG . 14.2 tt0 -76.47 -53.47 8.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.975 0.417 . . . . 1.0 111.621 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 pt -71.33 -40.32 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.824 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -50.91 -31.05 16.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.347 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.95 -39.67 94.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.326 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.454 ' OG1' ' NH1' ' A' ' 44' ' ' ARG . 21.6 m -60.1 -48.7 80.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.823 0.344 . . . . 1.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.511 ' CZ ' ' CD1' ' A' ' 41' ' ' PHE . 98.0 m-85 -69.51 -37.29 77.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.572 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.28 -43.07 92.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.662 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.75 -179.726 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.892 0.377 . . . . 1.0 110.417 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 4' ' ' ILE . 85.0 mt -49.37 155.64 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-O 120.776 0.322 . . . . 1.0 110.267 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.416 ' N ' HG22 ' A' ' 3' ' ' ILE . 48.1 mm -127.25 -37.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.434 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -171.65 158.69 5.13 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.127 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.466 ' CG2' ' SD ' ' A' ' 15' ' ' MET . 74.9 mt -104.23 131.83 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 m -114.56 104.85 12.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.105 0.479 . . . . 1.0 110.007 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -76.86 144.78 38.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.085 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -122.71 161.76 42.24 Favored Pre-proline 0 N--CA 1.472 0.655 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.0 21.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.529 2.153 . . . . 1.0 112.215 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 9' ' ' THR . 14.9 m120 -96.42 -174.23 2.99 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.457 ' O ' ' CH2' ' A' ' 71' ' ' TRP . 59.3 t-80 -110.72 -51.27 2.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.825 0.345 . . . . 1.0 111.652 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 65' ' ' LYS . 42.2 p30 -116.22 7.57 14.11 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.875 -0.602 . . . . 1.0 112.103 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 m -111.72 130.06 55.91 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.466 ' SD ' ' CG2' ' A' ' 6' ' ' ILE . 38.8 ttm -139.7 150.9 45.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -107.29 131.4 54.25 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.94 -0.573 . . . . 1.0 109.579 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.7 t -108.61 109.98 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -90.48 133.19 35.22 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.6 pt? -166.05 155.55 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.063 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -88.25 83.79 6.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 -179.729 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.155 0.503 . . . . 1.0 110.21 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 46.2 p90 -102.79 131.21 49.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.217 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.41 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.1 m -160.81 108.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -79.64 117.79 20.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.668 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 29' ' ' THR . 9.5 p90 -142.27 162.38 35.63 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.252 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -170.34 114.08 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.562 . . . . 1.0 109.972 177.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 169.29 139.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.296 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.8 120.97 25.35 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.799 -0.445 . . . . 1.0 109.799 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -148.07 146.91 29.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.029 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -70.5 142.75 51.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.828 -0.624 . . . . 1.0 111.122 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.22 -13.03 62.73 Favored Glycine 0 N--CA 1.46 0.286 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -97.3 147.42 32.94 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 122.837 -0.214 . . . . 1.0 110.932 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -41.92 128.06 3.88 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.136 1.891 . . . . 1.0 112.896 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.452 ' OE2' ' NZ ' ' A' ' 84' ' ' LYS . 95.9 mt-10 -66.89 -26.28 66.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.023 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.453 ' O ' HD13 ' A' ' 45' ' ' LEU . 99.3 m-85 -60.26 -11.98 7.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.903 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -110.32 -39.65 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 110.105 -0.331 . . . . 1.0 110.105 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -66.23 -38.15 87.22 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.863 -0.335 . . . . 1.0 111.281 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -60.23 -34.09 73.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.19 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.2 mp -66.02 -36.86 84.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.21 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 75.7 t80 -74.11 13.41 0.55 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.818 0.342 . . . . 1.0 111.193 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 45' ' ' LEU . 80.8 mm-40 -87.51 -20.92 25.84 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.611 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.15 142.2 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.3 pm0 -68.71 148.96 49.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.095 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.61 -36.0 3.01 Favored Glycine 0 N--CA 1.468 0.779 0 N-CA-C 111.366 -0.693 . . . . 1.0 111.366 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.82 114.88 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.3 0.571 . . . . 1.0 110.656 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.87 -42.81 8.89 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 p -165.04 161.74 19.96 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.508 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.8 mt -130.98 136.2 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -111.34 129.63 55.94 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.156 -0.474 . . . . 1.0 109.866 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -124.17 118.46 26.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.632 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 p -164.79 146.92 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.997 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 tp 62.4 -131.25 0.57 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.83 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 19' ' ' LEU . 48.3 p-10 -115.25 23.56 12.36 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.156 0.582 . . . . 1.0 110.971 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.35 159.63 43.11 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.7 pt -132.09 149.44 32.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.147 -0.479 . . . . 1.0 109.808 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.2 t -114.96 122.49 46.43 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.31 115.42 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -100.37 114.95 28.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.1 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.487 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 38.6 mtmt -125.47 153.12 44.0 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.674 0.273 . . . . 1.0 110.793 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -61.79 167.58 3.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.854 -0.424 . . . . 1.0 109.854 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.08 -18.62 65.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.649 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -85.95 4.5 37.34 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.862 0.363 . . . . 1.0 110.768 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.33 149.54 21.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.281 0.562 . . . . 1.0 110.502 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -138.31 126.86 23.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.142 -0.935 . . . . 1.0 110.654 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.457 ' CH2' ' O ' ' A' ' 12' ' ' HIS . 4.5 m-90 -57.72 -27.43 62.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.978 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -55.49 -29.61 59.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.331 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.53 -35.6 30.14 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.132 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.7 mm? -70.51 -38.78 74.34 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 121.078 -0.249 . . . . 1.0 111.601 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mt -39.92 -62.62 0.83 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.165 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -62.74 -24.21 74.64 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.895 1.73 . . . . 1.0 112.315 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -75.95 -54.05 7.47 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.465 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.3 pt -67.5 -41.24 85.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.524 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.32 -28.37 7.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.255 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -58.73 -33.38 70.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.142 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.7 p -64.44 -44.35 91.42 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.139 0.495 . . . . 1.0 110.245 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.13 -36.13 83.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.576 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -46.19 -46.87 17.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.908 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.452 ' NZ ' ' OE2' ' A' ' 40' ' ' GLU . 98.9 mttt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.399 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.772 0.32 . . . . 1.0 110.506 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 99.1 mt -51.65 118.23 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-O 121.05 0.452 . . . . 1.0 110.804 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 67.8 mt -92.81 -35.24 6.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.038 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.5 151.63 1.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.226 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.6 mt -107.42 125.91 63.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -107.25 116.9 32.74 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.99 0.424 . . . . 1.0 110.437 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -72.67 145.93 46.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.434 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -121.68 168.72 10.64 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.293 -179.235 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.69 -7.8 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.47 2.113 . . . . 1.0 112.159 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' THR . 98.4 m-20 -92.83 173.95 7.49 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.071 0.462 . . . . 1.0 110.05 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.56 ' CG ' ' N ' ' A' ' 13' ' ' ASN . 46.0 p-80 -113.7 -55.1 2.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.34 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.56 ' N ' ' CG ' ' A' ' 12' ' ' HIS . 51.0 p30 -82.62 3.7 27.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.866 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -124.23 145.66 49.22 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.27 0.557 . . . . 1.0 109.98 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.3 tpp -144.8 153.78 42.0 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.703 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -101.65 123.94 46.49 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.058 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.5 t -104.07 106.52 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.932 0.396 . . . . 1.0 110.007 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -88.85 134.44 33.94 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.746 0.308 . . . . 1.0 110.445 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.687 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.5 pt? -170.17 160.77 8.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.056 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -81.06 99.02 8.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.995 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 121.088 0.47 . . . . 1.0 110.191 178.809 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 CA--C 1.517 -0.309 0 CA-C-O 120.799 0.333 . . . . 1.0 110.123 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 54.4 p90 -102.77 127.44 49.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.136 0.493 . . . . 1.0 110.515 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.2 m -161.72 149.28 14.66 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.041 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.67 130.14 52.18 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.18 -0.463 . . . . 1.0 111.013 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.74 170.26 16.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.41 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 32' ' ' THR . 8.9 t -167.43 116.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.669 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 168.15 134.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.095 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.59 120.83 31.99 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.119 0.485 . . . . 1.0 110.413 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -147.94 153.15 38.67 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.712 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -68.14 131.42 45.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.283 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.37 -16.35 57.81 Favored Glycine 0 N--CA 1.466 0.677 0 N-CA-C 110.743 -0.943 . . . . 1.0 110.743 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -88.24 151.7 49.23 Favored Pre-proline 0 N--CA 1.455 -0.18 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.64 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -36.86 114.23 0.12 Allowed 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.81 2.34 . . . . 1.0 112.879 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.81 -27.2 66.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.394 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.519 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 39.1 m-85 -60.8 -23.71 65.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.384 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.9 mm -100.36 -31.34 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.75 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -63.57 -40.53 97.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.037 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -59.75 -32.74 70.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.068 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.6 mp -66.65 -39.35 88.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.874 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.3 -22.82 65.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.852 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.56 -15.29 63.58 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.874 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.45 140.4 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.413 0.625 . . . . 1.0 110.31 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.63 136.37 41.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.135 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.54 -43.28 1.19 Allowed Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 51' ' ' VAL . 14.8 p -60.22 119.69 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.158 0.504 . . . . 1.0 111.104 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -96.76 -42.71 7.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 1.0 109.99 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.4 p -166.19 165.99 17.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.301 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 54' ' ' ILE . 4.5 mp -135.34 152.84 32.64 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.889 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.447 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -127.4 129.73 48.08 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.421 0.451 . . . . 1.0 109.981 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -121.76 122.66 40.01 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.194 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -164.89 149.02 2.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.506 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.0 tp 57.39 -128.5 1.7 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.127 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -118.97 24.31 10.9 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 123.302 0.376 . . . . 1.0 110.822 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -144.42 155.69 43.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 pt -129.68 147.58 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.329 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.7 m -120.29 119.92 34.57 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.411 -0.588 . . . . 1.0 109.411 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.2 mt -105.25 124.41 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.549 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -101.32 124.78 47.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.443 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.414 ' NZ ' HD21 ' A' ' 74' ' ' LEU . 4.5 mtpt -135.66 154.17 51.38 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.267 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 67' ' ' ASP . 71.0 tt0 -61.52 169.89 2.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.48 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.442 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 50.9 t0 -67.8 -21.86 65.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.118 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -82.96 -5.41 59.06 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.773 0.32 . . . . 1.0 110.568 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.5 152.49 26.03 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.074 0.464 . . . . 1.0 110.51 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -141.69 118.68 11.24 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.299 0.571 . . . . 1.0 109.787 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -57.64 -21.24 38.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.988 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -57.92 -35.18 70.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.561 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -75.95 -35.89 59.53 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 121.11 0.481 . . . . 1.0 110.607 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 74' ' ' LEU . 9.2 mp -69.12 -37.81 78.53 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.212 -0.305 . . . . 1.0 111.3 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.456 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 3.6 mp -38.4 -63.67 0.54 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.021 0.378 . . . . 1.0 112.021 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 40.0 Cg_endo -62.26 -26.51 77.45 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.428 2.086 . . . . 1.0 112.551 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -76.15 -54.38 6.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.301 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.5 pt -69.77 -42.95 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.916 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -51.34 -35.73 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.145 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -66.59 -36.69 83.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.472 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.1 m -57.25 -47.21 81.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.02 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.519 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 95.3 m-85 -70.72 -33.14 70.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 1.0 111.028 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.91 -48.12 81.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.749 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 84' ' ' LYS . 4.5 mptp? . . . . . 0 N--CA 1.466 0.368 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.755 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.908 0.385 . . . . 1.0 110.956 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.7 pt -51.7 146.62 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.542 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 mm -123.31 -43.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.356 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.05 140.73 7.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.43 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.19 123.53 60.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.622 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.1 m -106.09 103.25 12.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.205 -0.452 . . . . 1.0 109.87 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -70.21 155.63 40.37 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -132.35 158.36 75.83 Favored Pre-proline 0 N--CA 1.474 0.763 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 -178.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.85 32.62 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.436 2.091 . . . . 1.0 112.023 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 9' ' ' THR . 13.5 m120 -90.62 -169.57 2.43 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -109.98 -39.57 5.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.521 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' C ' HD21 ' A' ' 13' ' ' ASN . 0.2 OUTLIER -145.29 15.3 1.48 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.993 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -116.32 125.5 52.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.541 -0.3 . . . . 1.0 110.276 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.24 148.39 46.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.178 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -100.6 137.98 38.27 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.229 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.64 108.4 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -92.4 131.44 37.56 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.2 pt? -169.11 165.09 11.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.955 0.407 . . . . 1.0 110.515 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.8 t -84.38 119.48 25.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.969 0.414 . . . . 1.0 110.754 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 N--CA 1.475 0.817 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.73 178.602 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 C--O 1.223 -0.295 0 CA-C-O 120.812 0.339 . . . . 1.0 110.455 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -123.07 145.15 48.79 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.427 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 m -167.07 107.11 0.61 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.119 -0.697 . . . . 1.0 109.119 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.2 m -84.27 115.64 22.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.273 0.559 . . . . 1.0 110.331 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -141.41 167.16 22.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.651 -0.704 . . . . 1.0 110.198 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.556 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 98.1 m -170.21 112.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.96 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.57 137.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.309 . . . . 1.0 110.807 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.8 112.37 8.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.157 0.504 . . . . 1.0 110.659 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -150.77 147.51 27.39 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.71 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.49 143.97 53.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.71 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.84 -25.47 20.68 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -102.65 146.76 32.96 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 116.949 0.374 . . . . 1.0 110.493 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -41.98 123.95 2.64 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.08 1.853 . . . . 1.0 112.627 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -45.33 -23.7 0.22 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.769 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -56.4 -43.05 78.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.49 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.5 mm -62.29 -47.05 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.676 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -62.02 -39.64 92.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.746 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -57.52 -49.08 77.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mt -55.63 -39.1 70.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 73.6 t80 -77.37 16.18 0.65 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.84 0.352 . . . . 1.0 110.756 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -95.7 -35.95 11.38 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.567 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -115.17 139.72 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.855 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -62.04 136.11 57.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.782 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.98 -42.85 0.98 Allowed Glycine 0 C--O 1.228 -0.256 0 N-CA-C 111.28 -0.728 . . . . 1.0 111.28 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 51' ' ' VAL . 13.2 p -66.02 113.18 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.136 0.493 . . . . 1.0 111.205 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -83.68 -49.38 9.2 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -158.81 153.74 25.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.411 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 51' ' ' VAL . 48.9 mm -121.12 136.43 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.673 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -112.49 142.93 44.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.826 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -135.41 117.0 14.88 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.859 -0.422 . . . . 1.0 109.859 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' PHE . 8.8 p -165.79 145.18 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.226 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.33 -156.17 0.33 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.195 0.522 . . . . 1.0 110.966 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 19' ' ' LEU . 82.8 m-20 -91.51 13.42 17.78 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' A' ' 57' ' ' VAL . 36.4 p90 -140.71 149.11 41.77 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.703 0.287 . . . . 1.0 110.235 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 pt -128.17 159.66 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.9 p -122.85 130.24 52.63 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.6 mt -115.36 110.47 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.524 -0.546 . . . . 1.0 109.524 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.54 109.75 21.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.331 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.655 ' NZ ' ' HE1' ' A' ' 71' ' ' TRP . 24.3 mtmm -122.14 153.66 38.44 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.222 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.31 164.91 17.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.203 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 68' ' ' ASN . 42.6 p-10 -58.48 -28.74 65.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.736 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 71.3 m-20 -70.32 3.29 3.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.583 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.53 145.43 24.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.274 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.47 HD22 ' CD ' ' A' ' 73' ' ' GLU . 5.5 p30 -140.88 123.4 15.98 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.26 -0.427 . . . . 1.0 109.991 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.655 ' HE1' ' NZ ' ' A' ' 65' ' ' LYS . 3.1 m0 -64.78 -27.23 68.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.237 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -57.57 -16.25 9.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.583 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' CD ' HD22 ' A' ' 70' ' ' ASN . 97.0 mt-10 -96.01 -33.5 12.11 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.588 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 74' ' ' LEU . 4.0 mm? -74.86 -31.3 61.59 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.066 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -41.17 -61.94 1.19 Allowed Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 123.022 0.201 . . . . 1.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.97 -24.81 67.01 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.06 1.84 . . . . 1.0 112.718 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -79.06 -55.75 4.89 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.108 0.48 . . . . 1.0 111.56 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.461 ' O ' ' OG1' ' A' ' 81' ' ' THR . 2.3 pp -65.23 -39.01 84.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.044 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -49.11 -29.42 5.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.906 0.384 . . . . 1.0 110.606 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -70.69 -25.95 63.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.615 -0.266 . . . . 1.0 111.307 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 78' ' ' ILE . 81.9 p -60.62 -48.78 80.25 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.916 0.389 . . . . 1.0 111.921 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -35.65 58.29 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.221 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.85 69.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.396 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.49 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -141.18 131.33 24.81 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.61 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -57.32 119.87 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.87 0.843 . . . . 1.0 111.553 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.01 -48.74 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.519 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.56 179.12 7.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.45 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 pt -131.05 125.4 57.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.253 -0.885 . . . . 1.0 110.421 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.8 t -89.0 110.35 21.06 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -86.84 99.56 11.91 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.489 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -84.63 159.66 57.79 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.678 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.41 31.17 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.632 2.221 . . . . 1.0 111.846 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 9' ' ' THR . 12.1 m120 -93.49 -165.94 1.42 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -108.57 -56.18 2.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.991 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 69' ' ' ALA . 2.6 m-20 -129.22 10.46 5.8 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.359 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.5 m -109.29 130.77 55.48 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.492 ' SD ' ' CE2' ' A' ' 71' ' ' TRP . 10.5 ptp -150.85 153.57 35.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -102.65 134.31 46.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.644 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.4 t -109.44 110.39 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.546 -0.539 . . . . 1.0 109.546 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m -90.38 134.42 34.34 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.462 -0.569 . . . . 1.0 109.462 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.649 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -167.38 151.92 6.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.453 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 m -84.09 84.06 7.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.937 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -93.55 155.73 40.41 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.25 141.21 81.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.19 1.927 . . . . 1.0 111.27 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' C ' ' HE ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -97.67 8.28 44.94 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.52 -0.763 . . . . 1.0 109.742 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -52.96 -49.6 65.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.61 -0.436 . . . . 1.0 110.304 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -127.26 60.13 1.4 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.628 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.36 50.77 0.17 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.299 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.6 t -84.72 152.45 23.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 54.3 p90 -102.09 129.95 48.56 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.158 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 m -166.26 136.3 3.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.889 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.97 116.53 29.36 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.406 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -141.35 160.68 39.62 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.578 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 32' ' ' THR . 9.9 t -171.32 116.61 0.43 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.037 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 170.62 130.94 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.978 -0.379 . . . . 1.0 109.978 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.09 117.48 20.94 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.928 0.394 . . . . 1.0 110.039 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -147.17 150.85 35.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.319 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -68.93 141.77 54.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.691 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 -8.53 76.26 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 110.821 -0.911 . . . . 1.0 110.821 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -99.09 147.52 33.36 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 121.119 -0.232 . . . . 1.0 111.018 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.26 127.47 2.99 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.214 1.943 . . . . 1.0 112.728 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.44 -24.79 63.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.291 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 37.4 m-85 -65.3 -12.99 57.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.945 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -110.68 -37.86 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.977 0.418 . . . . 1.0 110.24 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -63.68 -39.14 93.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.153 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -61.32 -35.57 77.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.053 0.454 . . . . 1.0 110.899 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 45' ' ' LEU . 9.8 mp -66.9 -37.41 84.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.829 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -66.3 -21.27 66.26 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.259 -0.576 . . . . 1.0 111.095 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -70.4 -4.5 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.602 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -117.95 134.29 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 110.08 -0.341 . . . . 1.0 110.08 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.621 ' N ' HD13 ' A' ' 48' ' ' ILE . 19.3 pt-20 -72.63 133.39 44.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.965 -0.561 . . . . 1.0 109.794 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 139.07 -46.5 0.96 Allowed Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.23 134.81 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -118.95 -30.91 4.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.196 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.1 p -160.99 154.05 21.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.892 0.377 . . . . 1.0 110.023 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.1 mt -134.83 125.21 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.149 -0.685 . . . . 1.0 109.149 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.86 130.1 48.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 1.0 110.442 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -119.87 118.07 29.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.825 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.93 143.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.457 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.455 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.4 OUTLIER 62.35 -150.05 0.37 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.853 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 86.6 m-20 -97.35 16.82 18.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -141.99 157.13 45.3 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.9 pt -134.25 154.0 36.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.229 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -125.79 123.21 38.27 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.42 127.39 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.202 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -103.37 120.21 40.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.08 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.746 ' HZ3' ' CD2' ' A' ' 74' ' ' LEU . 63.4 mttt -135.81 148.34 48.68 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.613 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 96.8 mt-10 -58.98 172.48 0.55 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.525 -0.761 . . . . 1.0 109.927 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.39 -13.67 61.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.29 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -90.84 12.23 20.04 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.628 -0.26 . . . . 1.0 111.009 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -100.96 147.8 25.75 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -138.43 120.72 15.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.492 ' CE2' ' SD ' ' A' ' 15' ' ' MET . 95.9 m95 -64.81 -17.05 63.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.715 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -59.64 -20.83 58.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.874 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -98.0 -30.36 12.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.746 ' CD2' ' HZ3' ' A' ' 65' ' ' LYS . 9.3 mp -71.28 -38.83 71.8 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.473 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.8 mp -39.4 -63.16 0.68 Allowed Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 123.368 0.418 . . . . 1.0 110.735 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.95 -22.38 68.47 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.492 1.461 . . . . 1.0 111.927 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -75.43 -54.74 6.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.83 0.348 . . . . 1.0 111.415 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.7 pt -72.8 -40.82 61.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -51.17 -30.18 16.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.138 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -63.78 -41.07 98.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.16 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -62.2 -50.78 70.42 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.705 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 78.4 m-85 -67.96 -41.53 82.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.778 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.74 69.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.266 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -62.21 -62.11 2.0 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.035 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.0 p -58.79 -46.24 88.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.357 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.93 -1.033 . . . . 1.0 110.357 179.86 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.0 mmm . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.46 141.39 22.9 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.785 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 98.0 mt -58.68 120.01 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.161 0.505 . . . . 1.0 111.147 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.21 -45.83 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.887 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.68 179.08 4.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.94 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.2 mt -130.05 128.5 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.871 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.9 t -95.14 113.08 24.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.867 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.55 100.95 10.43 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.877 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -83.58 159.18 61.73 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.789 -0.641 . . . . 1.0 109.975 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.62 29.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.579 2.186 . . . . 1.0 111.861 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 9' ' ' THR . 9.2 m120 -96.72 -168.7 1.76 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -110.5 -60.13 1.85 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.482 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -116.82 5.1 13.0 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.298 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.8 m -107.53 127.53 53.7 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.2 mtt -142.32 150.5 40.88 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -106.11 131.0 53.9 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.738 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 t -107.39 113.74 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.0 m -92.09 128.38 37.92 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.811 -0.441 . . . . 1.0 109.811 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.704 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.7 pt? -162.08 150.09 14.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.618 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.1 t -87.25 78.76 8.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.819 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -77.27 156.24 81.64 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.164 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.44 141.55 81.39 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.38 2.053 . . . . 1.0 111.364 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.506 ' HE ' ' H ' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -92.94 12.64 23.16 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -57.27 -51.11 70.66 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.273 -0.571 . . . . 1.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 27' ' ' SER . 93.9 m-20 -138.93 60.76 1.59 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.609 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.451 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -71.99 45.72 0.12 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.495 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 25' ' ' ASP . 46.0 t -83.15 166.39 18.7 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.439 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 51.8 p90 -101.75 131.5 48.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.8 m -159.55 112.3 2.17 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.0 m -94.76 123.82 38.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.841 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.71 170.59 15.48 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.183 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -171.16 113.01 0.38 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.384 -0.826 . . . . 1.0 110.342 178.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.15 133.96 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.174 -0.306 . . . . 1.0 110.174 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.19 113.11 19.8 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.873 0.368 . . . . 1.0 110.205 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -146.04 149.63 34.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.345 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.35 138.54 53.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.824 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.31 -13.94 62.29 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -91.4 151.39 42.67 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 121.016 -0.274 . . . . 1.0 110.923 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -38.9 117.69 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.644 2.23 . . . . 1.0 112.708 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.2 mp0 -63.95 -23.33 67.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.939 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.508 ' O ' HD13 ' A' ' 45' ' ' LEU . 36.9 t80 -69.04 -8.57 46.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.758 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 41' ' ' PHE . 1.6 mp -111.64 -41.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -63.33 -40.17 96.57 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.254 -0.578 . . . . 1.0 111.122 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.42 ' CD ' ' OG1' ' A' ' 81' ' ' THR . 92.7 mtt-85 -61.11 -32.92 72.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.615 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 45' ' ' LEU . 7.9 mp -65.56 -39.24 91.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.749 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -68.27 -20.23 64.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.065 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -59.7 -23.84 63.46 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.093 -0.243 . . . . 1.0 111.646 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.98 141.69 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 110.105 -0.332 . . . . 1.0 110.105 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.34 138.29 56.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.784 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.1 -55.7 0.57 Allowed Glycine 0 N--CA 1.465 0.6 0 N-CA-C 111.382 -0.687 . . . . 1.0 111.382 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 51' ' ' VAL . 12.3 p -61.26 126.58 19.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.785 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -106.02 -30.1 9.51 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -167.03 161.29 14.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.468 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.56 131.85 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 116.135 -0.484 . . . . 1.0 109.709 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.42 121.98 46.65 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -122.13 112.32 18.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.716 -0.674 . . . . 1.0 109.47 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 60' ' ' PHE . 11.5 p -164.99 149.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.217 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.26 -156.27 0.28 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.006 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 19' ' ' LEU . 6.2 p30 -93.49 12.49 24.89 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.691 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' A' ' 57' ' ' VAL . 39.1 p90 -139.66 149.6 43.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 pt -132.22 157.58 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.454 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.3 t -134.26 122.92 23.42 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.584 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.85 128.46 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.045 0.45 . . . . 1.0 109.91 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -96.7 111.41 23.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.903 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -122.33 144.71 48.84 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.595 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' OE1' ' ND2' ' A' ' 68' ' ' ASN . 71.2 tt0 -58.88 165.61 2.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.024 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 68' ' ' ASN . 34.5 p30 -69.8 -19.93 63.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.214 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 42.3 p30 -89.67 15.67 9.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.627 -0.26 . . . . 1.0 111.206 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.44 162.6 18.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.897 0.379 . . . . 1.0 110.128 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -145.98 132.89 20.16 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.688 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -62.04 -17.69 58.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.334 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -56.78 -30.34 63.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.616 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -83.76 -38.5 21.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.784 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 74' ' ' LEU . 7.2 mp -71.76 -40.31 69.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 121.1 -0.24 . . . . 1.0 111.417 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.415 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 1.9 mt -40.23 -63.22 0.75 Allowed Pre-proline 0 N--CA 1.467 0.382 0 O-C-N 123.477 0.486 . . . . 1.0 111.088 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 47.7 Cg_endo -63.35 -25.39 71.31 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.513 1.475 . . . . 1.0 111.953 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -78.18 -56.05 4.77 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.055 0.455 . . . . 1.0 111.967 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.08 -43.62 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.742 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -50.25 -36.46 31.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.862 0.363 . . . . 1.0 110.35 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -66.77 -28.83 68.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.097 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.42 ' OG1' ' CD ' ' A' ' 44' ' ' ARG . 5.3 m -60.9 -47.14 87.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.785 0.326 . . . . 1.0 110.825 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -68.33 -37.2 80.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.661 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.81 -41.76 82.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.534 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.01 -15.71 56.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 1.0 110.69 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.0 p -85.55 40.29 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.429 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.4 p30 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.964 -1.017 . . . . 1.0 110.569 179.848 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 4' ' ' ILE . 76.9 mt-10 -119.16 115.88 25.17 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 116.603 -0.272 . . . . 1.0 110.906 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.57 127.82 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.593 0.711 . . . . 1.0 111.882 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 2' ' ' GLU . 1.2 mp -90.82 -43.57 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 114.679 -1.146 . . . . 1.0 109.398 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.86 168.81 7.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.394 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.59 128.71 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.542 -0.754 . . . . 1.0 109.284 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 m -105.75 107.59 18.67 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.94 116.23 19.96 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -90.94 176.08 3.15 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.37 14.34 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.824 1.682 . . . . 1.0 112.019 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' THR . 18.9 m120 -95.82 -179.81 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.847 0.356 . . . . 1.0 110.608 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.449 ' O ' ' CZ2' ' A' ' 71' ' ' TRP . 78.1 t60 -110.15 -58.9 2.01 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.584 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 56.0 p30 -101.03 7.59 43.36 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.745 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -116.37 130.08 56.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -140.53 151.69 44.97 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.075 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -109.56 134.08 52.34 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.67 117.29 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.7 t -92.13 127.77 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.599 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -169.88 158.64 7.42 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 120.831 0.348 . . . . 1.0 111.104 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.5 t -96.01 95.24 8.06 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.633 0.254 . . . . 1.0 110.371 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 21.0 pt-20 -126.61 46.13 1.81 Allowed Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.888 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 73.6 Cg_endo -68.31 155.54 68.92 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.207 1.938 . . . . 1.0 111.683 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -151.76 -156.22 0.69 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.081 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.566 ' CD ' ' H ' ' A' ' 24' ' ' GLN . 27.8 mp0 -46.86 -72.73 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.857 0.36 . . . . 1.0 111.152 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' A' ' 27' ' ' SER . 80.0 m-20 -142.8 57.6 1.42 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.209 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 52.71 -72.48 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.721 0.296 . . . . 1.0 111.61 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.623 ' N ' ' O ' ' A' ' 25' ' ' ASP . 2.6 t 67.03 109.84 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.144 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 53.6 p90 -99.2 127.93 45.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.299 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.402 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 25.5 m -165.4 108.46 0.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.58 124.94 28.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.217 0.532 . . . . 1.0 110.7 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.416 ' OH ' ' CB ' ' A' ' 56' ' ' TYR . 1.2 p90 -139.86 163.83 31.61 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.337 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -168.16 116.34 0.73 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.189 178.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 171.3 133.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.467 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.68 120.39 26.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.104 0.478 . . . . 1.0 110.268 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -168.16 168.59 11.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.763 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -78.02 142.1 38.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.031 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.64 -27.05 19.28 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.703 -0.559 . . . . 1.0 111.703 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -90.89 147.94 37.06 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 117.163 0.482 . . . . 1.0 110.342 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -44.58 128.8 8.68 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.717 1.611 . . . . 1.0 113.317 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.81 -23.22 66.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.354 -0.839 . . . . 1.0 110.362 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -61.71 -48.53 80.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.114 0.483 . . . . 1.0 110.39 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.98 -40.38 80.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.782 -0.644 . . . . 1.0 110.52 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -58.48 -37.03 74.68 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.917 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -63.43 -40.13 96.34 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.321 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 47' ' ' GLU . 18.4 mt -61.84 -41.32 97.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.723 -0.217 . . . . 1.0 111.239 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 71.1 t80 -72.05 13.12 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.895 0.378 . . . . 1.0 111.012 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 45' ' ' LEU . 77.0 tt0 -89.76 -22.34 22.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.448 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.2 pp -121.77 141.25 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.09 0.471 . . . . 1.0 111.067 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.1 145.42 55.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.657 -0.702 . . . . 1.0 111.029 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.68 -32.78 3.95 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 111.588 -0.605 . . . . 1.0 111.588 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.4 t -63.75 113.57 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 120.19 -0.604 . . . . 1.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -87.51 -47.38 8.78 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.821 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p -164.42 167.06 20.04 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.074 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -133.36 151.11 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.568 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.63 130.42 52.64 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.347 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 39.4 t80 -123.22 112.81 18.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.63 149.83 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.711 0.291 . . . . 1.0 110.368 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.5 OUTLIER 59.2 -148.85 0.46 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.793 0.33 . . . . 1.0 110.619 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.458 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 38.2 p30 -100.11 15.58 26.93 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.673 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -141.32 156.49 45.84 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 pt -132.59 154.09 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.399 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.4 m -126.96 124.39 39.36 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.778 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.2 mp -106.76 118.26 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -104.81 112.34 25.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.719 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.446 ' NZ ' ' CD1' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -125.21 157.78 35.65 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -58.29 169.89 0.79 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.99 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.448 ' OD1' ' ND2' ' A' ' 13' ' ' ASN . 88.4 m-20 -70.17 -17.01 63.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.115 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -84.38 5.78 25.77 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.784 0.326 . . . . 1.0 110.677 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.21 151.16 19.76 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.252 0.549 . . . . 1.0 109.833 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -136.26 123.15 21.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.115 -0.948 . . . . 1.0 110.226 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.477 ' N ' ' CD1' ' A' ' 71' ' ' TRP . 13.6 m0 -61.29 -23.97 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.608 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -56.37 -33.31 65.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.163 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -77.97 -38.33 45.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.843 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 74' ' ' LEU . 7.0 mp -67.72 -38.39 83.52 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.746 -0.206 . . . . 1.0 111.0 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mp -41.79 -64.6 0.63 Allowed Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.319 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -61.42 -25.44 79.96 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.095 1.863 . . . . 1.0 112.44 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -76.96 -54.28 6.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.98 0.419 . . . . 1.0 111.477 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 pt -68.78 -43.05 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.007 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.97 -32.26 61.41 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.308 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.93 -41.16 97.71 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.368 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.0 m -64.29 -49.95 69.79 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.188 0.518 . . . . 1.0 110.43 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -63.29 -47.48 82.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.474 -0.784 . . . . 1.0 110.189 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.55 68.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.535 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -65.38 -55.45 18.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.466 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -58.29 -43.83 88.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.323 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.0 t30 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.373 179.697 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ptt? . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.94 139.44 26.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.424 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.6 pt -48.05 155.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.56 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -130.93 -46.06 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 123.576 0.547 . . . . 1.0 111.041 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.71 153.24 5.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -108.66 118.57 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.174 -179.104 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -95.91 113.16 24.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.433 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.13 117.73 21.2 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.068 -0.715 . . . . 1.0 109.068 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -91.59 176.32 2.87 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.198 -178.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.99 12.53 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.336 2.024 . . . . 1.0 111.933 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' THR . 22.5 m120 -98.39 -179.68 4.43 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -112.05 -61.42 1.72 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.842 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 65' ' ' LYS . 42.8 p30 -92.55 1.4 57.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.361 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -116.1 128.54 55.76 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.8 mmt -135.06 145.67 48.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.844 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -95.75 128.38 42.57 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.53 105.92 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.6 m -90.52 132.6 35.6 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.7 pt? -162.78 153.6 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.446 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -77.51 100.3 6.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.813 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -146.29 69.88 12.87 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.414 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 23' ' ' ARG . 29.3 Cg_exo -60.9 -72.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.277 1.984 . . . . 1.0 111.597 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 25' ' ' ASP . 85.1 mtp180 47.46 105.66 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 O-C-N 123.539 0.524 . . . . 1.0 111.09 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -57.52 -2.32 0.12 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.947 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 23' ' ' ARG . 8.9 p-10 -116.77 35.73 4.47 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.968 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 27' ' ' SER . 8.7 p30 -42.24 -56.41 2.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.672 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 26' ' ' ASN . 27.4 t 55.1 123.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 O-C-N 123.85 0.719 . . . . 1.0 110.238 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 51.2 p90 -99.57 127.92 45.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.359 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.3 m -166.32 145.38 5.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.25 117.13 33.81 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.743 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -141.2 172.13 13.11 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.526 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -172.11 114.94 0.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.049 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 169.78 135.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.678 0.275 . . . . 1.0 110.352 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.89 129.08 34.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.245 0.545 . . . . 1.0 110.2 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -164.46 162.82 22.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.798 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -83.22 143.64 30.31 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.395 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.07 -28.38 15.93 Favored Glycine 0 N--CA 1.465 0.629 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -94.68 146.79 32.07 Favored Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.94 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -41.76 130.99 4.08 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.125 1.883 . . . . 1.0 112.727 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 42' ' ' ILE . 81.2 mm-40 -64.9 -25.83 68.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.203 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -57.8 -1.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.158 -0.217 . . . . 1.0 111.582 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 40' ' ' GLU . 38.2 mm -114.57 -34.5 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.076 0.465 . . . . 1.0 110.747 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -63.12 -39.97 96.23 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.306 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -44.44 87.99 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.1 mp -63.16 -40.89 98.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.988 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 81.4 t80 -78.11 12.37 1.87 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.996 0.427 . . . . 1.0 110.243 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -88.52 -29.76 19.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.897 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.72 140.58 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.427 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -67.42 142.09 56.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.748 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 137.04 -39.98 1.56 Allowed Glycine 0 N--CA 1.464 0.505 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 51' ' ' VAL . 33.7 m -65.66 124.31 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.02 0.438 . . . . 1.0 110.935 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -94.71 -43.24 8.35 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.0 p -158.89 156.81 30.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.843 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.1 mt -129.15 123.38 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.136 -0.691 . . . . 1.0 109.136 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 47.0 m-85 -101.63 138.99 37.9 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.075 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -126.8 112.71 15.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.114 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' PHE . 10.1 p -165.94 155.39 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.646 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mt 54.75 -163.18 0.13 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.581 0.705 . . . . 1.0 111.127 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -87.62 13.07 11.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.047 -0.979 . . . . 1.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 57' ' ' VAL . 44.1 p90 -148.44 157.62 43.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.97 0.414 . . . . 1.0 110.004 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.7 pt -133.9 164.84 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.3 p -135.01 134.28 40.29 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.493 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.64 131.1 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.892 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -100.25 103.02 14.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.277 -0.874 . . . . 1.0 110.261 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 16.3 mtpt -110.99 142.23 43.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.742 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -63.9 173.11 1.94 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.101 0.477 . . . . 1.0 110.106 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -70.2 -14.06 62.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.902 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -89.49 9.5 26.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.416 0.151 . . . . 1.0 110.597 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.412 ' HB1' ' HZ3' ' A' ' 65' ' ' LYS . . . -102.47 150.65 23.16 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -143.85 127.13 16.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.257 0.551 . . . . 1.0 109.566 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.441 ' CE3' HD22 ' A' ' 74' ' ' LEU . 85.3 m95 -64.44 -19.64 65.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.798 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 42.8 p-10 -54.13 -19.77 5.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.95 0.405 . . . . 1.0 110.93 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 72' ' ' ASN . 54.8 mm-40 -95.83 -33.38 12.26 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.322 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 74' ' ' LEU . 9.3 mp -68.95 -42.07 77.15 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 120.519 -0.472 . . . . 1.0 111.334 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 mp -44.61 -61.65 2.04 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 120.905 0.383 . . . . 1.0 110.855 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.88 -28.34 42.73 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.398 1.399 . . . . 1.0 111.95 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -75.89 -51.45 12.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.493 0.663 . . . . 1.0 112.344 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.42 -40.32 88.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.191 -0.913 . . . . 1.0 110.764 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.95 -27.84 5.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.166 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -62.33 -45.81 91.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.742 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -64.8 -51.91 59.64 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.293 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -59.7 -48.33 82.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.207 0.527 . . . . 1.0 109.839 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.49 93.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.558 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -70.63 -7.69 46.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.531 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 p -60.73 -44.6 96.44 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.382 -0.527 . . . . 1.0 110.656 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.755 -179.819 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 20' ' ' SER . 89.0 mmm . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 49.3 mp0 -122.81 116.75 24.22 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.442 0.464 . . . . 1.0 110.374 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 4' ' ' ILE . 89.9 mt -47.26 156.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 1.0 109.693 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.452 ' N ' HG22 ' A' ' 3' ' ' ILE . 43.5 mm -129.19 -39.31 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.87 -0.605 . . . . 1.0 111.178 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.71 153.47 2.75 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.356 0.41 . . . . 1.0 110.093 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.7 mt -109.68 119.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 p -94.98 110.9 22.75 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.124 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 8' ' ' GLU . 55.1 mp0 -83.34 108.72 16.73 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.341 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -87.27 157.49 53.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.134 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.86 23.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.571 2.181 . . . . 1.0 112.074 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' A' ' 9' ' ' THR . 96.4 m-20 -88.75 -168.56 2.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -110.71 -71.14 0.77 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.231 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 16.8 p30 -106.72 11.16 30.59 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.065 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.1 m -115.0 131.59 56.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' ' CD2' ' A' ' 71' ' ' TRP . 11.6 ptt? -142.33 149.35 39.34 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.119 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -105.32 131.39 52.82 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.019 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -108.87 111.3 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -90.69 128.84 36.78 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -170.47 162.47 8.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.87 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 1' ' ' MET . 77.9 p -80.14 109.14 14.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.556 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 4.8 mm-40 -136.56 54.71 9.62 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.383 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 41.0 Cg_endo -66.62 144.36 72.04 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 C-N-CA 122.14 1.893 . . . . 1.0 111.486 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 25' ' ' ASP . 66.1 ttt180 -156.52 146.54 21.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.442 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.11 -2.64 16.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.48 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' H ' ' HG2' ' A' ' 23' ' ' ARG . 55.3 t0 -142.0 59.26 1.48 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.685 0.279 . . . . 1.0 110.56 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.71 -86.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.283 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.9 t 45.09 -163.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.165 -0.309 . . . . 1.0 110.165 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -104.55 139.31 39.61 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.121 0.486 . . . . 1.0 110.461 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.3 m -165.25 107.24 0.8 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.23 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -105.41 131.64 52.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.348 0.594 . . . . 1.0 111.262 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.8 170.58 15.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.289 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -167.59 113.15 0.71 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.406 -0.816 . . . . 1.0 110.64 178.013 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.72 126.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.674 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.76 126.13 32.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.216 0.531 . . . . 1.0 110.371 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -167.41 170.29 11.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.68 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.87 142.98 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.581 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.99 -26.84 21.79 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -94.36 147.93 34.16 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 121.09 -0.244 . . . . 1.0 110.696 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -40.65 121.29 1.15 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.646 2.231 . . . . 1.0 112.505 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.99 -24.96 66.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.358 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.427 ' O ' HD13 ' A' ' 45' ' ' LEU . 92.4 m-85 -62.01 -18.45 60.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.624 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.1 mm -102.33 -33.1 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 123.321 0.388 . . . . 1.0 110.655 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -63.38 -38.34 90.76 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.207 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -60.06 -33.03 71.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.071 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 45' ' ' LEU . 9.4 mp -63.46 -38.77 92.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.667 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 70.0 t80 -76.3 14.89 0.66 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.989 0.424 . . . . 1.0 110.501 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 45' ' ' LEU . 82.1 tt0 -90.77 -23.66 20.58 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.689 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.9 pp -121.4 142.26 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.047 0.451 . . . . 1.0 110.544 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.46 143.95 54.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.344 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.77 -43.81 1.26 Allowed Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.246 -0.742 . . . . 1.0 111.246 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 51' ' ' VAL . 17.1 m -54.86 115.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.454 0.645 . . . . 1.0 111.274 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -88.47 -42.76 11.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.3 p -170.2 168.94 8.04 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.288 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.41 137.71 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.07 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -110.64 136.27 49.99 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.423 0.452 . . . . 1.0 109.896 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -124.11 118.74 27.6 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.382 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -165.76 141.3 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.42 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.51 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.4 OUTLIER 64.05 -149.58 0.3 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.948 178.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.51 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 55.9 p-10 -97.68 18.56 15.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.785 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 28.9 p90 -141.58 156.82 45.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 61' ' ' ILE . 28.5 pt -132.79 144.47 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.283 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 t -111.07 124.31 51.92 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.1 mt -112.2 125.58 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -116.5 133.27 56.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.215 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' HG3' ' HB3' ' A' ' 69' ' ' ALA . 4.0 ptpt -144.19 156.12 44.18 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.558 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -51.27 162.83 0.29 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.688 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.496 ' OD1' ' ND2' ' A' ' 13' ' ' ASN . 92.3 m-20 -69.99 -14.26 62.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.76 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -88.27 9.98 21.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.775 -0.193 . . . . 1.0 110.598 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.509 ' HB3' ' HG3' ' A' ' 65' ' ' LYS . . . -104.92 164.92 11.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.325 0.583 . . . . 1.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -150.04 134.01 16.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.477 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.461 ' CD2' ' SD ' ' A' ' 15' ' ' MET . 3.9 m0 -68.22 -18.09 64.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.256 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 73' ' ' GLU . 39.3 p-10 -57.78 -20.47 35.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.978 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.435 ' N ' ' OD1' ' A' ' 72' ' ' ASN . 80.7 mt-10 -95.24 -29.03 14.72 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.236 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 74' ' ' LEU . 8.8 mp -74.75 -39.41 61.85 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.976 -0.29 . . . . 1.0 111.298 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.437 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 2.2 mt -40.87 -62.35 1.02 Allowed Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 123.444 0.465 . . . . 1.0 111.917 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 36.8 Cg_endo -61.24 -27.84 84.1 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.878 1.718 . . . . 1.0 112.267 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -75.62 -49.97 16.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.288 0.566 . . . . 1.0 111.444 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 pt -70.28 -42.92 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.586 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -53.19 -35.13 59.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.263 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -63.47 -39.44 94.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.035 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.8 m -62.04 -48.08 81.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.013 0.435 . . . . 1.0 110.222 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.93 -44.59 80.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.987 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -45.17 -33.85 2.46 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.524 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 86' ' ' ASN . 9.3 mtpm? -67.04 -51.73 51.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.46 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.0 m -76.67 34.46 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.404 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 84' ' ' LYS . 24.6 m120 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.628 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.9 mtt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 82' ' ' PHE . 38.6 tp10 -109.49 106.55 16.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.053 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.7 mt -49.09 142.6 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.929 0.395 . . . . 1.0 110.421 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -120.05 -34.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.343 -0.844 . . . . 1.0 110.639 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.02 178.1 3.05 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.078 0.466 . . . . 1.0 110.177 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.1 pt -143.23 136.73 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.576 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.2 m -116.09 111.88 20.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.838 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.437 ' OE1' ' N ' ' A' ' 8' ' ' GLU . 39.2 mp0 -84.16 113.87 21.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -82.88 177.18 3.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.304 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.86 21.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.216 1.944 . . . . 1.0 112.296 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 9' ' ' THR . 94.3 m-20 -103.5 -178.25 3.61 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.55 -55.26 2.54 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.794 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' A' ' 67' ' ' ASP . 20.3 p30 -100.94 3.83 42.03 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.284 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -116.22 131.36 56.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.6 mtt -146.23 153.54 40.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.816 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -106.8 135.99 47.4 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.805 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.46 120.68 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.748 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.2 t -96.06 127.57 42.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.327 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -164.33 154.42 14.44 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.419 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -92.71 99.07 11.83 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' OE2' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -82.91 151.39 63.86 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.281 -0.418 . . . . 1.0 109.999 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.74 -18.83 32.1 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.535 2.156 . . . . 1.0 112.038 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -67.48 91.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.963 0.411 . . . . 1.0 110.961 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -88.44 26.54 1.43 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.165 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -128.3 8.33 6.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.665 -0.243 . . . . 1.0 110.438 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 38.06 80.81 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.485 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.2 t -103.64 126.3 50.7 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.078 -0.341 . . . . 1.0 110.078 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 54.1 p90 -99.08 132.94 44.02 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 m -166.95 107.01 0.62 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.618 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.8 m -81.11 120.78 25.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.358 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -141.65 164.72 29.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.671 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 32' ' ' THR . 9.7 t -168.97 113.89 0.57 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.253 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.93 132.68 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.51 -0.313 . . . . 1.0 110.357 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.439 ' O ' ' NE2' ' A' ' 35' ' ' GLN . . . -81.29 122.69 27.75 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 1.0 110.068 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 34' ' ' ALA . 99.1 mm-40 -143.34 155.7 44.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.317 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.71 142.38 46.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.837 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.67 -3.55 55.0 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -98.71 155.61 36.52 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 122.889 -0.183 . . . . 1.0 110.583 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -36.34 109.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.866 2.378 . . . . 1.0 112.453 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.62 -36.59 74.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.936 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -55.83 -51.7 66.57 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.641 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.09 -41.22 91.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.957 0.408 . . . . 1.0 110.364 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -59.86 -38.92 83.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.01 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -61.02 -39.52 90.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.869 0.366 . . . . 1.0 110.421 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.44 ' O ' HG22 ' A' ' 48' ' ' ILE . 8.5 mp -63.63 -41.8 98.23 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.996 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -65.07 -29.09 69.95 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.911 -0.715 . . . . 1.0 111.14 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.79 -10.08 59.24 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.097 -0.241 . . . . 1.0 111.347 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -105.89 134.55 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.844 0.355 . . . . 1.0 110.301 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.624 ' N ' HD13 ' A' ' 48' ' ' ILE . 17.8 tp10 -73.26 128.84 36.63 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.32 -37.78 1.88 Allowed Glycine 0 N--CA 1.461 0.357 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.74 128.39 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.581 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.473 ' NZ ' ' OD1' ' A' ' 64' ' ' ASP . 27.7 mtmm -99.87 -40.8 7.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.421 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.6 m -165.71 171.19 13.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.362 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.4 137.35 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.04 -0.527 . . . . 1.0 109.998 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -111.46 133.4 53.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.698 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -122.88 108.16 12.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.221 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 60' ' ' PHE . 11.1 p -164.43 147.51 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.104 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 64.68 -160.54 0.29 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.897 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 19' ' ' LEU . 81.7 m-20 -89.3 15.03 9.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 57' ' ' VAL . 40.9 p90 -147.88 158.98 44.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.442 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 pt -129.44 152.19 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.411 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.0 m -113.91 118.96 35.65 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.9 mt -104.88 114.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.076 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.473 ' OD1' ' NZ ' ' A' ' 52' ' ' LYS . 60.2 t0 -98.04 126.24 43.38 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.419 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HZ3' ' HB1' ' A' ' 69' ' ' ALA . 4.8 mtmp? -139.15 143.91 38.38 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.45 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' OE1' ' ND2' ' A' ' 68' ' ' ASN . 95.6 mt-10 -55.71 167.66 0.52 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.351 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.438 ' HA ' HD21 ' A' ' 13' ' ' ASN . 50.5 p-10 -68.62 -23.79 64.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.827 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 9.9 p30 -77.93 -7.2 56.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.785 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.546 ' HB1' ' HZ3' ' A' ' 65' ' ' LYS . . . -76.04 142.49 41.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -126.9 119.95 28.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.297 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -60.28 -28.81 68.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.739 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -57.53 -16.61 10.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.572 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -97.92 -34.63 10.76 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.33 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 74' ' ' LEU . 8.7 mp -74.27 -39.83 62.73 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.33 -0.231 . . . . 1.0 110.948 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 3.9 mp -41.92 -62.55 1.11 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.025 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 37.4 Cg_endo -60.56 -27.5 84.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.768 1.645 . . . . 1.0 112.124 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.56 -53.72 7.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.985 0.421 . . . . 1.0 111.491 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 pt -70.6 -44.1 77.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.031 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -52.07 -32.81 36.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.327 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -64.54 -39.43 93.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.227 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.5 m -62.99 -50.49 70.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.899 0.381 . . . . 1.0 110.71 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.448 ' CE1' ' OE2' ' A' ' 2' ' ' GLU . 3.0 t80 -62.06 -48.56 79.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.011 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.88 97.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.793 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -78.35 5.0 11.47 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.92 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m -57.26 -41.83 80.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.477 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.691 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -157.5 149.81 22.68 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.605 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 3' ' ' ILE . 18.0 tt -50.86 118.47 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.495 0.664 . . . . 1.0 111.082 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mm -92.25 -48.33 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.2 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.91 178.76 9.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.213 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 tt -132.49 135.64 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.264 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 t -100.61 111.26 23.47 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.047 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.29 110.45 16.76 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -87.32 177.63 2.64 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 -178.403 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.25 7.95 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.988 1.792 . . . . 1.0 112.229 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 9' ' ' THR . 22.6 m120 -93.25 171.69 8.76 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.421 ' O ' ' CZ2' ' A' ' 71' ' ' TRP . 80.0 m80 -111.59 -38.29 4.95 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.169 -0.468 . . . . 1.0 111.352 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -110.42 -2.33 16.64 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.795 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -113.81 130.87 56.41 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.472 ' SD ' ' CG ' ' A' ' 71' ' ' TRP . 11.7 ptt? -142.74 151.81 41.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 1.0 109.767 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -113.89 138.34 50.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.947 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.8 t -100.44 127.6 53.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 t -104.22 132.32 50.6 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -169.64 158.04 7.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.91 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -102.75 86.19 2.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -98.22 146.16 31.05 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.37 86.14 0.83 Allowed 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.144 1.896 . . . . 1.0 111.924 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' NE ' ' OH ' ' A' ' 56' ' ' TYR . 37.6 mmt180 -133.85 89.68 2.61 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.109 0.48 . . . . 1.0 110.341 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -94.91 20.6 8.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.378 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 27' ' ' SER . 94.6 m-20 -129.6 -6.92 4.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.78 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 54.7 -84.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.607 -0.27 . . . . 1.0 110.396 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 25' ' ' ASP . 14.4 p 56.77 107.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.985 0.422 . . . . 1.0 110.112 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 51.9 p90 -100.09 127.65 46.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.346 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.8 m -161.42 132.54 5.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.416 ' CB ' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -101.8 120.15 39.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.259 0.552 . . . . 1.0 111.038 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -140.14 133.49 29.9 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.817 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 32' ' ' THR . 10.4 t -138.24 116.44 11.82 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.037 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 170.07 137.63 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.957 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.16 122.37 32.39 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -154.16 154.36 33.42 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.11 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -71.16 128.87 37.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.797 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.51 -19.82 52.5 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.437 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 38.9 mm-40 -82.18 152.0 67.31 Favored Pre-proline 0 CA--C 1.543 0.709 0 O-C-N 122.746 -0.267 . . . . 1.0 110.602 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.17 119.74 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.606 2.204 . . . . 1.0 112.923 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -68.77 -23.32 64.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.539 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.601 ' C ' HD12 ' A' ' 42' ' ' ILE . 56.7 m-85 -69.26 -10.2 56.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.961 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.601 HD12 ' C ' ' A' ' 41' ' ' PHE . 2.0 mp -118.07 -33.71 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 123.3 0.375 . . . . 1.0 110.312 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 38' ' ' GLN . 67.3 m-20 -63.18 -39.87 95.89 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.211 -0.595 . . . . 1.0 110.71 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.454 ' NH1' ' OG1' ' A' ' 81' ' ' THR . 25.0 mmt85 -64.51 -34.67 78.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.49 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.7 mp -63.21 -41.05 99.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.005 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -69.8 -5.2 23.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.861 -0.336 . . . . 1.0 111.034 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -68.12 -24.3 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.634 -0.257 . . . . 1.0 111.364 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.483 HG12 HD11 ' A' ' 74' ' ' LEU . 2.3 pp -121.76 142.99 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.899 0.381 . . . . 1.0 110.816 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -67.14 143.85 56.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.847 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.93 -40.42 1.59 Allowed Glycine 0 N--CA 1.465 0.601 0 N-CA-C 111.452 -0.659 . . . . 1.0 111.452 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.11 112.38 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.543 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -82.02 -50.86 8.63 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.042 0.448 . . . . 1.0 110.176 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.8 p -160.96 160.54 30.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 30' ' ' THR . 49.5 mm -121.73 151.57 25.23 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.921 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.37 120.93 20.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.495 ' OH ' ' NE ' ' A' ' 23' ' ' ARG . 53.1 t80 -114.7 118.41 33.55 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.689 -0.485 . . . . 1.0 109.689 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -164.57 148.39 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.413 . . . . 1.0 110.192 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER 63.85 -138.94 0.32 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.774 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' H ' HD12 ' A' ' 58' ' ' LEU . 56.0 p30 -110.25 23.79 13.83 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 122.619 0.367 . . . . 1.0 110.865 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -147.42 157.56 43.63 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 mp -126.52 132.84 69.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 1.0 109.844 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t -103.11 123.58 46.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.433 ' CG2' ' NZ ' ' A' ' 65' ' ' LYS . 65.4 mt -112.05 127.52 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.673 -0.492 . . . . 1.0 109.673 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.04 111.72 23.03 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.579 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' NZ ' ' CG2' ' A' ' 63' ' ' ILE . 47.3 mttp -115.78 155.75 27.26 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.388 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 67' ' ' ASP . 7.3 tp10 -67.09 175.25 2.66 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.412 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 90.8 m-20 -70.12 -20.32 63.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.032 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -85.74 3.03 43.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.71 0.291 . . . . 1.0 111.098 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.21 153.36 17.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.423 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.32 121.82 14.13 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.032 0.444 . . . . 1.0 110.362 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.472 ' CG ' ' SD ' ' A' ' 15' ' ' MET . 5.6 m0 -58.16 -26.47 62.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.539 . . . . 1.0 111.266 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -56.48 -36.61 69.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.749 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -74.56 -40.29 61.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.646 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.9 mm? -70.7 -38.43 73.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mp -39.55 -62.49 0.82 Allowed Pre-proline 0 CA--C 1.541 0.599 0 O-C-N 123.441 0.463 . . . . 1.0 110.89 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.38 -22.61 59.54 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.783 1.656 . . . . 1.0 112.11 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.432 ' NE2' ' O ' ' A' ' 44' ' ' ARG . 14.2 tt0 -76.47 -53.47 8.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.975 0.417 . . . . 1.0 111.621 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 pt -71.33 -40.32 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.824 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -50.91 -31.05 16.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.347 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -63.95 -39.67 94.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.326 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.454 ' OG1' ' NH1' ' A' ' 44' ' ' ARG . 21.6 m -60.1 -48.7 80.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.823 0.344 . . . . 1.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.511 ' CZ ' ' CD1' ' A' ' 41' ' ' PHE . 98.0 m-85 -69.51 -37.29 77.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.572 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.28 -43.07 92.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.662 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -62.46 -61.41 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.75 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.8 t -60.12 -45.73 92.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.459 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.696 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 66.7 mtt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.449 -0.574 . . . . 1.0 109.449 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.78 125.04 42.28 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.417 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 4' ' ' ILE . 85.0 mt -49.37 155.64 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-O 120.776 0.322 . . . . 1.0 110.267 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.416 ' N ' HG22 ' A' ' 3' ' ' ILE . 48.1 mm -127.25 -37.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.434 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -171.65 158.69 5.13 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.127 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.466 ' CG2' ' SD ' ' A' ' 15' ' ' MET . 74.9 mt -104.23 131.83 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 m -114.56 104.85 12.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.105 0.479 . . . . 1.0 110.007 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -76.86 144.78 38.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.085 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -122.71 161.76 42.24 Favored Pre-proline 0 N--CA 1.472 0.655 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.0 21.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.529 2.153 . . . . 1.0 112.215 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 9' ' ' THR . 14.9 m120 -96.42 -174.23 2.99 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.457 ' O ' ' CH2' ' A' ' 71' ' ' TRP . 59.3 t-80 -110.72 -51.27 2.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.825 0.345 . . . . 1.0 111.652 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 65' ' ' LYS . 42.2 p30 -116.22 7.57 14.11 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.875 -0.602 . . . . 1.0 112.103 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 m -111.72 130.06 55.91 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.466 ' SD ' ' CG2' ' A' ' 6' ' ' ILE . 38.8 ttm -139.7 150.9 45.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -107.29 131.4 54.25 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.94 -0.573 . . . . 1.0 109.579 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.7 t -108.61 109.98 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -90.48 133.19 35.22 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.6 pt? -166.05 155.55 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.063 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -88.25 83.79 6.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 23' ' ' ARG . 20.8 pt-20 -107.16 147.36 35.02 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -38.66 86.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 122.456 2.104 . . . . 1.0 112.85 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 21' ' ' GLU . 49.2 ptt85 -78.49 -18.66 54.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.706 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -43.48 -27.41 0.28 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.122 0.487 . . . . 1.0 110.502 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -70.84 -42.59 69.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.432 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 23' ' ' ARG . 1.4 p-10 38.82 49.55 1.54 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.765 0.317 . . . . 1.0 111.41 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.5 t -120.02 142.59 48.67 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.21 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 46.2 p90 -102.79 131.21 49.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.217 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.41 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.1 m -160.81 108.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -79.64 117.79 20.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.668 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 29' ' ' THR . 9.5 p90 -142.27 162.38 35.63 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.252 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -170.34 114.08 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.562 . . . . 1.0 109.972 177.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 169.29 139.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.296 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.8 120.97 25.35 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.799 -0.445 . . . . 1.0 109.799 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -148.07 146.91 29.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.029 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -70.5 142.75 51.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.828 -0.624 . . . . 1.0 111.122 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.22 -13.03 62.73 Favored Glycine 0 N--CA 1.46 0.286 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -97.3 147.42 32.94 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 122.837 -0.214 . . . . 1.0 110.932 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -41.92 128.06 3.88 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.136 1.891 . . . . 1.0 112.896 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.452 ' OE2' ' NZ ' ' A' ' 84' ' ' LYS . 95.9 mt-10 -66.89 -26.28 66.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.023 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.453 ' O ' HD13 ' A' ' 45' ' ' LEU . 99.3 m-85 -60.26 -11.98 7.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.903 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -110.32 -39.65 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 110.105 -0.331 . . . . 1.0 110.105 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -66.23 -38.15 87.22 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.863 -0.335 . . . . 1.0 111.281 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -60.23 -34.09 73.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.19 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.2 mp -66.02 -36.86 84.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.21 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 75.7 t80 -74.11 13.41 0.55 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.818 0.342 . . . . 1.0 111.193 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 45' ' ' LEU . 80.8 mm-40 -87.51 -20.92 25.84 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.611 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.15 142.2 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.3 pm0 -68.71 148.96 49.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.095 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.61 -36.0 3.01 Favored Glycine 0 N--CA 1.468 0.779 0 N-CA-C 111.366 -0.693 . . . . 1.0 111.366 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.82 114.88 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.3 0.571 . . . . 1.0 110.656 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.87 -42.81 8.89 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 p -165.04 161.74 19.96 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.508 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.8 mt -130.98 136.2 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -111.34 129.63 55.94 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.156 -0.474 . . . . 1.0 109.866 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -124.17 118.46 26.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.632 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 p -164.79 146.92 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.997 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 tp 62.4 -131.25 0.57 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.83 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 19' ' ' LEU . 48.3 p-10 -115.25 23.56 12.36 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.156 0.582 . . . . 1.0 110.971 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.35 159.63 43.11 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.7 pt -132.09 149.44 32.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.147 -0.479 . . . . 1.0 109.808 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.2 t -114.96 122.49 46.43 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.31 115.42 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -100.37 114.95 28.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.1 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.487 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 38.6 mtmt -125.47 153.12 44.0 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.674 0.273 . . . . 1.0 110.793 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -61.79 167.58 3.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.854 -0.424 . . . . 1.0 109.854 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.08 -18.62 65.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.649 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -85.95 4.5 37.34 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.862 0.363 . . . . 1.0 110.768 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.33 149.54 21.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.281 0.562 . . . . 1.0 110.502 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -138.31 126.86 23.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.142 -0.935 . . . . 1.0 110.654 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.457 ' CH2' ' O ' ' A' ' 12' ' ' HIS . 4.5 m-90 -57.72 -27.43 62.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.978 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -55.49 -29.61 59.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.331 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.53 -35.6 30.14 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.132 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.7 mm? -70.51 -38.78 74.34 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 121.078 -0.249 . . . . 1.0 111.601 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mt -39.92 -62.62 0.83 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.165 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -62.74 -24.21 74.64 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.895 1.73 . . . . 1.0 112.315 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -75.95 -54.05 7.47 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.465 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.3 pt -67.5 -41.24 85.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.524 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.32 -28.37 7.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.255 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -58.73 -33.38 70.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.142 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.7 p -64.44 -44.35 91.42 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.139 0.495 . . . . 1.0 110.245 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.13 -36.13 83.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.576 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -46.19 -46.87 17.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.908 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.452 ' NZ ' ' OE2' ' A' ' 40' ' ' GLU . 98.9 mttt -62.66 -49.35 75.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.399 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.1 p -60.12 -51.4 69.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.582 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.0 t30 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.941 -1.028 . . . . 1.0 110.502 179.862 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ptp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -149.86 139.95 22.07 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.506 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 99.1 mt -51.65 118.23 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-O 121.05 0.452 . . . . 1.0 110.804 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 67.8 mt -92.81 -35.24 6.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.038 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.5 151.63 1.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.226 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.6 mt -107.42 125.91 63.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -107.25 116.9 32.74 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.99 0.424 . . . . 1.0 110.437 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -72.67 145.93 46.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.434 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -121.68 168.72 10.64 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.293 -179.235 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.69 -7.8 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.47 2.113 . . . . 1.0 112.159 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' THR . 98.4 m-20 -92.83 173.95 7.49 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.071 0.462 . . . . 1.0 110.05 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.56 ' CG ' ' N ' ' A' ' 13' ' ' ASN . 46.0 p-80 -113.7 -55.1 2.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.34 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.56 ' N ' ' CG ' ' A' ' 12' ' ' HIS . 51.0 p30 -82.62 3.7 27.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.866 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -124.23 145.66 49.22 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.27 0.557 . . . . 1.0 109.98 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.3 tpp -144.8 153.78 42.0 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.703 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -101.65 123.94 46.49 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.058 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.5 t -104.07 106.52 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.932 0.396 . . . . 1.0 110.007 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -88.85 134.44 33.94 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.746 0.308 . . . . 1.0 110.445 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.687 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.5 pt? -170.17 160.77 8.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.056 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -81.06 99.02 8.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.995 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 14.0 mm-40 -131.04 52.46 9.53 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 121.088 0.47 . . . . 1.0 110.191 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 43.1 Cg_endo -66.56 145.67 77.09 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.065 1.843 . . . . 1.0 111.819 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.496 ' C ' ' H ' ' A' ' 25' ' ' ASP . 72.9 ttt180 -155.84 140.7 17.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.361 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.664 ' CD ' ' H ' ' A' ' 24' ' ' GLN . 2.2 pm0 -60.99 0.46 0.22 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.41 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 23' ' ' ARG . 66.7 t0 -138.33 52.53 1.83 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.62 -0.263 . . . . 1.0 110.497 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -69.65 54.16 0.12 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.392 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.0 t -79.12 169.49 18.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.123 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 54.4 p90 -102.77 127.44 49.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.136 0.493 . . . . 1.0 110.515 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.2 m -161.72 149.28 14.66 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.041 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.67 130.14 52.18 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.18 -0.463 . . . . 1.0 111.013 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.74 170.26 16.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.41 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 32' ' ' THR . 8.9 t -167.43 116.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.669 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 168.15 134.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.095 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.59 120.83 31.99 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.119 0.485 . . . . 1.0 110.413 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -147.94 153.15 38.67 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.712 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -68.14 131.42 45.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.283 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.37 -16.35 57.81 Favored Glycine 0 N--CA 1.466 0.677 0 N-CA-C 110.743 -0.943 . . . . 1.0 110.743 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -88.24 151.7 49.23 Favored Pre-proline 0 N--CA 1.455 -0.18 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.64 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -36.86 114.23 0.12 Allowed 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.81 2.34 . . . . 1.0 112.879 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.81 -27.2 66.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.394 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.519 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 39.1 m-85 -60.8 -23.71 65.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.384 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.9 mm -100.36 -31.34 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.75 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -63.57 -40.53 97.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.037 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -59.75 -32.74 70.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.068 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.6 mp -66.65 -39.35 88.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.874 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.3 -22.82 65.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.852 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.56 -15.29 63.58 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.874 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.45 140.4 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.413 0.625 . . . . 1.0 110.31 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.63 136.37 41.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.135 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.54 -43.28 1.19 Allowed Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 51' ' ' VAL . 14.8 p -60.22 119.69 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.158 0.504 . . . . 1.0 111.104 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -96.76 -42.71 7.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 1.0 109.99 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.4 p -166.19 165.99 17.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.301 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 54' ' ' ILE . 4.5 mp -135.34 152.84 32.64 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.889 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.447 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -127.4 129.73 48.08 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.421 0.451 . . . . 1.0 109.981 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -121.76 122.66 40.01 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.194 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -164.89 149.02 2.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.506 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.0 tp 57.39 -128.5 1.7 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.127 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -118.97 24.31 10.9 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 123.302 0.376 . . . . 1.0 110.822 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -144.42 155.69 43.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 pt -129.68 147.58 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.329 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.7 m -120.29 119.92 34.57 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.411 -0.588 . . . . 1.0 109.411 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.2 mt -105.25 124.41 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.549 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -101.32 124.78 47.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.443 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.414 ' NZ ' HD21 ' A' ' 74' ' ' LEU . 4.5 mtpt -135.66 154.17 51.38 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.267 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 67' ' ' ASP . 71.0 tt0 -61.52 169.89 2.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.48 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.442 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 50.9 t0 -67.8 -21.86 65.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.118 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -82.96 -5.41 59.06 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.773 0.32 . . . . 1.0 110.568 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.5 152.49 26.03 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.074 0.464 . . . . 1.0 110.51 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -141.69 118.68 11.24 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.299 0.571 . . . . 1.0 109.787 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -57.64 -21.24 38.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.988 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -57.92 -35.18 70.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.561 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -75.95 -35.89 59.53 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 121.11 0.481 . . . . 1.0 110.607 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 74' ' ' LEU . 9.2 mp -69.12 -37.81 78.53 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.212 -0.305 . . . . 1.0 111.3 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.456 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 3.6 mp -38.4 -63.67 0.54 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.021 0.378 . . . . 1.0 112.021 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 40.0 Cg_endo -62.26 -26.51 77.45 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.428 2.086 . . . . 1.0 112.551 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -76.15 -54.38 6.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.301 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.5 pt -69.77 -42.95 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.916 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -51.34 -35.73 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.145 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -66.59 -36.69 83.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.472 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.1 m -57.25 -47.21 81.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.02 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.519 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 95.3 m-85 -70.72 -33.14 70.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 1.0 111.028 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.91 -48.12 81.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.749 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 84' ' ' LYS . 4.5 mptp? -83.22 -10.58 58.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.755 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.1 t -61.06 -46.63 89.9 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.619 0.574 . . . . 1.0 110.568 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.3 t30 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.848 -1.072 . . . . 1.0 110.53 -179.794 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -142.83 139.23 30.82 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.956 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.7 pt -51.7 146.62 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.542 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 mm -123.31 -43.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.356 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.05 140.73 7.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.43 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.19 123.53 60.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.622 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.1 m -106.09 103.25 12.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.205 -0.452 . . . . 1.0 109.87 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -70.21 155.63 40.37 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -132.35 158.36 75.83 Favored Pre-proline 0 N--CA 1.474 0.763 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 -178.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.85 32.62 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.436 2.091 . . . . 1.0 112.023 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 9' ' ' THR . 13.5 m120 -90.62 -169.57 2.43 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -109.98 -39.57 5.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.521 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' C ' HD21 ' A' ' 13' ' ' ASN . 0.2 OUTLIER -145.29 15.3 1.48 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.993 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -116.32 125.5 52.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.541 -0.3 . . . . 1.0 110.276 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.24 148.39 46.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.178 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -100.6 137.98 38.27 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.229 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.64 108.4 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -92.4 131.44 37.56 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.2 pt? -169.11 165.09 11.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.955 0.407 . . . . 1.0 110.515 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.8 t -84.38 119.48 25.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.969 0.414 . . . . 1.0 110.754 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -131.12 75.16 78.6 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.73 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.52 143.43 99.45 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.284 1.99 . . . . 1.0 111.977 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -166.97 155.7 10.18 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -43.0 -59.7 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 1.0 111.092 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' SER . 52.8 p-10 -143.29 60.47 1.4 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 119.235 -0.412 . . . . 1.0 111.869 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.45 ' HB3' ' H ' ' A' ' 58' ' ' LEU . 22.2 m-80 -23.08 83.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.392 0.615 . . . . 1.0 112.26 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' ASP . 13.9 m -93.31 -151.99 0.32 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.455 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -123.07 145.15 48.79 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.427 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 m -167.07 107.11 0.61 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.119 -0.697 . . . . 1.0 109.119 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.2 m -84.27 115.64 22.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.273 0.559 . . . . 1.0 110.331 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -141.41 167.16 22.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.651 -0.704 . . . . 1.0 110.198 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.556 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 98.1 m -170.21 112.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.96 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.57 137.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.309 . . . . 1.0 110.807 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.8 112.37 8.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.157 0.504 . . . . 1.0 110.659 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -150.77 147.51 27.39 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.71 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.49 143.97 53.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.71 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.84 -25.47 20.68 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -102.65 146.76 32.96 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 116.949 0.374 . . . . 1.0 110.493 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -41.98 123.95 2.64 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.08 1.853 . . . . 1.0 112.627 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -45.33 -23.7 0.22 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.769 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -56.4 -43.05 78.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.49 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.5 mm -62.29 -47.05 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.676 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -62.02 -39.64 92.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.746 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -57.52 -49.08 77.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mt -55.63 -39.1 70.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 73.6 t80 -77.37 16.18 0.65 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.84 0.352 . . . . 1.0 110.756 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -95.7 -35.95 11.38 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.567 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -115.17 139.72 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.855 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -62.04 136.11 57.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.782 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.98 -42.85 0.98 Allowed Glycine 0 C--O 1.228 -0.256 0 N-CA-C 111.28 -0.728 . . . . 1.0 111.28 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 51' ' ' VAL . 13.2 p -66.02 113.18 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.136 0.493 . . . . 1.0 111.205 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -83.68 -49.38 9.2 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -158.81 153.74 25.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.411 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 51' ' ' VAL . 48.9 mm -121.12 136.43 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.673 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -112.49 142.93 44.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.826 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -135.41 117.0 14.88 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.859 -0.422 . . . . 1.0 109.859 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' PHE . 8.8 p -165.79 145.18 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.226 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.45 ' H ' ' HB3' ' A' ' 26' ' ' ASN . 0.4 OUTLIER 58.33 -156.17 0.33 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.195 0.522 . . . . 1.0 110.966 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 19' ' ' LEU . 82.8 m-20 -91.51 13.42 17.78 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' A' ' 57' ' ' VAL . 36.4 p90 -140.71 149.11 41.77 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.703 0.287 . . . . 1.0 110.235 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 pt -128.17 159.66 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.9 p -122.85 130.24 52.63 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.6 mt -115.36 110.47 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.524 -0.546 . . . . 1.0 109.524 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.54 109.75 21.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.331 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.655 ' NZ ' ' HE1' ' A' ' 71' ' ' TRP . 24.3 mtmm -122.14 153.66 38.44 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.222 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.31 164.91 17.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.203 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 68' ' ' ASN . 42.6 p-10 -58.48 -28.74 65.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.736 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 71.3 m-20 -70.32 3.29 3.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.583 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.53 145.43 24.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.274 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.47 HD22 ' CD ' ' A' ' 73' ' ' GLU . 5.5 p30 -140.88 123.4 15.98 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.26 -0.427 . . . . 1.0 109.991 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.655 ' HE1' ' NZ ' ' A' ' 65' ' ' LYS . 3.1 m0 -64.78 -27.23 68.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.237 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -57.57 -16.25 9.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.583 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' CD ' HD22 ' A' ' 70' ' ' ASN . 97.0 mt-10 -96.01 -33.5 12.11 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.588 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 74' ' ' LEU . 4.0 mm? -74.86 -31.3 61.59 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.066 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -41.17 -61.94 1.19 Allowed Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 123.022 0.201 . . . . 1.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.97 -24.81 67.01 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.06 1.84 . . . . 1.0 112.718 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -79.06 -55.75 4.89 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.108 0.48 . . . . 1.0 111.56 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.461 ' O ' ' OG1' ' A' ' 81' ' ' THR . 2.3 pp -65.23 -39.01 84.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.044 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -49.11 -29.42 5.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.906 0.384 . . . . 1.0 110.606 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -70.69 -25.95 63.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.615 -0.266 . . . . 1.0 111.307 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 78' ' ' ILE . 81.9 p -60.62 -48.78 80.25 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.916 0.389 . . . . 1.0 111.921 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -35.65 58.29 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.221 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.85 69.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.396 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -67.63 -1.62 5.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.49 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.3 p -60.78 -33.1 72.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.517 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.5 p30 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.545 179.761 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 110.61 -0.144 . . . . 1.0 110.61 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -57.32 119.87 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.87 0.843 . . . . 1.0 111.553 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.01 -48.74 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.519 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.56 179.12 7.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.45 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 pt -131.05 125.4 57.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.253 -0.885 . . . . 1.0 110.421 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.8 t -89.0 110.35 21.06 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -86.84 99.56 11.91 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.489 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -84.63 159.66 57.79 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.678 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.41 31.17 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.632 2.221 . . . . 1.0 111.846 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 9' ' ' THR . 12.1 m120 -93.49 -165.94 1.42 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -108.57 -56.18 2.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.991 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 69' ' ' ALA . 2.6 m-20 -129.22 10.46 5.8 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.359 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.5 m -109.29 130.77 55.48 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.492 ' SD ' ' CE2' ' A' ' 71' ' ' TRP . 10.5 ptp -150.85 153.57 35.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -102.65 134.31 46.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.644 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.4 t -109.44 110.39 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.546 -0.539 . . . . 1.0 109.546 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m -90.38 134.42 34.34 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.462 -0.569 . . . . 1.0 109.462 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.649 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -167.38 151.92 6.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.453 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 m -84.09 84.06 7.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.937 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 179.395 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.521 -0.158 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 54.3 p90 -102.09 129.95 48.56 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.158 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 m -166.26 136.3 3.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.889 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.97 116.53 29.36 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.406 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -141.35 160.68 39.62 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.578 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 32' ' ' THR . 9.9 t -171.32 116.61 0.43 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.037 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 170.62 130.94 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.978 -0.379 . . . . 1.0 109.978 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.09 117.48 20.94 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.928 0.394 . . . . 1.0 110.039 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -147.17 150.85 35.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.319 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -68.93 141.77 54.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.691 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 -8.53 76.26 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 110.821 -0.911 . . . . 1.0 110.821 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -99.09 147.52 33.36 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 121.119 -0.232 . . . . 1.0 111.018 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.26 127.47 2.99 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.214 1.943 . . . . 1.0 112.728 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.44 -24.79 63.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.291 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 37.4 m-85 -65.3 -12.99 57.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.945 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -110.68 -37.86 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.977 0.418 . . . . 1.0 110.24 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -63.68 -39.14 93.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.153 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -61.32 -35.57 77.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.053 0.454 . . . . 1.0 110.899 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 45' ' ' LEU . 9.8 mp -66.9 -37.41 84.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.829 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -66.3 -21.27 66.26 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.259 -0.576 . . . . 1.0 111.095 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -70.4 -4.5 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.602 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -117.95 134.29 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 110.08 -0.341 . . . . 1.0 110.08 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.621 ' N ' HD13 ' A' ' 48' ' ' ILE . 19.3 pt-20 -72.63 133.39 44.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.965 -0.561 . . . . 1.0 109.794 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 139.07 -46.5 0.96 Allowed Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.23 134.81 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -118.95 -30.91 4.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.196 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.1 p -160.99 154.05 21.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.892 0.377 . . . . 1.0 110.023 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.1 mt -134.83 125.21 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.149 -0.685 . . . . 1.0 109.149 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.86 130.1 48.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 1.0 110.442 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -119.87 118.07 29.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.825 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.93 143.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.457 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.455 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.4 OUTLIER 62.35 -150.05 0.37 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.853 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 86.6 m-20 -97.35 16.82 18.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -141.99 157.13 45.3 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.9 pt -134.25 154.0 36.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.229 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -125.79 123.21 38.27 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.42 127.39 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.202 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -103.37 120.21 40.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.08 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.746 ' HZ3' ' CD2' ' A' ' 74' ' ' LEU . 63.4 mttt -135.81 148.34 48.68 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.613 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 96.8 mt-10 -58.98 172.48 0.55 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.525 -0.761 . . . . 1.0 109.927 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.39 -13.67 61.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.29 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -90.84 12.23 20.04 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.628 -0.26 . . . . 1.0 111.009 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -100.96 147.8 25.75 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' ND2' ' CG ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -138.43 120.72 15.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.492 ' CE2' ' SD ' ' A' ' 15' ' ' MET . 95.9 m95 -64.81 -17.05 63.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.715 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -59.64 -20.83 58.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.874 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' CG ' ' ND2' ' A' ' 70' ' ' ASN . 81.0 mm-40 -98.0 -30.36 12.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.819 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.746 ' CD2' ' HZ3' ' A' ' 65' ' ' LYS . 9.3 mp -71.28 -38.83 71.8 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.473 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.8 mp -39.4 -63.16 0.68 Allowed Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 123.368 0.418 . . . . 1.0 110.735 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.95 -22.38 68.47 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.492 1.461 . . . . 1.0 111.927 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -75.43 -54.74 6.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.83 0.348 . . . . 1.0 111.415 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.7 pt -72.8 -40.82 61.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -51.17 -30.18 16.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.138 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -63.78 -41.07 98.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.16 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -62.2 -50.78 70.42 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.705 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 78.4 m-85 -67.96 -41.53 82.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.778 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.74 69.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.266 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.035 -179.766 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.468 0.44 0 CA-C-O 120.37 0.129 . . . . 1.0 110.785 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 98.0 mt -58.68 120.01 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.161 0.505 . . . . 1.0 111.147 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.21 -45.83 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.887 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.68 179.08 4.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.94 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.2 mt -130.05 128.5 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.871 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.9 t -95.14 113.08 24.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.867 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.55 100.95 10.43 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.877 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -83.58 159.18 61.73 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.789 -0.641 . . . . 1.0 109.975 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.62 29.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.579 2.186 . . . . 1.0 111.861 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 9' ' ' THR . 9.2 m120 -96.72 -168.7 1.76 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -110.5 -60.13 1.85 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.482 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -116.82 5.1 13.0 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.298 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.8 m -107.53 127.53 53.7 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.2 mtt -142.32 150.5 40.88 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -106.11 131.0 53.9 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.738 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 t -107.39 113.74 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.0 m -92.09 128.38 37.92 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.811 -0.441 . . . . 1.0 109.811 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.704 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.7 pt? -162.08 150.09 14.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.618 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.1 t -87.25 78.76 8.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.819 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 . . . . . 0 CA--C 1.538 0.495 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.164 179.762 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.439 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 51.8 p90 -101.75 131.5 48.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.8 m -159.55 112.3 2.17 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.0 m -94.76 123.82 38.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.841 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.71 170.59 15.48 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.183 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -171.16 113.01 0.38 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.384 -0.826 . . . . 1.0 110.342 178.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.15 133.96 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.174 -0.306 . . . . 1.0 110.174 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.19 113.11 19.8 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.873 0.368 . . . . 1.0 110.205 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -146.04 149.63 34.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.345 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.35 138.54 53.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.824 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.31 -13.94 62.29 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -91.4 151.39 42.67 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 121.016 -0.274 . . . . 1.0 110.923 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -38.9 117.69 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.644 2.23 . . . . 1.0 112.708 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.2 mp0 -63.95 -23.33 67.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.939 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.508 ' O ' HD13 ' A' ' 45' ' ' LEU . 36.9 t80 -69.04 -8.57 46.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.758 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 41' ' ' PHE . 1.6 mp -111.64 -41.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -63.33 -40.17 96.57 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.254 -0.578 . . . . 1.0 111.122 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.42 ' CD ' ' OG1' ' A' ' 81' ' ' THR . 92.7 mtt-85 -61.11 -32.92 72.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.615 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 45' ' ' LEU . 7.9 mp -65.56 -39.24 91.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.749 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -68.27 -20.23 64.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.065 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -59.7 -23.84 63.46 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.093 -0.243 . . . . 1.0 111.646 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.98 141.69 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 110.105 -0.332 . . . . 1.0 110.105 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.34 138.29 56.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.784 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.1 -55.7 0.57 Allowed Glycine 0 N--CA 1.465 0.6 0 N-CA-C 111.382 -0.687 . . . . 1.0 111.382 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 51' ' ' VAL . 12.3 p -61.26 126.58 19.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.785 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -106.02 -30.1 9.51 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -167.03 161.29 14.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.468 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.56 131.85 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 116.135 -0.484 . . . . 1.0 109.709 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.42 121.98 46.65 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -122.13 112.32 18.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.716 -0.674 . . . . 1.0 109.47 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 60' ' ' PHE . 11.5 p -164.99 149.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.217 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.26 -156.27 0.28 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.006 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 19' ' ' LEU . 6.2 p30 -93.49 12.49 24.89 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.691 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' A' ' 57' ' ' VAL . 39.1 p90 -139.66 149.6 43.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 pt -132.22 157.58 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.454 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.3 t -134.26 122.92 23.42 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.584 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.85 128.46 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.045 0.45 . . . . 1.0 109.91 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -96.7 111.41 23.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.903 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -122.33 144.71 48.84 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.595 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' OE1' ' ND2' ' A' ' 68' ' ' ASN . 71.2 tt0 -58.88 165.61 2.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.024 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 68' ' ' ASN . 34.5 p30 -69.8 -19.93 63.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.214 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 42.3 p30 -89.67 15.67 9.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.627 -0.26 . . . . 1.0 111.206 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.44 162.6 18.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.897 0.379 . . . . 1.0 110.128 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.425 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -145.98 132.89 20.16 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.688 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -62.04 -17.69 58.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.334 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -56.78 -30.34 63.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.616 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -83.76 -38.5 21.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.784 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 74' ' ' LEU . 7.2 mp -71.76 -40.31 69.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 121.1 -0.24 . . . . 1.0 111.417 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.415 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 1.9 mt -40.23 -63.22 0.75 Allowed Pre-proline 0 N--CA 1.467 0.382 0 O-C-N 123.477 0.486 . . . . 1.0 111.088 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 47.7 Cg_endo -63.35 -25.39 71.31 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.513 1.475 . . . . 1.0 111.953 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -78.18 -56.05 4.77 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.055 0.455 . . . . 1.0 111.967 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.08 -43.62 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.742 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -50.25 -36.46 31.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.862 0.363 . . . . 1.0 110.35 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -66.77 -28.83 68.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.097 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.42 ' OG1' ' CD ' ' A' ' 44' ' ' ARG . 5.3 m -60.9 -47.14 87.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.785 0.326 . . . . 1.0 110.825 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -68.33 -37.2 80.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.661 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.81 -41.76 82.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.534 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 1.0 110.69 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 4' ' ' ILE . 76.9 mt-10 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.906 -0.035 . . . . 1.0 110.906 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.57 127.82 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.593 0.711 . . . . 1.0 111.882 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 2' ' ' GLU . 1.2 mp -90.82 -43.57 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 114.679 -1.146 . . . . 1.0 109.398 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.86 168.81 7.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.394 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.59 128.71 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.542 -0.754 . . . . 1.0 109.284 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 m -105.75 107.59 18.67 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.94 116.23 19.96 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -90.94 176.08 3.15 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.37 14.34 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.824 1.682 . . . . 1.0 112.019 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' THR . 18.9 m120 -95.82 -179.81 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.847 0.356 . . . . 1.0 110.608 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.449 ' O ' ' CZ2' ' A' ' 71' ' ' TRP . 78.1 t60 -110.15 -58.9 2.01 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.584 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 56.0 p30 -101.03 7.59 43.36 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.745 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -116.37 130.08 56.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -140.53 151.69 44.97 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.075 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -109.56 134.08 52.34 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.67 117.29 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.7 t -92.13 127.77 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.599 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -169.88 158.64 7.42 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 120.831 0.348 . . . . 1.0 111.104 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.5 t -96.01 95.24 8.06 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.633 0.254 . . . . 1.0 110.371 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 . . . . . 0 N--CA 1.471 0.606 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.888 179.702 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 121.13 0.49 . . . . 1.0 110.144 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 53.6 p90 -99.2 127.93 45.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.299 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.402 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 25.5 m -165.4 108.46 0.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.58 124.94 28.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.217 0.532 . . . . 1.0 110.7 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.416 ' OH ' ' CB ' ' A' ' 56' ' ' TYR . 1.2 p90 -139.86 163.83 31.61 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.337 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -168.16 116.34 0.73 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.189 178.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 171.3 133.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.467 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.68 120.39 26.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.104 0.478 . . . . 1.0 110.268 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -168.16 168.59 11.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.763 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -78.02 142.1 38.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.031 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.64 -27.05 19.28 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.703 -0.559 . . . . 1.0 111.703 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -90.89 147.94 37.06 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 117.163 0.482 . . . . 1.0 110.342 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -44.58 128.8 8.68 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.717 1.611 . . . . 1.0 113.317 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.81 -23.22 66.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.354 -0.839 . . . . 1.0 110.362 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -61.71 -48.53 80.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.114 0.483 . . . . 1.0 110.39 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.98 -40.38 80.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.782 -0.644 . . . . 1.0 110.52 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -58.48 -37.03 74.68 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.917 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -63.43 -40.13 96.34 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.321 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 47' ' ' GLU . 18.4 mt -61.84 -41.32 97.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.723 -0.217 . . . . 1.0 111.239 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 71.1 t80 -72.05 13.12 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.895 0.378 . . . . 1.0 111.012 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 45' ' ' LEU . 77.0 tt0 -89.76 -22.34 22.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.448 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.62 ' CG2' HE22 ' A' ' 77' ' ' GLN . 2.2 pp -121.77 141.25 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.09 0.471 . . . . 1.0 111.067 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.1 145.42 55.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.657 -0.702 . . . . 1.0 111.029 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.68 -32.78 3.95 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 111.588 -0.605 . . . . 1.0 111.588 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.4 t -63.75 113.57 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 120.19 -0.604 . . . . 1.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -87.51 -47.38 8.78 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.821 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p -164.42 167.06 20.04 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.074 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -133.36 151.11 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.568 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.63 130.42 52.64 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.347 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 39.4 t80 -123.22 112.81 18.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.63 149.83 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.711 0.291 . . . . 1.0 110.368 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.5 OUTLIER 59.2 -148.85 0.46 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.793 0.33 . . . . 1.0 110.619 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.458 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 38.2 p30 -100.11 15.58 26.93 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.673 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -141.32 156.49 45.84 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 pt -132.59 154.09 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.399 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.4 m -126.96 124.39 39.36 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.778 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.2 mp -106.76 118.26 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -104.81 112.34 25.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.719 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.446 ' NZ ' ' CD1' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -125.21 157.78 35.65 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -58.29 169.89 0.79 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.99 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.448 ' OD1' ' ND2' ' A' ' 13' ' ' ASN . 88.4 m-20 -70.17 -17.01 63.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.115 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -84.38 5.78 25.77 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.784 0.326 . . . . 1.0 110.677 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.21 151.16 19.76 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.252 0.549 . . . . 1.0 109.833 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.502 ' ND2' ' H ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -136.26 123.15 21.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.115 -0.948 . . . . 1.0 110.226 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.5 ' N ' HD22 ' A' ' 70' ' ' ASN . 13.6 m0 -61.29 -23.97 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.608 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.502 ' H ' ' ND2' ' A' ' 70' ' ' ASN . 5.7 m120 -56.37 -33.31 65.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.163 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -77.97 -38.33 45.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.843 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 74' ' ' LEU . 7.0 mp -67.72 -38.39 83.52 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.746 -0.206 . . . . 1.0 111.0 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mp -41.79 -64.6 0.63 Allowed Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.319 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -61.42 -25.44 79.96 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.095 1.863 . . . . 1.0 112.44 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.62 HE22 ' CG2' ' A' ' 48' ' ' ILE . 86.6 mt-30 -76.96 -54.28 6.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.98 0.419 . . . . 1.0 111.477 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 pt -68.78 -43.05 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.007 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.97 -32.26 61.41 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.308 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.93 -41.16 97.71 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.368 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.0 m -64.29 -49.95 69.79 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.188 0.518 . . . . 1.0 110.43 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -63.29 -47.48 82.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.474 -0.784 . . . . 1.0 110.189 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.55 68.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.535 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.466 179.768 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 120.657 0.265 . . . . 1.0 110.424 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.6 pt -48.05 155.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.56 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -130.93 -46.06 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 123.576 0.547 . . . . 1.0 111.041 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.71 153.24 5.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -108.66 118.57 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.174 -179.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -95.91 113.16 24.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.433 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.13 117.73 21.2 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.068 -0.715 . . . . 1.0 109.068 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -91.59 176.32 2.87 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.198 -178.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.99 12.53 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.336 2.024 . . . . 1.0 111.933 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' THR . 86.7 m-20 -98.39 -179.68 4.43 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -112.05 -61.42 1.72 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.842 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.585 HD22 ' N ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -92.55 1.4 57.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.361 -179.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.585 ' N ' HD22 ' A' ' 13' ' ' ASN . 27.3 m -116.1 128.54 55.76 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.8 mmt -135.06 145.67 48.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.844 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -95.75 128.38 42.57 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.53 105.92 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.6 m -90.52 132.6 35.6 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.7 pt? -162.78 153.6 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.446 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -77.51 100.3 6.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.813 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 . . . . . 0 N--CA 1.468 0.467 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.414 178.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 121.449 0.642 . . . . 1.0 110.238 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 51.2 p90 -99.57 127.92 45.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.359 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.3 m -166.32 145.38 5.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.25 117.13 33.81 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.743 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -141.2 172.13 13.11 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.526 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -172.11 114.94 0.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.049 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 169.78 135.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.678 0.275 . . . . 1.0 110.352 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.89 129.08 34.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.245 0.545 . . . . 1.0 110.2 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -164.46 162.82 22.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.798 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -83.22 143.64 30.31 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.395 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.07 -28.38 15.93 Favored Glycine 0 N--CA 1.465 0.629 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -94.68 146.79 32.07 Favored Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.94 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -41.76 130.99 4.08 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.125 1.883 . . . . 1.0 112.727 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 42' ' ' ILE . 81.2 mm-40 -64.9 -25.83 68.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.203 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -57.8 -1.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.158 -0.217 . . . . 1.0 111.582 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 40' ' ' GLU . 38.2 mm -114.57 -34.5 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.076 0.465 . . . . 1.0 110.747 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -63.12 -39.97 96.23 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.306 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -44.44 87.99 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.1 mp -63.16 -40.89 98.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.988 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 81.4 t80 -78.11 12.37 1.87 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.996 0.427 . . . . 1.0 110.243 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -88.52 -29.76 19.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.897 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.72 140.58 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.427 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -67.42 142.09 56.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.748 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 137.04 -39.98 1.56 Allowed Glycine 0 N--CA 1.464 0.505 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 51' ' ' VAL . 33.7 m -65.66 124.31 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.02 0.438 . . . . 1.0 110.935 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -94.71 -43.24 8.35 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.0 p -158.89 156.81 30.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.843 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.1 mt -129.15 123.38 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.136 -0.691 . . . . 1.0 109.136 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 47.0 m-85 -101.63 138.99 37.9 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.075 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -126.8 112.71 15.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.114 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' PHE . 10.1 p -165.94 155.39 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.646 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mt 54.75 -163.18 0.13 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.581 0.705 . . . . 1.0 111.127 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -87.62 13.07 11.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.047 -0.979 . . . . 1.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 57' ' ' VAL . 44.1 p90 -148.44 157.62 43.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.97 0.414 . . . . 1.0 110.004 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.7 pt -133.9 164.84 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.3 p -135.01 134.28 40.29 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.493 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.64 131.1 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.892 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -100.25 103.02 14.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.277 -0.874 . . . . 1.0 110.261 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HZ1' HD11 ' A' ' 74' ' ' LEU . 16.3 mtpt -110.99 142.23 43.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.742 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -63.9 173.11 1.94 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.101 0.477 . . . . 1.0 110.106 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -70.2 -14.06 62.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.902 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -89.49 9.5 26.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.416 0.151 . . . . 1.0 110.597 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.412 ' HB1' ' HZ3' ' A' ' 65' ' ' LYS . . . -102.47 150.65 23.16 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.541 ' CG ' HD21 ' A' ' 72' ' ' ASN . 0.1 OUTLIER -143.85 127.13 16.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.257 0.551 . . . . 1.0 109.566 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.441 ' CE3' HD22 ' A' ' 74' ' ' LEU . 85.3 m95 -64.44 -19.64 65.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.798 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.623 HD22 ' H ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -54.13 -19.77 5.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.95 0.405 . . . . 1.0 110.93 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.623 ' H ' HD22 ' A' ' 72' ' ' ASN . 54.8 mm-40 -95.83 -33.38 12.26 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.322 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 74' ' ' LEU . 9.3 mp -68.95 -42.07 77.15 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 120.519 -0.472 . . . . 1.0 111.334 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 mp -44.61 -61.65 2.04 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 120.905 0.383 . . . . 1.0 110.855 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.88 -28.34 42.73 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.398 1.399 . . . . 1.0 111.95 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -75.89 -51.45 12.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.493 0.663 . . . . 1.0 112.344 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.42 -40.32 88.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.191 -0.913 . . . . 1.0 110.764 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.95 -27.84 5.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.166 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -62.33 -45.81 91.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.742 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -64.8 -51.91 59.64 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.293 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -59.7 -48.33 82.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.207 0.527 . . . . 1.0 109.839 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.49 93.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.558 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.531 179.836 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 49.3 mp0 . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 120.739 0.304 . . . . 1.0 110.374 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 4' ' ' ILE . 89.9 mt -47.26 156.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 1.0 109.693 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.452 ' N ' HG22 ' A' ' 3' ' ' ILE . 43.5 mm -129.19 -39.31 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.87 -0.605 . . . . 1.0 111.178 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.71 153.47 2.75 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.356 0.41 . . . . 1.0 110.093 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.7 mt -109.68 119.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 p -94.98 110.9 22.75 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.124 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 8' ' ' GLU . 55.1 mp0 -83.34 108.72 16.73 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.341 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -87.27 157.49 53.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.134 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.86 23.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.571 2.181 . . . . 1.0 112.074 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' A' ' 9' ' ' THR . 96.4 m-20 -88.75 -168.56 2.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -110.71 -71.14 0.77 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.231 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 16.8 p30 -106.72 11.16 30.59 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.065 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.1 m -115.0 131.59 56.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' ' CD2' ' A' ' 71' ' ' TRP . 11.6 ptt? -142.33 149.35 39.34 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.119 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -105.32 131.39 52.82 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.019 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -108.87 111.3 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -90.69 128.84 36.78 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -170.47 162.47 8.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.87 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.9 p -80.14 109.14 14.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.556 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 N--CA 1.473 0.696 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.383 179.417 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 110.165 -0.309 . . . . 1.0 110.165 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -104.55 139.31 39.61 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.121 0.486 . . . . 1.0 110.461 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.3 m -165.25 107.24 0.8 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.23 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -105.41 131.64 52.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.348 0.594 . . . . 1.0 111.262 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.8 170.58 15.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.289 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -167.59 113.15 0.71 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.406 -0.816 . . . . 1.0 110.64 178.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.72 126.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.674 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.76 126.13 32.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.216 0.531 . . . . 1.0 110.371 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -167.41 170.29 11.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.68 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.87 142.98 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.581 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.99 -26.84 21.79 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -94.36 147.93 34.16 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 121.09 -0.244 . . . . 1.0 110.696 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -40.65 121.29 1.15 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.646 2.231 . . . . 1.0 112.505 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.99 -24.96 66.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.358 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.427 ' O ' HD13 ' A' ' 45' ' ' LEU . 92.4 m-85 -62.01 -18.45 60.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.624 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.1 mm -102.33 -33.1 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 123.321 0.388 . . . . 1.0 110.655 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -63.38 -38.34 90.76 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.207 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -60.06 -33.03 71.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.071 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 45' ' ' LEU . 9.4 mp -63.46 -38.77 92.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.667 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 70.0 t80 -76.3 14.89 0.66 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.989 0.424 . . . . 1.0 110.501 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 45' ' ' LEU . 82.1 tt0 -90.77 -23.66 20.58 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.689 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.671 ' CG2' HE22 ' A' ' 77' ' ' GLN . 1.9 pp -121.4 142.26 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.047 0.451 . . . . 1.0 110.544 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.46 143.95 54.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.344 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.77 -43.81 1.26 Allowed Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.246 -0.742 . . . . 1.0 111.246 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 51' ' ' VAL . 17.1 m -54.86 115.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.454 0.645 . . . . 1.0 111.274 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -88.47 -42.76 11.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.3 p -170.2 168.94 8.04 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.288 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.41 137.71 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.07 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -110.64 136.27 49.99 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.423 0.452 . . . . 1.0 109.896 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -124.11 118.74 27.6 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.382 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -165.76 141.3 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.42 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.51 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.4 OUTLIER 64.05 -149.58 0.3 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.948 178.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.51 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 55.9 p-10 -97.68 18.56 15.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.785 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 28.9 p90 -141.58 156.82 45.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 61' ' ' ILE . 28.5 pt -132.79 144.47 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.283 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 t -111.07 124.31 51.92 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.1 mt -112.2 125.58 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -116.5 133.27 56.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.215 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' HG3' ' HB3' ' A' ' 69' ' ' ALA . 4.0 ptpt -144.19 156.12 44.18 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.558 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -51.27 162.83 0.29 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.688 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.496 ' OD1' ' ND2' ' A' ' 13' ' ' ASN . 92.3 m-20 -69.99 -14.26 62.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.76 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -88.27 9.98 21.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.775 -0.193 . . . . 1.0 110.598 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.509 ' HB3' ' HG3' ' A' ' 65' ' ' LYS . . . -104.92 164.92 11.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.325 0.583 . . . . 1.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.547 ' CG ' HD21 ' A' ' 72' ' ' ASN . 0.1 OUTLIER -150.04 134.01 16.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.477 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.461 ' CD2' ' SD ' ' A' ' 15' ' ' MET . 3.9 m0 -68.22 -18.09 64.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.256 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.624 HD22 ' H ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -57.78 -20.47 35.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.978 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.624 ' H ' HD22 ' A' ' 72' ' ' ASN . 80.7 mt-10 -95.24 -29.03 14.72 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.236 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 74' ' ' LEU . 8.8 mp -74.75 -39.41 61.85 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.976 -0.29 . . . . 1.0 111.298 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.437 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 2.2 mt -40.87 -62.35 1.02 Allowed Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 123.444 0.465 . . . . 1.0 111.917 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 36.8 Cg_endo -61.24 -27.84 84.1 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.878 1.718 . . . . 1.0 112.267 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.671 HE22 ' CG2' ' A' ' 48' ' ' ILE . 86.5 mt-30 -75.62 -49.97 16.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.288 0.566 . . . . 1.0 111.444 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 pt -70.28 -42.92 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.586 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -53.19 -35.13 59.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.263 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -63.47 -39.44 94.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.035 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.8 m -62.04 -48.08 81.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.013 0.435 . . . . 1.0 110.222 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.93 -44.59 80.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.987 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -45.17 -33.85 2.46 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.524 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.46 179.392 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 82' ' ' PHE . 38.6 tp10 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 110.053 -0.351 . . . . 1.0 110.053 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.7 mt -49.09 142.6 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.929 0.395 . . . . 1.0 110.421 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -120.05 -34.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.343 -0.844 . . . . 1.0 110.639 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.02 178.1 3.05 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.078 0.466 . . . . 1.0 110.177 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.1 pt -143.23 136.73 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.576 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.2 m -116.09 111.88 20.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.838 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.437 ' OE1' ' N ' ' A' ' 8' ' ' GLU . 39.2 mp0 -84.16 113.87 21.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -82.88 177.18 3.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.304 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.86 21.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.216 1.944 . . . . 1.0 112.296 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 9' ' ' THR . 94.3 m-20 -103.5 -178.25 3.61 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.55 -55.26 2.54 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.794 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -100.94 3.83 42.03 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.284 -178.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -116.22 131.36 56.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.6 mtt -146.23 153.54 40.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.816 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -106.8 135.99 47.4 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.805 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.46 120.68 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.748 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.2 t -96.06 127.57 42.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.327 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -164.33 154.42 14.44 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.419 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -92.71 99.07 11.83 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' OE2' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.699 0 CA-C-N 116.281 -0.418 . . . . 1.0 109.999 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 110.078 -0.341 . . . . 1.0 110.078 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 54.1 p90 -99.08 132.94 44.02 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 m -166.95 107.01 0.62 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.618 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.8 m -81.11 120.78 25.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.358 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -141.65 164.72 29.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.671 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 32' ' ' THR . 9.7 t -168.97 113.89 0.57 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.253 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.93 132.68 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.51 -0.313 . . . . 1.0 110.357 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.439 ' O ' ' NE2' ' A' ' 35' ' ' GLN . . . -81.29 122.69 27.75 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 1.0 110.068 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 34' ' ' ALA . 99.1 mm-40 -143.34 155.7 44.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.317 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.71 142.38 46.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.837 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.67 -3.55 55.0 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -98.71 155.61 36.52 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 122.889 -0.183 . . . . 1.0 110.583 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -36.34 109.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.866 2.378 . . . . 1.0 112.453 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.62 -36.59 74.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.936 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -55.83 -51.7 66.57 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.641 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.09 -41.22 91.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.957 0.408 . . . . 1.0 110.364 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -59.86 -38.92 83.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.01 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -61.02 -39.52 90.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.869 0.366 . . . . 1.0 110.421 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.44 ' O ' HG22 ' A' ' 48' ' ' ILE . 8.5 mp -63.63 -41.8 98.23 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.996 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -65.07 -29.09 69.95 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.911 -0.715 . . . . 1.0 111.14 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.79 -10.08 59.24 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.097 -0.241 . . . . 1.0 111.347 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -105.89 134.55 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.844 0.355 . . . . 1.0 110.301 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.624 ' N ' HD13 ' A' ' 48' ' ' ILE . 17.8 tp10 -73.26 128.84 36.63 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.32 -37.78 1.88 Allowed Glycine 0 N--CA 1.461 0.357 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.74 128.39 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.581 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.473 ' NZ ' ' OD1' ' A' ' 64' ' ' ASP . 27.7 mtmm -99.87 -40.8 7.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.421 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.6 m -165.71 171.19 13.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.362 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.4 137.35 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.04 -0.527 . . . . 1.0 109.998 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -111.46 133.4 53.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.698 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -122.88 108.16 12.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.221 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 60' ' ' PHE . 11.1 p -164.43 147.51 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.104 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 64.68 -160.54 0.29 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.897 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 19' ' ' LEU . 81.7 m-20 -89.3 15.03 9.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 57' ' ' VAL . 40.9 p90 -147.88 158.98 44.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.442 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 pt -129.44 152.19 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.411 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.0 m -113.91 118.96 35.65 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.9 mt -104.88 114.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.076 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.473 ' OD1' ' NZ ' ' A' ' 52' ' ' LYS . 60.2 t0 -98.04 126.24 43.38 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.419 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HZ3' ' HB1' ' A' ' 69' ' ' ALA . 4.8 mtmp? -139.15 143.91 38.38 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.45 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -55.71 167.66 0.52 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.351 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 68' ' ' ASN . 50.5 p-10 -68.62 -23.79 64.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.827 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 2.0 p-10 -77.93 -7.2 56.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.785 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.546 ' HB1' ' HZ3' ' A' ' 65' ' ' LYS . . . -76.04 142.49 41.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.428 ' ND2' ' H ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -126.9 119.95 28.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.297 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -60.28 -28.81 68.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.739 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.428 ' H ' ' ND2' ' A' ' 70' ' ' ASN . 6.1 m120 -57.53 -16.61 10.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.572 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -97.92 -34.63 10.76 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.33 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 74' ' ' LEU . 8.7 mp -74.27 -39.83 62.73 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.33 -0.231 . . . . 1.0 110.948 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 3.9 mp -41.92 -62.55 1.11 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.025 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 37.4 Cg_endo -60.56 -27.5 84.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.768 1.645 . . . . 1.0 112.124 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.56 -53.72 7.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.985 0.421 . . . . 1.0 111.491 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 pt -70.6 -44.1 77.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.031 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -52.07 -32.81 36.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.327 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -64.54 -39.43 93.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.227 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.5 m -62.99 -50.49 70.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.899 0.381 . . . . 1.0 110.71 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.448 ' CE1' ' OE2' ' A' ' 2' ' ' GLU . 3.0 t80 -62.06 -48.56 79.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.011 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.88 97.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.793 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp . . . . . 0 CA--C 1.516 -0.328 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.92 -179.587 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 120.521 0.2 . . . . 1.0 110.605 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 3' ' ' ILE . 18.0 tt -50.86 118.47 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.495 0.664 . . . . 1.0 111.082 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mm -92.25 -48.33 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.2 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.91 178.76 9.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.213 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 tt -132.49 135.64 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.264 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 t -100.61 111.26 23.47 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.047 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.29 110.45 16.76 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -87.32 177.63 2.64 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 -178.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.25 7.95 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.988 1.792 . . . . 1.0 112.229 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 9' ' ' THR . 22.6 m120 -93.25 171.69 8.76 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.421 ' O ' ' CZ2' ' A' ' 71' ' ' TRP . 80.0 m80 -111.59 -38.29 4.95 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.169 -0.468 . . . . 1.0 111.352 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -110.42 -2.33 16.64 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.795 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -113.81 130.87 56.41 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.472 ' SD ' ' CG ' ' A' ' 71' ' ' TRP . 11.7 ptt? -142.74 151.81 41.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 1.0 109.767 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -113.89 138.34 50.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.947 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.8 t -100.44 127.6 53.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 t -104.22 132.32 50.6 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -169.64 158.04 7.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.91 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -102.75 86.19 2.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 -179.676 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.518 -0.253 0 CA-C-O 120.985 0.422 . . . . 1.0 110.112 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 51.9 p90 -100.09 127.65 46.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.346 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.8 m -161.42 132.54 5.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.416 ' CB ' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -101.8 120.15 39.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.259 0.552 . . . . 1.0 111.038 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -140.14 133.49 29.9 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.817 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 32' ' ' THR . 10.4 t -138.24 116.44 11.82 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.037 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 170.07 137.63 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.957 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.16 122.37 32.39 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -154.16 154.36 33.42 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.11 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -71.16 128.87 37.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.797 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.51 -19.82 52.5 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.437 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 38.9 mm-40 -82.18 152.0 67.31 Favored Pre-proline 0 CA--C 1.543 0.709 0 O-C-N 122.746 -0.267 . . . . 1.0 110.602 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.17 119.74 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.606 2.204 . . . . 1.0 112.923 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -68.77 -23.32 64.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.539 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.601 ' C ' HD12 ' A' ' 42' ' ' ILE . 56.7 m-85 -69.26 -10.2 56.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.961 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.601 HD12 ' C ' ' A' ' 41' ' ' PHE . 2.0 mp -118.07 -33.71 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 123.3 0.375 . . . . 1.0 110.312 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 38' ' ' GLN . 67.3 m-20 -63.18 -39.87 95.89 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.211 -0.595 . . . . 1.0 110.71 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.454 ' NH1' ' OG1' ' A' ' 81' ' ' THR . 25.0 mmt85 -64.51 -34.67 78.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.49 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.7 mp -63.21 -41.05 99.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.005 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -69.8 -5.2 23.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.861 -0.336 . . . . 1.0 111.034 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.47 ' OE1' ' NE2' ' A' ' 77' ' ' GLN . 82.2 tt0 -68.12 -24.3 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.634 -0.257 . . . . 1.0 111.364 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.483 HG12 HD11 ' A' ' 74' ' ' LEU . 2.3 pp -121.76 142.99 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.899 0.381 . . . . 1.0 110.816 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -67.14 143.85 56.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.847 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.93 -40.42 1.59 Allowed Glycine 0 N--CA 1.465 0.601 0 N-CA-C 111.452 -0.659 . . . . 1.0 111.452 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.11 112.38 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.543 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -82.02 -50.86 8.63 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.042 0.448 . . . . 1.0 110.176 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.8 p -160.96 160.54 30.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 30' ' ' THR . 49.5 mm -121.73 151.57 25.23 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.921 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.37 120.93 20.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -114.7 118.41 33.55 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.689 -0.485 . . . . 1.0 109.689 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -164.57 148.39 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.413 . . . . 1.0 110.192 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER 63.85 -138.94 0.32 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.774 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.43 ' H ' HD12 ' A' ' 58' ' ' LEU . 56.0 p30 -110.25 23.79 13.83 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 122.619 0.367 . . . . 1.0 110.865 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -147.42 157.56 43.63 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 mp -126.52 132.84 69.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 1.0 109.844 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t -103.11 123.58 46.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.433 ' CG2' ' NZ ' ' A' ' 65' ' ' LYS . 65.4 mt -112.05 127.52 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.673 -0.492 . . . . 1.0 109.673 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.04 111.72 23.03 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.579 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.433 ' NZ ' ' CG2' ' A' ' 63' ' ' ILE . 47.3 mttp -115.78 155.75 27.26 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.388 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 67' ' ' ASP . 7.3 tp10 -67.09 175.25 2.66 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.412 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 90.8 m-20 -70.12 -20.32 63.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.032 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -85.74 3.03 43.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.71 0.291 . . . . 1.0 111.098 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.21 153.36 17.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.423 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.448 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -141.32 121.82 14.13 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.032 0.444 . . . . 1.0 110.362 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.472 ' CG ' ' SD ' ' A' ' 15' ' ' MET . 5.6 m0 -58.16 -26.47 62.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.539 . . . . 1.0 111.266 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -56.48 -36.61 69.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.749 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -74.56 -40.29 61.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.646 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.9 mm? -70.7 -38.43 73.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mp -39.55 -62.49 0.82 Allowed Pre-proline 0 CA--C 1.541 0.599 0 O-C-N 123.441 0.463 . . . . 1.0 110.89 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.38 -22.61 59.54 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.783 1.656 . . . . 1.0 112.11 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.47 ' NE2' ' OE1' ' A' ' 47' ' ' GLU . 40.4 tt0 -76.47 -53.47 8.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.975 0.417 . . . . 1.0 111.621 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 pt -71.33 -40.32 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.824 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -50.91 -31.05 16.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.347 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -63.95 -39.67 94.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.326 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.454 ' OG1' ' NH1' ' A' ' 44' ' ' ARG . 21.6 m -60.1 -48.7 80.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.823 0.344 . . . . 1.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.511 ' CZ ' ' CD1' ' A' ' 41' ' ' PHE . 98.0 m-85 -69.51 -37.29 77.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.572 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.28 -43.07 92.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.662 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.75 -179.726 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.892 0.377 . . . . 1.0 110.417 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 4' ' ' ILE . 85.0 mt -49.37 155.64 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-O 120.776 0.322 . . . . 1.0 110.267 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.416 ' N ' HG22 ' A' ' 3' ' ' ILE . 48.1 mm -127.25 -37.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.434 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -171.65 158.69 5.13 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.127 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.466 ' CG2' ' SD ' ' A' ' 15' ' ' MET . 74.9 mt -104.23 131.83 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 m -114.56 104.85 12.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.105 0.479 . . . . 1.0 110.007 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -76.86 144.78 38.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.085 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -122.71 161.76 42.24 Favored Pre-proline 0 N--CA 1.472 0.655 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.0 21.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.529 2.153 . . . . 1.0 112.215 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 9' ' ' THR . 14.9 m120 -96.42 -174.23 2.99 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.457 ' O ' ' CH2' ' A' ' 71' ' ' TRP . 59.3 t-80 -110.72 -51.27 2.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.825 0.345 . . . . 1.0 111.652 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.523 HD22 ' N ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -116.22 7.57 14.11 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.875 -0.602 . . . . 1.0 112.103 -178.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.523 ' N ' HD22 ' A' ' 13' ' ' ASN . 24.1 m -111.72 130.06 55.91 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.466 ' SD ' ' CG2' ' A' ' 6' ' ' ILE . 38.8 ttm -139.7 150.9 45.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -107.29 131.4 54.25 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.94 -0.573 . . . . 1.0 109.579 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.7 t -108.61 109.98 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -90.48 133.19 35.22 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.6 pt? -166.05 155.55 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.063 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -88.25 83.79 6.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 -179.729 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.155 0.503 . . . . 1.0 110.21 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 46.2 p90 -102.79 131.21 49.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.217 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.41 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.1 m -160.81 108.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -79.64 117.79 20.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.668 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 29' ' ' THR . 9.5 p90 -142.27 162.38 35.63 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.252 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -170.34 114.08 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.562 . . . . 1.0 109.972 177.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 169.29 139.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.296 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.8 120.97 25.35 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.799 -0.445 . . . . 1.0 109.799 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.478 ' OE1' ' NE2' ' A' ' 38' ' ' GLN . 81.9 mt-30 -148.07 146.91 29.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.029 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -70.5 142.75 51.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.828 -0.624 . . . . 1.0 111.122 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.22 -13.03 62.73 Favored Glycine 0 N--CA 1.46 0.286 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.478 ' NE2' ' OE1' ' A' ' 35' ' ' GLN . 75.6 mt-30 -97.3 147.42 32.94 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 122.837 -0.214 . . . . 1.0 110.932 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -41.92 128.06 3.88 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.136 1.891 . . . . 1.0 112.896 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.452 ' OE2' ' NZ ' ' A' ' 84' ' ' LYS . 95.9 mt-10 -66.89 -26.28 66.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.023 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.453 ' O ' HD13 ' A' ' 45' ' ' LEU . 99.3 m-85 -60.26 -11.98 7.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.903 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -110.32 -39.65 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 110.105 -0.331 . . . . 1.0 110.105 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -66.23 -38.15 87.22 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.863 -0.335 . . . . 1.0 111.281 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -60.23 -34.09 73.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.19 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.2 mp -66.02 -36.86 84.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.21 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 75.7 t80 -74.11 13.41 0.55 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.818 0.342 . . . . 1.0 111.193 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 45' ' ' LEU . 80.8 mm-40 -87.51 -20.92 25.84 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.611 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.15 142.2 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.3 pm0 -68.71 148.96 49.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.095 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.61 -36.0 3.01 Favored Glycine 0 N--CA 1.468 0.779 0 N-CA-C 111.366 -0.693 . . . . 1.0 111.366 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.82 114.88 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.3 0.571 . . . . 1.0 110.656 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.87 -42.81 8.89 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 p -165.04 161.74 19.96 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.508 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.8 mt -130.98 136.2 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -111.34 129.63 55.94 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.156 -0.474 . . . . 1.0 109.866 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -124.17 118.46 26.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.632 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 p -164.79 146.92 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.997 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 tp 62.4 -131.25 0.57 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.83 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 19' ' ' LEU . 48.3 p-10 -115.25 23.56 12.36 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.156 0.582 . . . . 1.0 110.971 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.35 159.63 43.11 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.7 pt -132.09 149.44 32.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.147 -0.479 . . . . 1.0 109.808 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.2 t -114.96 122.49 46.43 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.31 115.42 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -100.37 114.95 28.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.1 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HZ3' ' HG ' ' A' ' 74' ' ' LEU . 38.6 mtmt -125.47 153.12 44.0 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.674 0.273 . . . . 1.0 110.793 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -61.79 167.58 3.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.854 -0.424 . . . . 1.0 109.854 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.08 -18.62 65.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.649 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -85.95 4.5 37.34 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.862 0.363 . . . . 1.0 110.768 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.33 149.54 21.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.281 0.562 . . . . 1.0 110.502 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.588 HD22 ' N ' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -138.31 126.86 23.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.142 -0.935 . . . . 1.0 110.654 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.588 ' N ' HD22 ' A' ' 70' ' ' ASN . 4.5 m-90 -57.72 -27.43 62.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.978 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.458 ' H ' ' ND2' ' A' ' 70' ' ' ASN . 5.7 m120 -55.49 -29.61 59.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.331 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.53 -35.6 30.14 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.132 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.7 mm? -70.51 -38.78 74.34 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 121.078 -0.249 . . . . 1.0 111.601 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mt -39.92 -62.62 0.83 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.165 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -62.74 -24.21 74.64 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.895 1.73 . . . . 1.0 112.315 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -75.95 -54.05 7.47 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.465 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.3 pt -67.5 -41.24 85.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.524 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.32 -28.37 7.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.255 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -58.73 -33.38 70.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.142 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.7 p -64.44 -44.35 91.42 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.139 0.495 . . . . 1.0 110.245 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.13 -36.13 83.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.576 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -46.19 -46.87 17.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.908 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.452 ' NZ ' ' OE2' ' A' ' 40' ' ' GLU . 98.9 mttt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.399 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.772 0.32 . . . . 1.0 110.506 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 99.1 mt -51.65 118.23 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-O 121.05 0.452 . . . . 1.0 110.804 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 67.8 mt -92.81 -35.24 6.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.038 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.5 151.63 1.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.226 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.6 mt -107.42 125.91 63.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -107.25 116.9 32.74 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.99 0.424 . . . . 1.0 110.437 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -72.67 145.93 46.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.434 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -121.68 168.72 10.64 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.293 -179.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.69 -7.8 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.47 2.113 . . . . 1.0 112.159 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' THR . 98.4 m-20 -92.83 173.95 7.49 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.071 0.462 . . . . 1.0 110.05 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.56 ' CG ' ' N ' ' A' ' 13' ' ' ASN . 46.0 p-80 -113.7 -55.1 2.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.34 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.56 ' N ' ' CG ' ' A' ' 12' ' ' HIS . 51.0 p30 -82.62 3.7 27.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.866 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -124.23 145.66 49.22 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.27 0.557 . . . . 1.0 109.98 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.3 tpp -144.8 153.78 42.0 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.703 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -101.65 123.94 46.49 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.058 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.5 t -104.07 106.52 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.932 0.396 . . . . 1.0 110.007 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -88.85 134.44 33.94 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.746 0.308 . . . . 1.0 110.445 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.687 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.5 pt? -170.17 160.77 8.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.056 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -81.06 99.02 8.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.995 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 121.088 0.47 . . . . 1.0 110.191 178.809 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 CA--C 1.517 -0.309 0 CA-C-O 120.799 0.333 . . . . 1.0 110.123 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 54.4 p90 -102.77 127.44 49.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.136 0.493 . . . . 1.0 110.515 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.2 m -161.72 149.28 14.66 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.041 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.67 130.14 52.18 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.18 -0.463 . . . . 1.0 111.013 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.74 170.26 16.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.41 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 32' ' ' THR . 8.9 t -167.43 116.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.669 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 168.15 134.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.095 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.59 120.83 31.99 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.119 0.485 . . . . 1.0 110.413 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -147.94 153.15 38.67 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.712 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -68.14 131.42 45.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.283 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.37 -16.35 57.81 Favored Glycine 0 N--CA 1.466 0.677 0 N-CA-C 110.743 -0.943 . . . . 1.0 110.743 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -88.24 151.7 49.23 Favored Pre-proline 0 N--CA 1.455 -0.18 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.64 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -36.86 114.23 0.12 Allowed 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.81 2.34 . . . . 1.0 112.879 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.81 -27.2 66.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.394 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.519 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 39.1 m-85 -60.8 -23.71 65.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.384 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.9 mm -100.36 -31.34 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.75 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -63.57 -40.53 97.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.037 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -59.75 -32.74 70.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.068 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.6 mp -66.65 -39.35 88.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.874 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.3 -22.82 65.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.852 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.56 -15.29 63.58 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.874 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.45 140.4 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.413 0.625 . . . . 1.0 110.31 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.63 136.37 41.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.135 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.54 -43.28 1.19 Allowed Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 51' ' ' VAL . 14.8 p -60.22 119.69 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.158 0.504 . . . . 1.0 111.104 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -96.76 -42.71 7.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 1.0 109.99 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.4 p -166.19 165.99 17.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.301 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 54' ' ' ILE . 4.5 mp -135.34 152.84 32.64 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.889 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.447 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -127.4 129.73 48.08 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.421 0.451 . . . . 1.0 109.981 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -121.76 122.66 40.01 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.194 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -164.89 149.02 2.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.506 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.0 tp 57.39 -128.5 1.7 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.127 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -118.97 24.31 10.9 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 123.302 0.376 . . . . 1.0 110.822 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -144.42 155.69 43.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 pt -129.68 147.58 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.329 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.7 m -120.29 119.92 34.57 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.411 -0.588 . . . . 1.0 109.411 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.2 mt -105.25 124.41 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.549 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -101.32 124.78 47.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.443 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.414 ' NZ ' HD21 ' A' ' 74' ' ' LEU . 4.5 mtpt -135.66 154.17 51.38 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.267 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 67' ' ' ASP . 71.0 tt0 -61.52 169.89 2.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.48 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.442 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 50.9 t0 -67.8 -21.86 65.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.118 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -82.96 -5.41 59.06 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.773 0.32 . . . . 1.0 110.568 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.5 152.49 26.03 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.074 0.464 . . . . 1.0 110.51 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.457 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -141.69 118.68 11.24 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.299 0.571 . . . . 1.0 109.787 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -57.64 -21.24 38.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.988 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -57.92 -35.18 70.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.561 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -75.95 -35.89 59.53 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 121.11 0.481 . . . . 1.0 110.607 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 74' ' ' LEU . 9.2 mp -69.12 -37.81 78.53 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.212 -0.305 . . . . 1.0 111.3 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.456 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 3.6 mp -38.4 -63.67 0.54 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.021 0.378 . . . . 1.0 112.021 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 40.0 Cg_endo -62.26 -26.51 77.45 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.428 2.086 . . . . 1.0 112.551 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -76.15 -54.38 6.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.301 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.5 pt -69.77 -42.95 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.916 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -51.34 -35.73 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.145 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -66.59 -36.69 83.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.472 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.1 m -57.25 -47.21 81.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.02 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.519 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 95.3 m-85 -70.72 -33.14 70.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 1.0 111.028 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.91 -48.12 81.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.749 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 84' ' ' LYS . 4.5 mptp? . . . . . 0 N--CA 1.466 0.368 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.755 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 120.908 0.385 . . . . 1.0 110.956 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.7 pt -51.7 146.62 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.542 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 mm -123.31 -43.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.356 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.05 140.73 7.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.43 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.19 123.53 60.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.622 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.1 m -106.09 103.25 12.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.205 -0.452 . . . . 1.0 109.87 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -70.21 155.63 40.37 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -132.35 158.36 75.83 Favored Pre-proline 0 N--CA 1.474 0.763 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 -178.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.85 32.62 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.436 2.091 . . . . 1.0 112.023 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 9' ' ' THR . 13.5 m120 -90.62 -169.57 2.43 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -109.98 -39.57 5.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.521 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.595 HD22 ' N ' ' A' ' 67' ' ' ASP . 12.5 p30 -145.29 15.3 1.48 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.993 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -116.32 125.5 52.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.541 -0.3 . . . . 1.0 110.276 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.24 148.39 46.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.178 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -100.6 137.98 38.27 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.229 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.64 108.4 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -92.4 131.44 37.56 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.2 pt? -169.11 165.09 11.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.955 0.407 . . . . 1.0 110.515 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.8 t -84.38 119.48 25.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.969 0.414 . . . . 1.0 110.754 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 N--CA 1.475 0.817 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.73 178.602 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 C--O 1.223 -0.295 0 CA-C-O 120.812 0.339 . . . . 1.0 110.455 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -123.07 145.15 48.79 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.427 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 m -167.07 107.11 0.61 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.119 -0.697 . . . . 1.0 109.119 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.2 m -84.27 115.64 22.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.273 0.559 . . . . 1.0 110.331 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -141.41 167.16 22.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.651 -0.704 . . . . 1.0 110.198 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.556 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 98.1 m -170.21 112.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.96 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.57 137.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.309 . . . . 1.0 110.807 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.8 112.37 8.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.157 0.504 . . . . 1.0 110.659 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -150.77 147.51 27.39 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.71 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.49 143.97 53.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.71 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.84 -25.47 20.68 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -102.65 146.76 32.96 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 116.949 0.374 . . . . 1.0 110.493 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -41.98 123.95 2.64 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.08 1.853 . . . . 1.0 112.627 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -45.33 -23.7 0.22 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.769 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -56.4 -43.05 78.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.49 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.5 mm -62.29 -47.05 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.676 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -62.02 -39.64 92.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.746 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -57.52 -49.08 77.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mt -55.63 -39.1 70.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 73.6 t80 -77.37 16.18 0.65 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.84 0.352 . . . . 1.0 110.756 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -95.7 -35.95 11.38 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.567 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -115.17 139.72 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.855 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -62.04 136.11 57.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.782 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.98 -42.85 0.98 Allowed Glycine 0 C--O 1.228 -0.256 0 N-CA-C 111.28 -0.728 . . . . 1.0 111.28 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 51' ' ' VAL . 13.2 p -66.02 113.18 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.136 0.493 . . . . 1.0 111.205 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -83.68 -49.38 9.2 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -158.81 153.74 25.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.411 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 51' ' ' VAL . 48.9 mm -121.12 136.43 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.673 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -112.49 142.93 44.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.826 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -135.41 117.0 14.88 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.859 -0.422 . . . . 1.0 109.859 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' PHE . 8.8 p -165.79 145.18 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.226 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.33 -156.17 0.33 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.195 0.522 . . . . 1.0 110.966 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 19' ' ' LEU . 82.8 m-20 -91.51 13.42 17.78 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' A' ' 57' ' ' VAL . 36.4 p90 -140.71 149.11 41.77 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.703 0.287 . . . . 1.0 110.235 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 pt -128.17 159.66 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.9 p -122.85 130.24 52.63 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.6 mt -115.36 110.47 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.524 -0.546 . . . . 1.0 109.524 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.54 109.75 21.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.331 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.655 ' NZ ' ' HE1' ' A' ' 71' ' ' TRP . 24.3 mtmm -122.14 153.66 38.44 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.222 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.31 164.91 17.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.203 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.595 ' N ' HD22 ' A' ' 13' ' ' ASN . 42.6 p-10 -58.48 -28.74 65.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.736 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 14.3 m120 -70.32 3.29 3.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.583 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.53 145.43 24.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.274 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.506 HD21 ' CD ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -140.88 123.4 15.98 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.26 -0.427 . . . . 1.0 109.991 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.655 ' HE1' ' NZ ' ' A' ' 65' ' ' LYS . 3.1 m0 -64.78 -27.23 68.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.237 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -57.57 -16.25 9.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.583 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.506 ' CD ' HD21 ' A' ' 70' ' ' ASN . 97.0 mt-10 -96.01 -33.5 12.11 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.588 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 74' ' ' LEU . 4.0 mm? -74.86 -31.3 61.59 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.066 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -41.17 -61.94 1.19 Allowed Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 123.022 0.201 . . . . 1.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.97 -24.81 67.01 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.06 1.84 . . . . 1.0 112.718 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -79.06 -55.75 4.89 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.108 0.48 . . . . 1.0 111.56 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.461 ' O ' ' OG1' ' A' ' 81' ' ' THR . 2.3 pp -65.23 -39.01 84.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.044 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -49.11 -29.42 5.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.906 0.384 . . . . 1.0 110.606 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -70.69 -25.95 63.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.615 -0.266 . . . . 1.0 111.307 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 78' ' ' ILE . 81.9 p -60.62 -48.78 80.25 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.916 0.389 . . . . 1.0 111.921 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -35.65 58.29 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.221 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.85 69.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.396 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.49 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 109.13 -0.693 . . . . 1.0 109.13 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -141.18 131.33 24.81 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.61 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -57.32 119.87 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.87 0.843 . . . . 1.0 111.553 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.01 -48.74 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.519 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.56 179.12 7.45 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.45 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.1 pt -131.05 125.4 57.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.253 -0.885 . . . . 1.0 110.421 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.8 t -89.0 110.35 21.06 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -86.84 99.56 11.91 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.489 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -84.63 159.66 57.79 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.678 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.41 31.17 0.1 OUTLIER 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.632 2.221 . . . . 1.0 111.846 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 9' ' ' THR . 12.1 m120 -93.49 -165.94 1.42 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -108.57 -56.18 2.29 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.991 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 69' ' ' ALA . 2.6 m-20 -129.22 10.46 5.8 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.359 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.5 m -109.29 130.77 55.48 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.492 ' SD ' ' CE2' ' A' ' 71' ' ' TRP . 10.5 ptp -150.85 153.57 35.61 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -102.65 134.31 46.24 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.644 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.4 t -109.44 110.39 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.546 -0.539 . . . . 1.0 109.546 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.6 m -90.38 134.42 34.34 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.462 -0.569 . . . . 1.0 109.462 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.649 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -167.38 151.92 6.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.453 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.4 m -84.09 84.06 7.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.937 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -93.55 155.73 40.41 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.25 141.21 81.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.19 1.927 . . . . 1.0 111.27 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' C ' ' HE ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -97.67 8.28 44.94 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.52 -0.763 . . . . 1.0 109.742 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -52.96 -49.6 65.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.61 -0.436 . . . . 1.0 110.304 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 52.7 p-10 -127.26 60.13 1.4 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.628 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.36 50.77 0.17 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.299 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.6 t -84.72 152.45 23.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.459 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 54.3 p90 -102.09 129.95 48.56 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.158 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 m -166.26 136.3 3.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.991 -0.549 . . . . 1.0 109.889 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.97 116.53 29.36 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.406 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -141.35 160.68 39.62 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.578 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 32' ' ' THR . 9.9 t -171.32 116.61 0.43 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.037 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 170.62 130.94 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.978 -0.379 . . . . 1.0 109.978 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.09 117.48 20.94 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.928 0.394 . . . . 1.0 110.039 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -147.17 150.85 35.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.319 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -68.93 141.77 54.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.691 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 -8.53 76.26 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 110.821 -0.911 . . . . 1.0 110.821 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -99.09 147.52 33.36 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 121.119 -0.232 . . . . 1.0 111.018 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.26 127.47 2.99 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.214 1.943 . . . . 1.0 112.728 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.44 -24.79 63.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.291 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 37.4 m-85 -65.3 -12.99 57.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.945 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.4 mm -110.68 -37.86 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.977 0.418 . . . . 1.0 110.24 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -63.68 -39.14 93.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.153 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -61.32 -35.57 77.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.053 0.454 . . . . 1.0 110.899 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 45' ' ' LEU . 9.8 mp -66.9 -37.41 84.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.829 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -66.3 -21.27 66.26 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.259 -0.576 . . . . 1.0 111.095 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -70.4 -4.5 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.739 -0.385 . . . . 1.0 110.602 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.621 HD13 ' N ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -117.95 134.29 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 110.08 -0.341 . . . . 1.0 110.08 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.621 ' N ' HD13 ' A' ' 48' ' ' ILE . 19.3 pt-20 -72.63 133.39 44.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.965 -0.561 . . . . 1.0 109.794 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 139.07 -46.5 0.96 Allowed Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.1 p -65.23 134.81 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.328 -0.549 . . . . 1.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -118.95 -30.91 4.91 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.572 -0.74 . . . . 1.0 110.196 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.1 p -160.99 154.05 21.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.892 0.377 . . . . 1.0 110.023 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.1 mt -134.83 125.21 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 109.149 -0.685 . . . . 1.0 109.149 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.86 130.1 48.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 1.0 110.442 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -119.87 118.07 29.8 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.825 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.93 143.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.457 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.455 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.4 OUTLIER 62.35 -150.05 0.37 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.853 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 86.6 m-20 -97.35 16.82 18.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -141.99 157.13 45.3 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.9 pt -134.25 154.0 36.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.229 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -125.79 123.21 38.27 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.42 127.39 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.202 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -103.37 120.21 40.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.08 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.746 ' HZ3' ' CD2' ' A' ' 74' ' ' LEU . 63.4 mttt -135.81 148.34 48.68 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.613 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 96.8 mt-10 -58.98 172.48 0.55 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.525 -0.761 . . . . 1.0 109.927 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.39 -13.67 61.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.29 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -90.84 12.23 20.04 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.628 -0.26 . . . . 1.0 111.009 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 13' ' ' ASN . . . -100.96 147.8 25.75 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' ND2' ' CG ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -138.43 120.72 15.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.492 ' CE2' ' SD ' ' A' ' 15' ' ' MET . 95.9 m95 -64.81 -17.05 63.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.715 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -59.64 -20.83 58.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.874 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' CG ' ' ND2' ' A' ' 70' ' ' ASN . 81.0 mm-40 -98.0 -30.36 12.75 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.819 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.746 ' CD2' ' HZ3' ' A' ' 65' ' ' LYS . 9.3 mp -71.28 -38.83 71.8 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.935 -0.306 . . . . 1.0 111.473 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.8 mp -39.4 -63.16 0.68 Allowed Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 123.368 0.418 . . . . 1.0 110.735 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.95 -22.38 68.47 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.492 1.461 . . . . 1.0 111.927 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -75.43 -54.74 6.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.83 0.348 . . . . 1.0 111.415 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.7 pt -72.8 -40.82 61.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -51.17 -30.18 16.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.138 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -63.78 -41.07 98.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.16 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 m -62.2 -50.78 70.42 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 120.885 -0.326 . . . . 1.0 110.705 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 78.4 m-85 -67.96 -41.53 82.29 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.778 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.74 69.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.266 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -62.21 -62.11 2.0 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.035 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.0 p -58.79 -46.24 88.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.357 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.93 -1.033 . . . . 1.0 110.357 179.86 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.0 mmm . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.46 141.39 22.9 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.785 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 98.0 mt -58.68 120.01 4.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.161 0.505 . . . . 1.0 111.147 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.21 -45.83 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 115.474 -0.785 . . . . 1.0 109.887 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.68 179.08 4.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.94 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 83.2 mt -130.05 128.5 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.871 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.9 t -95.14 113.08 24.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.19 -0.459 . . . . 1.0 109.867 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.55 100.95 10.43 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.877 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -83.58 159.18 61.73 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.789 -0.641 . . . . 1.0 109.975 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.62 29.49 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.579 2.186 . . . . 1.0 111.861 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 9' ' ' THR . 9.2 m120 -96.72 -168.7 1.76 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -110.5 -60.13 1.85 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.482 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -116.82 5.1 13.0 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.298 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.8 m -107.53 127.53 53.7 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.2 mtt -142.32 150.5 40.88 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -106.11 131.0 53.9 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.738 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 t -107.39 113.74 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.0 m -92.09 128.38 37.92 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.811 -0.441 . . . . 1.0 109.811 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.704 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.7 pt? -162.08 150.09 14.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.618 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.1 t -87.25 78.76 8.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.819 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -77.27 156.24 81.64 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.164 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.44 141.55 81.39 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.38 2.053 . . . . 1.0 111.364 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.506 ' HE ' ' H ' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -92.94 12.64 23.16 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -57.27 -51.11 70.66 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.273 -0.571 . . . . 1.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 27' ' ' SER . 93.9 m-20 -138.93 60.76 1.59 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.609 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -71.99 45.72 0.12 Allowed 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.495 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 25' ' ' ASP . 46.0 t -83.15 166.39 18.7 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.439 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 51.8 p90 -101.75 131.5 48.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.8 m -159.55 112.3 2.17 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.0 m -94.76 123.82 38.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.841 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.71 170.59 15.48 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.183 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -171.16 113.01 0.38 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.384 -0.826 . . . . 1.0 110.342 178.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.15 133.96 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 110.174 -0.306 . . . . 1.0 110.174 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.19 113.11 19.8 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.873 0.368 . . . . 1.0 110.205 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -146.04 149.63 34.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.345 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.35 138.54 53.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.824 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.31 -13.94 62.29 Favored Glycine 0 CA--C 1.518 0.252 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -91.4 151.39 42.67 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 121.016 -0.274 . . . . 1.0 110.923 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -38.9 117.69 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.644 2.23 . . . . 1.0 112.708 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.2 mp0 -63.95 -23.33 67.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.939 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.508 ' O ' HD13 ' A' ' 45' ' ' LEU . 36.9 t80 -69.04 -8.57 46.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.758 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 41' ' ' PHE . 1.6 mp -111.64 -41.04 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -63.33 -40.17 96.57 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.254 -0.578 . . . . 1.0 111.122 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.42 ' CD ' ' OG1' ' A' ' 81' ' ' THR . 92.7 mtt-85 -61.11 -32.92 72.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.615 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 45' ' ' LEU . 7.9 mp -65.56 -39.24 91.48 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.749 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -68.27 -20.23 64.77 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.065 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -59.7 -23.84 63.46 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 121.093 -0.243 . . . . 1.0 111.646 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.98 141.69 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 110.105 -0.332 . . . . 1.0 110.105 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -67.34 138.29 56.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.784 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.1 -55.7 0.57 Allowed Glycine 0 N--CA 1.465 0.6 0 N-CA-C 111.382 -0.687 . . . . 1.0 111.382 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 51' ' ' VAL . 12.3 p -61.26 126.58 19.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.785 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -106.02 -30.1 9.51 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -167.03 161.29 14.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.468 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.0 mp -125.56 131.85 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 116.135 -0.484 . . . . 1.0 109.709 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -111.42 121.98 46.65 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -122.13 112.32 18.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.716 -0.674 . . . . 1.0 109.47 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 60' ' ' PHE . 11.5 p -164.99 149.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.217 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.26 -156.27 0.28 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.006 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 19' ' ' LEU . 6.2 p30 -93.49 12.49 24.89 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.691 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' A' ' 57' ' ' VAL . 39.1 p90 -139.66 149.6 43.92 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 pt -132.22 157.58 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.454 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.3 t -134.26 122.92 23.42 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.971 -0.559 . . . . 1.0 109.584 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.85 128.46 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.045 0.45 . . . . 1.0 109.91 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -96.7 111.41 23.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.903 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -122.33 144.71 48.84 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.595 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' OE1' ' ND2' ' A' ' 68' ' ' ASN . 71.2 tt0 -58.88 165.61 2.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.024 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 68' ' ' ASN . 34.5 p30 -69.8 -19.93 63.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.214 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 42.3 p30 -89.67 15.67 9.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.627 -0.26 . . . . 1.0 111.206 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.44 162.6 18.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.897 0.379 . . . . 1.0 110.128 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.425 ' ND2' ' N ' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -145.98 132.89 20.16 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.688 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 28.0 m95 -62.04 -17.69 58.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.334 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -56.78 -30.34 63.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.616 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -83.76 -38.5 21.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.784 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 74' ' ' LEU . 7.2 mp -71.76 -40.31 69.41 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 121.1 -0.24 . . . . 1.0 111.417 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.415 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 1.9 mt -40.23 -63.22 0.75 Allowed Pre-proline 0 N--CA 1.467 0.382 0 O-C-N 123.477 0.486 . . . . 1.0 111.088 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 47.7 Cg_endo -63.35 -25.39 71.31 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.513 1.475 . . . . 1.0 111.953 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -78.18 -56.05 4.77 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.055 0.455 . . . . 1.0 111.967 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.08 -43.62 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.742 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -50.25 -36.46 31.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.862 0.363 . . . . 1.0 110.35 -178.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -66.77 -28.83 68.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.097 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.42 ' OG1' ' CD ' ' A' ' 44' ' ' ARG . 5.3 m -60.9 -47.14 87.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.785 0.326 . . . . 1.0 110.825 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -68.33 -37.2 80.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.661 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.81 -41.76 82.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.534 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.01 -15.71 56.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.081 0.467 . . . . 1.0 110.69 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.0 p -85.55 40.29 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.429 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.4 p30 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.964 -1.017 . . . . 1.0 110.569 179.848 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.418 ' O ' ' CD1' ' A' ' 4' ' ' ILE . 76.9 mt-10 -119.16 115.88 25.17 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 116.603 -0.272 . . . . 1.0 110.906 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 81.4 mt -55.57 127.82 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.593 0.711 . . . . 1.0 111.882 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 2' ' ' GLU . 1.2 mp -90.82 -43.57 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 114.679 -1.146 . . . . 1.0 109.398 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.86 168.81 7.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.394 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 mm -116.59 128.71 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.542 -0.754 . . . . 1.0 109.284 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 m -105.75 107.59 18.67 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.94 116.23 19.96 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -90.94 176.08 3.15 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 110.12 -0.326 . . . . 1.0 110.12 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.37 14.34 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.824 1.682 . . . . 1.0 112.019 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' THR . 18.9 m120 -95.82 -179.81 4.84 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.847 0.356 . . . . 1.0 110.608 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.449 ' O ' ' CZ2' ' A' ' 71' ' ' TRP . 78.1 t60 -110.15 -58.9 2.01 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.584 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.448 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 56.0 p30 -101.03 7.59 43.36 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.745 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -116.37 130.08 56.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -140.53 151.69 44.97 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.075 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -109.56 134.08 52.34 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.67 117.29 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.7 t -92.13 127.77 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.599 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -169.88 158.64 7.42 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 120.831 0.348 . . . . 1.0 111.104 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.5 t -96.01 95.24 8.06 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.633 0.254 . . . . 1.0 110.371 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 21.0 pt-20 -126.61 46.13 1.81 Allowed Pre-proline 0 N--CA 1.471 0.606 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.888 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 73.6 Cg_endo -68.31 155.54 68.92 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.207 1.938 . . . . 1.0 111.683 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -151.76 -156.22 0.69 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.081 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.566 ' CD ' ' H ' ' A' ' 24' ' ' GLN . 27.8 mp0 -46.86 -72.73 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.857 0.36 . . . . 1.0 111.152 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.623 ' O ' ' N ' ' A' ' 27' ' ' SER . 80.0 m-20 -142.8 57.6 1.42 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.209 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 52.71 -72.48 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.721 0.296 . . . . 1.0 111.61 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.623 ' N ' ' O ' ' A' ' 25' ' ' ASP . 2.6 t 67.03 109.84 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.144 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 53.6 p90 -99.2 127.93 45.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.299 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.402 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 25.5 m -165.4 108.46 0.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.58 124.94 28.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.217 0.532 . . . . 1.0 110.7 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.416 ' OH ' ' CB ' ' A' ' 56' ' ' TYR . 1.2 p90 -139.86 163.83 31.61 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.427 -0.806 . . . . 1.0 110.337 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -168.16 116.34 0.73 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.189 178.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 171.3 133.68 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.467 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.68 120.39 26.34 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.104 0.478 . . . . 1.0 110.268 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -168.16 168.59 11.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.763 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -78.02 142.1 38.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.031 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.64 -27.05 19.28 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.703 -0.559 . . . . 1.0 111.703 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -90.89 147.94 37.06 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 117.163 0.482 . . . . 1.0 110.342 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -44.58 128.8 8.68 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.717 1.611 . . . . 1.0 113.317 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.81 -23.22 66.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.354 -0.839 . . . . 1.0 110.362 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -61.71 -48.53 80.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.114 0.483 . . . . 1.0 110.39 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.98 -40.38 80.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.782 -0.644 . . . . 1.0 110.52 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -58.48 -37.03 74.68 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.917 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -63.43 -40.13 96.34 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.614 -0.434 . . . . 1.0 110.321 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 47' ' ' GLU . 18.4 mt -61.84 -41.32 97.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.723 -0.217 . . . . 1.0 111.239 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 71.1 t80 -72.05 13.12 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.895 0.378 . . . . 1.0 111.012 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 45' ' ' LEU . 77.0 tt0 -89.76 -22.34 22.21 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.448 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.62 ' CG2' HE22 ' A' ' 77' ' ' GLN . 2.2 pp -121.77 141.25 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.09 0.471 . . . . 1.0 111.067 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.1 145.42 55.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.657 -0.702 . . . . 1.0 111.029 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.68 -32.78 3.95 Favored Glycine 0 N--CA 1.465 0.595 0 N-CA-C 111.588 -0.605 . . . . 1.0 111.588 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.4 t -63.75 113.57 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 120.19 -0.604 . . . . 1.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -87.51 -47.38 8.78 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.821 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p -164.42 167.06 20.04 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.074 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.4 mt -133.36 151.11 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.568 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.63 130.42 52.64 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.347 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 39.4 t80 -123.22 112.81 18.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.63 149.83 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.711 0.291 . . . . 1.0 110.368 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.5 OUTLIER 59.2 -148.85 0.46 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.793 0.33 . . . . 1.0 110.619 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.458 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 38.2 p30 -100.11 15.58 26.93 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.673 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -141.32 156.49 45.84 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.719 -0.475 . . . . 1.0 109.719 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.3 pt -132.59 154.09 39.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.399 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.4 m -126.96 124.39 39.36 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.511 -0.552 . . . . 1.0 109.511 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.778 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.2 mp -106.76 118.26 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -104.81 112.34 25.41 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.719 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.446 ' NZ ' ' CD1' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -125.21 157.78 35.65 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -58.29 169.89 0.79 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.99 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.448 ' OD1' ' ND2' ' A' ' 13' ' ' ASN . 88.4 m-20 -70.17 -17.01 63.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.115 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -84.38 5.78 25.77 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.784 0.326 . . . . 1.0 110.677 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.21 151.16 19.76 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.252 0.549 . . . . 1.0 109.833 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.502 ' ND2' ' H ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -136.26 123.15 21.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.115 -0.948 . . . . 1.0 110.226 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.5 ' N ' HD22 ' A' ' 70' ' ' ASN . 13.6 m0 -61.29 -23.97 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.608 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.502 ' H ' ' ND2' ' A' ' 70' ' ' ASN . 5.7 m120 -56.37 -33.31 65.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.163 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -77.97 -38.33 45.39 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.843 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 74' ' ' LEU . 7.0 mp -67.72 -38.39 83.52 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.746 -0.206 . . . . 1.0 111.0 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mp -41.79 -64.6 0.63 Allowed Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.319 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -61.42 -25.44 79.96 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.095 1.863 . . . . 1.0 112.44 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.62 HE22 ' CG2' ' A' ' 48' ' ' ILE . 86.6 mt-30 -76.96 -54.28 6.77 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.98 0.419 . . . . 1.0 111.477 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 pt -68.78 -43.05 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.007 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.97 -32.26 61.41 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.308 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -63.93 -41.16 97.71 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.368 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 95.0 m -64.29 -49.95 69.79 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.188 0.518 . . . . 1.0 110.43 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -63.29 -47.48 82.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.474 -0.784 . . . . 1.0 110.189 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.55 68.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.535 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -65.38 -55.45 18.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.466 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -58.29 -43.83 88.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.323 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.0 t30 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.373 179.697 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ptt? . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -145.94 139.44 26.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.424 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.6 pt -48.05 155.67 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.56 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -130.93 -46.06 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 O-C-N 123.576 0.547 . . . . 1.0 111.041 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -168.71 153.24 5.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -108.66 118.57 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.174 -179.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -95.91 113.16 24.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.433 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.13 117.73 21.2 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.068 -0.715 . . . . 1.0 109.068 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -91.59 176.32 2.87 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.788 -0.642 . . . . 1.0 110.198 -178.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.99 12.53 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.336 2.024 . . . . 1.0 111.933 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' THR . 86.7 m-20 -98.39 -179.68 4.43 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -112.05 -61.42 1.72 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.842 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.585 HD22 ' N ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -92.55 1.4 57.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.361 -179.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.585 ' N ' HD22 ' A' ' 13' ' ' ASN . 27.3 m -116.1 128.54 55.76 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.8 mmt -135.06 145.67 48.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.993 -0.549 . . . . 1.0 109.844 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -95.75 128.38 42.57 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.53 105.92 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.6 m -90.52 132.6 35.6 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.7 pt? -162.78 153.6 17.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.446 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p -77.51 100.3 6.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.813 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -146.29 69.88 12.87 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.414 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 23' ' ' ARG . 29.3 Cg_exo -60.9 -72.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.277 1.984 . . . . 1.0 111.597 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 25' ' ' ASP . 85.1 mtp180 47.46 105.66 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.18 0 O-C-N 123.539 0.524 . . . . 1.0 111.09 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -57.52 -2.32 0.12 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.947 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 23' ' ' ARG . 8.9 p-10 -116.77 35.73 4.47 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.968 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 27' ' ' SER . 8.7 p30 -42.24 -56.41 2.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.672 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 26' ' ' ASN . 27.4 t 55.1 123.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 O-C-N 123.85 0.719 . . . . 1.0 110.238 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 51.2 p90 -99.57 127.92 45.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.359 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.3 m -166.32 145.38 5.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.25 117.13 33.81 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.743 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -141.2 172.13 13.11 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.526 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -172.11 114.94 0.33 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.049 178.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 169.78 135.85 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.678 0.275 . . . . 1.0 110.352 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.89 129.08 34.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.245 0.545 . . . . 1.0 110.2 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -164.46 162.82 22.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.798 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -83.22 143.64 30.31 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.395 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.07 -28.38 15.93 Favored Glycine 0 N--CA 1.465 0.629 0 N-CA-C 110.594 -1.002 . . . . 1.0 110.594 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -94.68 146.79 32.07 Favored Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.94 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -41.76 130.99 4.08 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.125 1.883 . . . . 1.0 112.727 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 42' ' ' ILE . 81.2 mm-40 -64.9 -25.83 68.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.203 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -57.8 -1.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.158 -0.217 . . . . 1.0 111.582 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 40' ' ' GLU . 38.2 mm -114.57 -34.5 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.076 0.465 . . . . 1.0 110.747 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -63.12 -39.97 96.23 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.306 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -44.44 87.99 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.1 mp -63.16 -40.89 98.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.988 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 81.4 t80 -78.11 12.37 1.87 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.996 0.427 . . . . 1.0 110.243 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -88.52 -29.76 19.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.897 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.0 pp -116.72 140.58 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.427 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -67.42 142.09 56.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.748 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 137.04 -39.98 1.56 Allowed Glycine 0 N--CA 1.464 0.505 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 51' ' ' VAL . 33.7 m -65.66 124.31 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.02 0.438 . . . . 1.0 110.935 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -94.71 -43.24 8.35 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.727 -0.472 . . . . 1.0 109.727 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.0 p -158.89 156.81 30.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.843 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.1 mt -129.15 123.38 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.136 -0.691 . . . . 1.0 109.136 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 55' ' ' PHE . 47.0 m-85 -101.63 138.99 37.9 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.075 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -126.8 112.71 15.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.114 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 60' ' ' PHE . 10.1 p -165.94 155.39 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.646 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.8 mt 54.75 -163.18 0.13 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.581 0.705 . . . . 1.0 111.127 178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -87.62 13.07 11.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.047 -0.979 . . . . 1.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 57' ' ' VAL . 44.1 p90 -148.44 157.62 43.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.97 0.414 . . . . 1.0 110.004 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.7 pt -133.9 164.84 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.3 p -135.01 134.28 40.29 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.493 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.64 131.1 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.01 -0.541 . . . . 1.0 109.892 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -100.25 103.02 14.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.277 -0.874 . . . . 1.0 110.261 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HZ1' HD11 ' A' ' 74' ' ' LEU . 16.3 mtpt -110.99 142.23 43.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.742 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -63.9 173.11 1.94 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.101 0.477 . . . . 1.0 110.106 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -70.2 -14.06 62.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.902 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -89.49 9.5 26.29 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.416 0.151 . . . . 1.0 110.597 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.412 ' HB1' ' HZ3' ' A' ' 65' ' ' LYS . . . -102.47 150.65 23.16 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.171 -0.307 . . . . 1.0 110.171 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.541 ' CG ' HD21 ' A' ' 72' ' ' ASN . 0.1 OUTLIER -143.85 127.13 16.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.257 0.551 . . . . 1.0 109.566 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.441 ' CE3' HD22 ' A' ' 74' ' ' LEU . 85.3 m95 -64.44 -19.64 65.67 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.892 -0.594 . . . . 1.0 110.798 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.623 HD22 ' H ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -54.13 -19.77 5.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.95 0.405 . . . . 1.0 110.93 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.623 ' H ' HD22 ' A' ' 72' ' ' ASN . 54.8 mm-40 -95.83 -33.38 12.26 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.322 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 74' ' ' LEU . 9.3 mp -68.95 -42.07 77.15 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 120.519 -0.472 . . . . 1.0 111.334 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 mp -44.61 -61.65 2.04 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 120.905 0.383 . . . . 1.0 110.855 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.88 -28.34 42.73 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.398 1.399 . . . . 1.0 111.95 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -75.89 -51.45 12.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.493 0.663 . . . . 1.0 112.344 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.42 -40.32 88.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.191 -0.913 . . . . 1.0 110.764 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -49.95 -27.84 5.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.166 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -62.33 -45.81 91.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.742 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -64.8 -51.91 59.64 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.293 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -59.7 -48.33 82.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.207 0.527 . . . . 1.0 109.839 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.49 93.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.558 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -70.63 -7.69 46.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.531 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 p -60.73 -44.6 96.44 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.382 -0.527 . . . . 1.0 110.656 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.755 -179.819 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 20' ' ' SER . 89.0 mmm . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 2' ' ' GLU . 49.3 mp0 -122.81 116.75 24.22 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.442 0.464 . . . . 1.0 110.374 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 4' ' ' ILE . 89.9 mt -47.26 156.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.544 . . . . 1.0 109.693 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.452 ' N ' HG22 ' A' ' 3' ' ' ILE . 43.5 mm -129.19 -39.31 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.87 -0.605 . . . . 1.0 111.178 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.71 153.47 2.75 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.356 0.41 . . . . 1.0 110.093 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.7 mt -109.68 119.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.8 p -94.98 110.9 22.75 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.124 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 8' ' ' GLU . 55.1 mp0 -83.34 108.72 16.73 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.341 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -87.27 157.49 53.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.134 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.86 23.09 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.571 2.181 . . . . 1.0 112.074 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' A' ' 9' ' ' THR . 96.4 m-20 -88.75 -168.56 2.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -110.71 -71.14 0.77 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.231 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.496 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 16.8 p30 -106.72 11.16 30.59 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.065 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.1 m -115.0 131.59 56.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 110.091 -0.337 . . . . 1.0 110.091 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' ' CD2' ' A' ' 71' ' ' TRP . 11.6 ptt? -142.33 149.35 39.34 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.119 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -105.32 131.39 52.82 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.019 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -108.87 111.3 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -90.69 128.84 36.78 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.319 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -170.47 162.47 8.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.87 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 1' ' ' MET . 77.9 p -80.14 109.14 14.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.556 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 4.8 mm-40 -136.56 54.71 9.62 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.383 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 41.0 Cg_endo -66.62 144.36 72.04 Favored 'Trans proline' 0 C--N 1.301 -1.923 0 C-N-CA 122.14 1.893 . . . . 1.0 111.486 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.449 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 66.1 ttt180 -156.52 146.54 21.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.442 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -71.11 -2.64 16.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.48 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' H ' ' HG2' ' A' ' 23' ' ' ARG . 55.3 t0 -142.0 59.26 1.48 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.685 0.279 . . . . 1.0 110.56 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 23' ' ' ARG . 56.4 m-80 -59.71 -86.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.283 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.9 t 45.09 -163.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.165 -0.309 . . . . 1.0 110.165 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -104.55 139.31 39.61 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.121 0.486 . . . . 1.0 110.461 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.3 m -165.25 107.24 0.8 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.23 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 t -105.41 131.64 52.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.348 0.594 . . . . 1.0 111.262 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.8 170.58 15.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.289 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -167.59 113.15 0.71 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.406 -0.816 . . . . 1.0 110.64 178.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.72 126.92 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.674 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.76 126.13 32.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.216 0.531 . . . . 1.0 110.371 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -167.41 170.29 11.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.68 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.87 142.98 30.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.581 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 97.99 -26.84 21.79 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 110.85 -0.9 . . . . 1.0 110.85 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -94.36 147.93 34.16 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 121.09 -0.244 . . . . 1.0 110.696 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -40.65 121.29 1.15 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.646 2.231 . . . . 1.0 112.505 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.99 -24.96 66.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.358 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.427 ' O ' HD13 ' A' ' 45' ' ' LEU . 92.4 m-85 -62.01 -18.45 60.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.624 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.1 mm -102.33 -33.1 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 123.321 0.388 . . . . 1.0 110.655 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -63.38 -38.34 90.76 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.207 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -60.06 -33.03 71.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.071 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 45' ' ' LEU . 9.4 mp -63.46 -38.77 92.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.667 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.465 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 70.0 t80 -76.3 14.89 0.66 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.989 0.424 . . . . 1.0 110.501 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 45' ' ' LEU . 82.1 tt0 -90.77 -23.66 20.58 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.689 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.671 ' CG2' HE22 ' A' ' 77' ' ' GLN . 1.9 pp -121.4 142.26 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.047 0.451 . . . . 1.0 110.544 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.46 143.95 54.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.344 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.77 -43.81 1.26 Allowed Glycine 0 N--CA 1.466 0.656 0 N-CA-C 111.246 -0.742 . . . . 1.0 111.246 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 51' ' ' VAL . 17.1 m -54.86 115.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.454 0.645 . . . . 1.0 111.274 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -88.47 -42.76 11.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.3 p -170.2 168.94 8.04 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.288 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.41 137.71 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.07 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -110.64 136.27 49.99 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.423 0.452 . . . . 1.0 109.896 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -124.11 118.74 27.6 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.382 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -165.76 141.3 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.42 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.51 ' CD2' ' H ' ' A' ' 59' ' ' ASP . 0.4 OUTLIER 64.05 -149.58 0.3 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.948 178.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.51 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 55.9 p-10 -97.68 18.56 15.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.785 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 28.9 p90 -141.58 156.82 45.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.61 -0.515 . . . . 1.0 109.61 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 61' ' ' ILE . 28.5 pt -132.79 144.47 36.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.283 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.3 t -111.07 124.31 51.92 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.1 mt -112.2 125.58 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -116.5 133.27 56.21 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.215 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' HG3' ' HB3' ' A' ' 69' ' ' ALA . 4.0 ptpt -144.19 156.12 44.18 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.558 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -51.27 162.83 0.29 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.688 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.496 ' OD1' ' ND2' ' A' ' 13' ' ' ASN . 92.3 m-20 -69.99 -14.26 62.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.76 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -88.27 9.98 21.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.775 -0.193 . . . . 1.0 110.598 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.509 ' HB3' ' HG3' ' A' ' 65' ' ' LYS . . . -104.92 164.92 11.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.325 0.583 . . . . 1.0 109.815 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.547 ' CG ' HD21 ' A' ' 72' ' ' ASN . 0.1 OUTLIER -150.04 134.01 16.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.477 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.461 ' CD2' ' SD ' ' A' ' 15' ' ' MET . 3.9 m0 -68.22 -18.09 64.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.256 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.624 HD22 ' H ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -57.78 -20.47 35.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.978 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.624 ' H ' HD22 ' A' ' 72' ' ' ASN . 80.7 mt-10 -95.24 -29.03 14.72 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.236 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 74' ' ' LEU . 8.8 mp -74.75 -39.41 61.85 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.976 -0.29 . . . . 1.0 111.298 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.437 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 2.2 mt -40.87 -62.35 1.02 Allowed Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 123.444 0.465 . . . . 1.0 111.917 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 36.8 Cg_endo -61.24 -27.84 84.1 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 121.878 1.718 . . . . 1.0 112.267 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.671 HE22 ' CG2' ' A' ' 48' ' ' ILE . 86.5 mt-30 -75.62 -49.97 16.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.288 0.566 . . . . 1.0 111.444 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 pt -70.28 -42.92 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.586 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -53.19 -35.13 59.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.263 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -63.47 -39.44 94.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.035 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.8 m -62.04 -48.08 81.88 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.013 0.435 . . . . 1.0 110.222 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.93 -44.59 80.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.987 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -45.17 -33.85 2.46 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.524 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 86' ' ' ASN . 9.3 mtpm? -67.04 -51.73 51.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.46 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.0 m -76.67 34.46 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.404 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 84' ' ' LYS . 24.6 m120 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.628 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.9 mtt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.448 ' OE2' ' CE1' ' A' ' 82' ' ' PHE . 38.6 tp10 -109.49 106.55 16.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.053 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.7 mt -49.09 142.6 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.929 0.395 . . . . 1.0 110.421 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -120.05 -34.87 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.343 -0.844 . . . . 1.0 110.639 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.02 178.1 3.05 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.078 0.466 . . . . 1.0 110.177 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.1 pt -143.23 136.73 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.576 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.2 m -116.09 111.88 20.92 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.838 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.437 ' OE1' ' N ' ' A' ' 8' ' ' GLU . 39.2 mp0 -84.16 113.87 21.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -82.88 177.18 3.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.304 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.86 21.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.216 1.944 . . . . 1.0 112.296 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' H ' ' C ' ' A' ' 9' ' ' THR . 94.3 m-20 -103.5 -178.25 3.61 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -112.55 -55.26 2.54 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.231 -0.44 . . . . 1.0 111.794 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 65' ' ' LYS . 0.6 OUTLIER -100.94 3.83 42.03 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.284 -178.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -116.22 131.36 56.96 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.6 mtt -146.23 153.54 40.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.816 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -106.8 135.99 47.4 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.044 -0.525 . . . . 1.0 109.805 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.46 120.68 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.748 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.2 t -96.06 127.57 42.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.327 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.4 pt? -164.33 154.42 14.44 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.419 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -92.71 99.07 11.83 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' OE2' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -82.91 151.39 63.86 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 116.281 -0.418 . . . . 1.0 109.999 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.74 -18.83 32.1 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.535 2.156 . . . . 1.0 112.038 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -67.48 91.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.963 0.411 . . . . 1.0 110.961 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -88.44 26.54 1.43 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.165 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -128.3 8.33 6.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.665 -0.243 . . . . 1.0 110.438 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 38.06 80.81 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.485 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 15.2 t -103.64 126.3 50.7 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.078 -0.341 . . . . 1.0 110.078 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 54.1 p90 -99.08 132.94 44.02 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 m -166.95 107.01 0.62 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.618 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.8 m -81.11 120.78 25.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.358 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -141.65 164.72 29.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.671 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 32' ' ' THR . 9.7 t -168.97 113.89 0.57 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.253 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.93 132.68 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.51 -0.313 . . . . 1.0 110.357 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.439 ' O ' ' NE2' ' A' ' 35' ' ' GLN . . . -81.29 122.69 27.75 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.833 0.349 . . . . 1.0 110.068 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.439 ' NE2' ' O ' ' A' ' 34' ' ' ALA . 99.1 mm-40 -143.34 155.7 44.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.317 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.71 142.38 46.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.837 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.67 -3.55 55.0 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -98.71 155.61 36.52 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 122.889 -0.183 . . . . 1.0 110.583 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -36.34 109.21 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.866 2.378 . . . . 1.0 112.453 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.62 -36.59 74.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.936 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -55.83 -51.7 66.57 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.641 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.7 mm -64.09 -41.22 91.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.957 0.408 . . . . 1.0 110.364 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -59.86 -38.92 83.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.903 -0.59 . . . . 1.0 111.01 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -61.02 -39.52 90.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.869 0.366 . . . . 1.0 110.421 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.44 ' O ' HG22 ' A' ' 48' ' ' ILE . 8.5 mp -63.63 -41.8 98.23 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.996 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -65.07 -29.09 69.95 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.911 -0.715 . . . . 1.0 111.14 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -71.79 -10.08 59.24 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.097 -0.241 . . . . 1.0 111.347 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.624 HD13 ' N ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -105.89 134.55 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.844 0.355 . . . . 1.0 110.301 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.624 ' N ' HD13 ' A' ' 48' ' ' ILE . 17.8 tp10 -73.26 128.84 36.63 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 135.32 -37.78 1.88 Allowed Glycine 0 N--CA 1.461 0.357 0 N-CA-C 110.901 -0.88 . . . . 1.0 110.901 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.74 128.39 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.306 -0.558 . . . . 1.0 110.581 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.473 ' NZ ' ' OD1' ' A' ' 64' ' ' ASP . 27.7 mtmm -99.87 -40.8 7.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.421 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.6 m -165.71 171.19 13.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.362 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.4 137.35 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.04 -0.527 . . . . 1.0 109.998 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -111.46 133.4 53.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.006 -0.543 . . . . 1.0 109.698 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -122.88 108.16 12.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.221 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 60' ' ' PHE . 11.1 p -164.43 147.51 2.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.104 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 64.68 -160.54 0.29 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.897 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 19' ' ' LEU . 81.7 m-20 -89.3 15.03 9.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 57' ' ' VAL . 40.9 p90 -147.88 158.98 44.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.442 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.4 pt -129.44 152.19 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.411 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 67.0 m -113.91 118.96 35.65 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.9 mt -104.88 114.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.076 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.473 ' OD1' ' NZ ' ' A' ' 52' ' ' LYS . 60.2 t0 -98.04 126.24 43.38 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.419 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.546 ' HZ3' ' HB1' ' A' ' 69' ' ' ALA . 4.8 mtmp? -139.15 143.91 38.38 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.45 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -55.71 167.66 0.52 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.351 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 68' ' ' ASN . 50.5 p-10 -68.62 -23.79 64.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.827 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.438 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 2.0 p-10 -77.93 -7.2 56.45 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.785 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.546 ' HB1' ' HZ3' ' A' ' 65' ' ' LYS . . . -76.04 142.49 41.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.428 ' ND2' ' H ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -126.9 119.95 28.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.297 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -60.28 -28.81 68.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.739 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.428 ' H ' ' ND2' ' A' ' 70' ' ' ASN . 6.1 m120 -57.53 -16.61 10.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.572 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -97.92 -34.63 10.76 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.33 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 74' ' ' LEU . 8.7 mp -74.27 -39.83 62.73 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.33 -0.231 . . . . 1.0 110.948 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 3.9 mp -41.92 -62.55 1.11 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.025 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 37.4 Cg_endo -60.56 -27.5 84.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.768 1.645 . . . . 1.0 112.124 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.56 -53.72 7.68 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.985 0.421 . . . . 1.0 111.491 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.4 pt -70.6 -44.1 77.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.031 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -52.07 -32.81 36.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.327 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -64.54 -39.43 93.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.227 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.5 m -62.99 -50.49 70.56 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.899 0.381 . . . . 1.0 110.71 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.448 ' CE1' ' OE2' ' A' ' 2' ' ' GLU . 3.0 t80 -62.06 -48.56 79.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.011 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.88 97.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.793 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -78.35 5.0 11.47 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.92 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.3 m -57.26 -41.83 80.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.824 -0.625 . . . . 1.0 110.477 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.691 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.233 -0.654 . . . . 1.0 109.233 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -157.5 149.81 22.68 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.605 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 3' ' ' ILE . 18.0 tt -50.86 118.47 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.495 0.664 . . . . 1.0 111.082 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mm -92.25 -48.33 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.2 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.91 178.76 9.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.213 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 tt -132.49 135.64 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.264 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 t -100.61 111.26 23.47 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.047 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.29 110.45 16.76 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -87.32 177.63 2.64 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 -178.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.25 7.95 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.988 1.792 . . . . 1.0 112.229 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 9' ' ' THR . 22.6 m120 -93.25 171.69 8.76 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.421 ' O ' ' CZ2' ' A' ' 71' ' ' TRP . 80.0 m80 -111.59 -38.29 4.95 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.169 -0.468 . . . . 1.0 111.352 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -110.42 -2.33 16.64 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 116.519 -0.309 . . . . 1.0 111.795 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -113.81 130.87 56.41 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.472 ' SD ' ' CG ' ' A' ' 71' ' ' TRP . 11.7 ptt? -142.74 151.81 41.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 1.0 109.767 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -113.89 138.34 50.45 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.947 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.8 t -100.44 127.6 53.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.484 -0.562 . . . . 1.0 109.484 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.8 t -104.22 132.32 50.6 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.796 -0.446 . . . . 1.0 109.796 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.693 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.8 pt? -169.64 158.04 7.42 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.91 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -102.75 86.19 2.7 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -98.22 146.16 31.05 Favored Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.37 86.14 0.83 Allowed 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.144 1.896 . . . . 1.0 111.924 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' NE ' ' OH ' ' A' ' 56' ' ' TYR . 37.6 mmt180 -133.85 89.68 2.61 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.109 0.48 . . . . 1.0 110.341 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -94.91 20.6 8.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.53 -0.759 . . . . 1.0 110.378 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 27' ' ' SER . 94.6 m-20 -129.6 -6.92 4.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.78 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.7 m120 54.7 -84.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.607 -0.27 . . . . 1.0 110.396 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 25' ' ' ASP . 14.4 p 56.77 107.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.985 0.422 . . . . 1.0 110.112 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 51.9 p90 -100.09 127.65 46.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.346 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 47.8 m -161.42 132.54 5.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.416 ' CB ' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -101.8 120.15 39.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.259 0.552 . . . . 1.0 111.038 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -140.14 133.49 29.9 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.817 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 32' ' ' THR . 10.4 t -138.24 116.44 11.82 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.037 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 170.07 137.63 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.957 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.16 122.37 32.39 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -154.16 154.36 33.42 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.11 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -71.16 128.87 37.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.797 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.51 -19.82 52.5 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.437 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 38.9 mm-40 -82.18 152.0 67.31 Favored Pre-proline 0 CA--C 1.543 0.709 0 O-C-N 122.746 -0.267 . . . . 1.0 110.602 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.17 119.74 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.606 2.204 . . . . 1.0 112.923 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.7 mp0 -68.77 -23.32 64.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.539 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.601 ' C ' HD12 ' A' ' 42' ' ' ILE . 56.7 m-85 -69.26 -10.2 56.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.961 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.601 HD12 ' C ' ' A' ' 41' ' ' PHE . 2.0 mp -118.07 -33.71 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 123.3 0.375 . . . . 1.0 110.312 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 38' ' ' GLN . 67.3 m-20 -63.18 -39.87 95.89 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.211 -0.595 . . . . 1.0 110.71 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.454 ' NH1' ' OG1' ' A' ' 81' ' ' THR . 25.0 mmt85 -64.51 -34.67 78.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.49 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.546 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.7 mp -63.21 -41.05 99.09 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.005 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -69.8 -5.2 23.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 120.861 -0.336 . . . . 1.0 111.034 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.47 ' OE1' ' NE2' ' A' ' 77' ' ' GLN . 82.2 tt0 -68.12 -24.3 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.634 -0.257 . . . . 1.0 111.364 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.483 HG12 HD11 ' A' ' 74' ' ' LEU . 2.3 pp -121.76 142.99 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 120.899 0.381 . . . . 1.0 110.816 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -67.14 143.85 56.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.847 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.93 -40.42 1.59 Allowed Glycine 0 N--CA 1.465 0.601 0 N-CA-C 111.452 -0.659 . . . . 1.0 111.452 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.11 112.38 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.543 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -82.02 -50.86 8.63 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.042 0.448 . . . . 1.0 110.176 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.8 p -160.96 160.54 30.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.224 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.416 ' O ' ' CB ' ' A' ' 30' ' ' THR . 49.5 mm -121.73 151.57 25.23 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.921 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -134.37 120.93 20.46 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.495 ' OH ' ' NE ' ' A' ' 23' ' ' ARG . 53.1 t80 -114.7 118.41 33.55 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.689 -0.485 . . . . 1.0 109.689 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.3 p -164.57 148.39 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.968 0.413 . . . . 1.0 110.192 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 59' ' ' ASP . 0.1 OUTLIER 63.85 -138.94 0.32 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.774 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' H ' HD12 ' A' ' 58' ' ' LEU . 56.0 p30 -110.25 23.79 13.83 Favored 'General case' 0 C--N 1.344 0.356 0 C-N-CA 122.619 0.367 . . . . 1.0 110.865 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -147.42 157.56 43.63 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 mp -126.52 132.84 69.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 1.0 109.844 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t -103.11 123.58 46.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.433 ' CG2' ' NZ ' ' A' ' 65' ' ' LYS . 65.4 mt -112.05 127.52 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 109.673 -0.492 . . . . 1.0 109.673 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.04 111.72 23.03 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.579 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' NZ ' ' CG2' ' A' ' 63' ' ' ILE . 47.3 mttp -115.78 155.75 27.26 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.388 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 67' ' ' ASP . 7.3 tp10 -67.09 175.25 2.66 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.412 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 90.8 m-20 -70.12 -20.32 63.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.032 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -85.74 3.03 43.07 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.71 0.291 . . . . 1.0 111.098 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.21 153.36 17.84 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.423 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.448 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 0.2 OUTLIER -141.32 121.82 14.13 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.032 0.444 . . . . 1.0 110.362 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.472 ' CG ' ' SD ' ' A' ' 15' ' ' MET . 5.6 m0 -58.16 -26.47 62.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.539 . . . . 1.0 111.266 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -56.48 -36.61 69.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.749 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -74.56 -40.29 61.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.646 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.9 mm? -70.7 -38.43 73.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.965 0.357 . . . . 1.0 111.965 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mp -39.55 -62.49 0.82 Allowed Pre-proline 0 CA--C 1.541 0.599 0 O-C-N 123.441 0.463 . . . . 1.0 110.89 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.38 -22.61 59.54 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.783 1.656 . . . . 1.0 112.11 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.47 ' NE2' ' OE1' ' A' ' 47' ' ' GLU . 40.4 tt0 -76.47 -53.47 8.07 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.975 0.417 . . . . 1.0 111.621 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 pt -71.33 -40.32 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.824 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -50.91 -31.05 16.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.347 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -63.95 -39.67 94.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.326 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.454 ' OG1' ' NH1' ' A' ' 44' ' ' ARG . 21.6 m -60.1 -48.7 80.6 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.823 0.344 . . . . 1.0 110.45 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.511 ' CZ ' ' CD1' ' A' ' 41' ' ' PHE . 98.0 m-85 -69.51 -37.29 77.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.572 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.28 -43.07 92.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.662 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -62.46 -61.41 2.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.75 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.8 t -60.12 -45.73 92.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.459 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.696 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' CE2' ' A' ' 41' ' ' PHE . 66.7 mtt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.449 -0.574 . . . . 1.0 109.449 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -125.78 125.04 42.28 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.417 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 4' ' ' ILE . 85.0 mt -49.37 155.64 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-O 120.776 0.322 . . . . 1.0 110.267 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.416 ' N ' HG22 ' A' ' 3' ' ' ILE . 48.1 mm -127.25 -37.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.434 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -171.65 158.69 5.13 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.736 -0.386 . . . . 1.0 110.127 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.466 ' CG2' ' SD ' ' A' ' 15' ' ' MET . 74.9 mt -104.23 131.83 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.484 -0.561 . . . . 1.0 109.484 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 m -114.56 104.85 12.42 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.105 0.479 . . . . 1.0 110.007 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -76.86 144.78 38.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.522 -0.763 . . . . 1.0 109.085 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.5 OUTLIER -122.71 161.76 42.24 Favored Pre-proline 0 N--CA 1.472 0.655 0 N-CA-C 109.514 -0.55 . . . . 1.0 109.514 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.0 21.67 0.05 OUTLIER 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.529 2.153 . . . . 1.0 112.215 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 9' ' ' THR . 14.9 m120 -96.42 -174.23 2.99 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.457 ' O ' ' CH2' ' A' ' 71' ' ' TRP . 59.3 t-80 -110.72 -51.27 2.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.825 0.345 . . . . 1.0 111.652 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.523 HD22 ' N ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -116.22 7.57 14.11 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.875 -0.602 . . . . 1.0 112.103 -178.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.523 ' N ' HD22 ' A' ' 13' ' ' ASN . 24.1 m -111.72 130.06 55.91 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.466 ' SD ' ' CG2' ' A' ' 6' ' ' ILE . 38.8 ttm -139.7 150.9 45.42 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -107.29 131.4 54.25 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.94 -0.573 . . . . 1.0 109.579 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.7 t -108.61 109.98 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.1 m -90.48 133.19 35.22 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.6 pt? -166.05 155.55 11.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.063 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m -88.25 83.79 6.91 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 23' ' ' ARG . 20.8 pt-20 -107.16 147.36 35.02 Favored Pre-proline 0 N--CA 1.473 0.715 0 N-CA-C 109.957 -0.386 . . . . 1.0 109.957 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -38.66 86.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 122.456 2.104 . . . . 1.0 112.85 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 21' ' ' GLU . 49.2 ptt85 -78.49 -18.66 54.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.706 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -43.48 -27.41 0.28 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.122 0.487 . . . . 1.0 110.502 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -70.84 -42.59 69.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.432 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 23' ' ' ARG . 11.5 p30 38.82 49.55 1.54 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.765 0.317 . . . . 1.0 111.41 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.5 t -120.02 142.59 48.67 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.21 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 46.2 p90 -102.79 131.21 49.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.217 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.41 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.1 m -160.81 108.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 m -79.64 117.79 20.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.668 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 29' ' ' THR . 9.5 p90 -142.27 162.38 35.63 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.252 178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -170.34 114.08 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.562 . . . . 1.0 109.972 177.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 169.29 139.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.296 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.8 120.97 25.35 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.799 -0.445 . . . . 1.0 109.799 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.478 ' OE1' ' NE2' ' A' ' 38' ' ' GLN . 81.9 mt-30 -148.07 146.91 29.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.029 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -70.5 142.75 51.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.828 -0.624 . . . . 1.0 111.122 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.22 -13.03 62.73 Favored Glycine 0 N--CA 1.46 0.286 0 N-CA-C 110.768 -0.933 . . . . 1.0 110.768 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.478 ' NE2' ' OE1' ' A' ' 35' ' ' GLN . 75.6 mt-30 -97.3 147.42 32.94 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 122.837 -0.214 . . . . 1.0 110.932 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -41.92 128.06 3.88 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.136 1.891 . . . . 1.0 112.896 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.452 ' OE2' ' NZ ' ' A' ' 84' ' ' LYS . 95.9 mt-10 -66.89 -26.28 66.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.023 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.453 ' O ' HD13 ' A' ' 45' ' ' LEU . 99.3 m-85 -60.26 -11.98 7.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.903 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -110.32 -39.65 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 110.105 -0.331 . . . . 1.0 110.105 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -66.23 -38.15 87.22 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.863 -0.335 . . . . 1.0 111.281 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 -60.23 -34.09 73.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.19 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.2 mp -66.02 -36.86 84.41 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.21 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' O ' ' A' ' 46' ' ' PHE . 75.7 t80 -74.11 13.41 0.55 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.818 0.342 . . . . 1.0 111.193 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 45' ' ' LEU . 80.8 mm-40 -87.51 -20.92 25.84 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.611 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.15 142.2 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.3 pm0 -68.71 148.96 49.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.095 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.61 -36.0 3.01 Favored Glycine 0 N--CA 1.468 0.779 0 N-CA-C 111.366 -0.693 . . . . 1.0 111.366 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.82 114.88 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 121.3 0.571 . . . . 1.0 110.656 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.87 -42.81 8.89 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 p -165.04 161.74 19.96 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.508 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 87.8 mt -130.98 136.2 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -111.34 129.63 55.94 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.156 -0.474 . . . . 1.0 109.866 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -124.17 118.46 26.93 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.632 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.7 p -164.79 146.92 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.997 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 tp 62.4 -131.25 0.57 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.818 -0.628 . . . . 1.0 110.83 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 19' ' ' LEU . 48.3 p-10 -115.25 23.56 12.36 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.156 0.582 . . . . 1.0 110.971 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.35 159.63 43.11 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.7 pt -132.09 149.44 32.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.147 -0.479 . . . . 1.0 109.808 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.2 t -114.96 122.49 46.43 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.31 115.42 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -100.37 114.95 28.88 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.1 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HZ3' ' HG ' ' A' ' 74' ' ' LEU . 38.6 mtmt -125.47 153.12 44.0 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.674 0.273 . . . . 1.0 110.793 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -61.79 167.58 3.57 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.854 -0.424 . . . . 1.0 109.854 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.08 -18.62 65.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.649 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -85.95 4.5 37.34 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.862 0.363 . . . . 1.0 110.768 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.33 149.54 21.57 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.281 0.562 . . . . 1.0 110.502 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.588 HD22 ' N ' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -138.31 126.86 23.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.142 -0.935 . . . . 1.0 110.654 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.588 ' N ' HD22 ' A' ' 70' ' ' ASN . 4.5 m-90 -57.72 -27.43 62.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.978 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.458 ' H ' ' ND2' ' A' ' 70' ' ' ASN . 5.7 m120 -55.49 -29.61 59.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.331 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -81.53 -35.6 30.14 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.132 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 74' ' ' LEU . 3.7 mm? -70.51 -38.78 74.34 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 121.078 -0.249 . . . . 1.0 111.601 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mt -39.92 -62.62 0.83 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.165 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -62.74 -24.21 74.64 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.895 1.73 . . . . 1.0 112.315 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -75.95 -54.05 7.47 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.465 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.3 pt -67.5 -41.24 85.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.524 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -50.32 -28.37 7.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.255 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -58.73 -33.38 70.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.142 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.7 p -64.44 -44.35 91.42 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.139 0.495 . . . . 1.0 110.245 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.13 -36.13 83.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.576 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -46.19 -46.87 17.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.908 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.452 ' NZ ' ' OE2' ' A' ' 40' ' ' GLU . 98.9 mttt -62.66 -49.35 75.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.399 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.1 p -60.12 -51.4 69.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.582 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.0 t30 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.941 -1.028 . . . . 1.0 110.502 179.862 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ptp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -149.86 139.95 22.07 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.506 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 99.1 mt -51.65 118.23 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-O 121.05 0.452 . . . . 1.0 110.804 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 67.8 mt -92.81 -35.24 6.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.038 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.5 151.63 1.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.226 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 78.6 mt -107.42 125.91 63.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 109.518 -0.549 . . . . 1.0 109.518 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -107.25 116.9 32.74 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.99 0.424 . . . . 1.0 110.437 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -72.67 145.93 46.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.434 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -121.68 168.72 10.64 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.293 -179.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.69 -7.8 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.47 2.113 . . . . 1.0 112.159 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.462 ' H ' ' C ' ' A' ' 9' ' ' THR . 98.4 m-20 -92.83 173.95 7.49 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.071 0.462 . . . . 1.0 110.05 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.56 ' CG ' ' N ' ' A' ' 13' ' ' ASN . 46.0 p-80 -113.7 -55.1 2.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.34 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.56 ' N ' ' CG ' ' A' ' 12' ' ' HIS . 51.0 p30 -82.62 3.7 27.77 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.866 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.6 m -124.23 145.66 49.22 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.27 0.557 . . . . 1.0 109.98 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.3 tpp -144.8 153.78 42.0 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.703 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -101.65 123.94 46.49 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.058 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.5 t -104.07 106.52 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.932 0.396 . . . . 1.0 110.007 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 m -88.85 134.44 33.94 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.746 0.308 . . . . 1.0 110.445 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.687 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.5 pt? -170.17 160.77 8.14 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.056 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -81.06 99.02 8.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.995 178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 14.0 mm-40 -131.04 52.46 9.53 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 121.088 0.47 . . . . 1.0 110.191 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 43.1 Cg_endo -66.56 145.67 77.09 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.065 1.843 . . . . 1.0 111.819 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.496 ' C ' ' H ' ' A' ' 25' ' ' ASP . 72.9 ttt180 -155.84 140.7 17.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.361 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.664 ' CD ' ' H ' ' A' ' 24' ' ' GLN . 2.2 pm0 -60.99 0.46 0.22 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.41 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 23' ' ' ARG . 66.7 t0 -138.33 52.53 1.83 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.62 -0.263 . . . . 1.0 110.497 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -69.65 54.16 0.12 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.392 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.0 t -79.12 169.49 18.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.123 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.453 ' CD2' ' O ' ' A' ' 28' ' ' PHE . 54.4 p90 -102.77 127.44 49.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.136 0.493 . . . . 1.0 110.515 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.2 m -161.72 149.28 14.66 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.041 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.67 130.14 52.18 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.18 -0.463 . . . . 1.0 111.013 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.74 170.26 16.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.41 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 32' ' ' THR . 8.9 t -167.43 116.28 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.669 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 168.15 134.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.095 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.59 120.83 31.99 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.119 0.485 . . . . 1.0 110.413 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -147.94 153.15 38.67 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.712 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -68.14 131.42 45.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.283 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.37 -16.35 57.81 Favored Glycine 0 N--CA 1.466 0.677 0 N-CA-C 110.743 -0.943 . . . . 1.0 110.743 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -88.24 151.7 49.23 Favored Pre-proline 0 N--CA 1.455 -0.18 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.64 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -36.86 114.23 0.12 Allowed 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.81 2.34 . . . . 1.0 112.879 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.81 -27.2 66.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.394 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.519 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 39.1 m-85 -60.8 -23.71 65.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.384 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 36.9 mm -100.36 -31.34 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.75 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -63.57 -40.53 97.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.037 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -59.75 -32.74 70.85 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.068 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.6 mp -66.65 -39.35 88.19 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.874 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.3 -22.82 65.62 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.852 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.56 -15.29 63.58 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.874 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.45 140.4 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.413 0.625 . . . . 1.0 110.31 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.63 136.37 41.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.135 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.54 -43.28 1.19 Allowed Glycine 0 N--CA 1.463 0.456 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 51' ' ' VAL . 14.8 p -60.22 119.69 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.158 0.504 . . . . 1.0 111.104 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -96.76 -42.71 7.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 1.0 109.99 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.4 p -166.19 165.99 17.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.301 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 54' ' ' ILE . 4.5 mp -135.34 152.84 32.64 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.889 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.447 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -127.4 129.73 48.08 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.421 0.451 . . . . 1.0 109.981 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -121.76 122.66 40.01 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.194 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -164.89 149.02 2.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.506 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 58' ' ' LEU . 14.0 tp 57.39 -128.5 1.7 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.127 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -118.97 24.31 10.9 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 123.302 0.376 . . . . 1.0 110.822 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -144.42 155.69 43.86 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 pt -129.68 147.58 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.329 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.7 m -120.29 119.92 34.57 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.411 -0.588 . . . . 1.0 109.411 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 66.2 mt -105.25 124.41 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.549 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -101.32 124.78 47.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.78 -0.646 . . . . 1.0 110.443 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.414 ' NZ ' HD21 ' A' ' 74' ' ' LEU . 4.5 mtpt -135.66 154.17 51.38 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.267 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 67' ' ' ASP . 71.0 tt0 -61.52 169.89 2.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.48 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.442 ' N ' ' HG2' ' A' ' 66' ' ' GLU . 50.9 t0 -67.8 -21.86 65.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.241 -0.436 . . . . 1.0 111.118 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -82.96 -5.41 59.06 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.773 0.32 . . . . 1.0 110.568 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.5 152.49 26.03 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.074 0.464 . . . . 1.0 110.51 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.457 ' O ' ' ND2' ' A' ' 70' ' ' ASN . 0.1 OUTLIER -141.69 118.68 11.24 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.299 0.571 . . . . 1.0 109.787 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -57.64 -21.24 38.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.988 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -57.92 -35.18 70.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.561 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -75.95 -35.89 59.53 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-O 121.11 0.481 . . . . 1.0 110.607 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.627 ' N ' HD12 ' A' ' 74' ' ' LEU . 9.2 mp -69.12 -37.81 78.53 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.212 -0.305 . . . . 1.0 111.3 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.456 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 3.6 mp -38.4 -63.67 0.54 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.021 0.378 . . . . 1.0 112.021 -179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 40.0 Cg_endo -62.26 -26.51 77.45 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.428 2.086 . . . . 1.0 112.551 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -76.15 -54.38 6.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.301 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.5 pt -69.77 -42.95 80.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.916 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -51.34 -35.73 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.145 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -66.59 -36.69 83.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.472 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.1 m -57.25 -47.21 81.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.02 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.519 ' CE1' ' CE1' ' A' ' 41' ' ' PHE . 95.3 m-85 -70.72 -33.14 70.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 1.0 111.028 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.91 -48.12 81.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.749 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 84' ' ' LYS . 4.5 mptp? -83.22 -10.58 58.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.755 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.1 t -61.06 -46.63 89.9 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 123.619 0.574 . . . . 1.0 110.568 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.3 t30 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.848 -1.072 . . . . 1.0 110.53 -179.794 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -142.83 139.23 30.82 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.956 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.7 pt -51.7 146.62 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.542 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 mm -123.31 -43.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.356 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -163.05 140.73 7.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.43 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.19 123.53 60.95 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 CA-C-N 115.686 -0.688 . . . . 1.0 109.622 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.1 m -106.09 103.25 12.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.205 -0.452 . . . . 1.0 109.87 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -70.21 155.63 40.37 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -132.35 158.36 75.83 Favored Pre-proline 0 N--CA 1.474 0.763 0 N-CA-C 109.897 -0.409 . . . . 1.0 109.897 -178.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.85 32.62 0.13 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.436 2.091 . . . . 1.0 112.023 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 9' ' ' THR . 13.5 m120 -90.62 -169.57 2.43 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -109.98 -39.57 5.01 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.521 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.595 HD22 ' N ' ' A' ' 67' ' ' ASP . 12.5 p30 -145.29 15.3 1.48 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.993 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -116.32 125.5 52.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.541 -0.3 . . . . 1.0 110.276 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -137.24 148.39 46.42 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.178 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -100.6 137.98 38.27 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.229 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.64 108.4 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -92.4 131.44 37.56 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 19' ' ' LEU . 1.2 pt? -169.11 165.09 11.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.955 0.407 . . . . 1.0 110.515 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.8 t -84.38 119.48 25.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.969 0.414 . . . . 1.0 110.754 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -131.12 75.16 78.6 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.73 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.52 143.43 99.45 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.284 1.99 . . . . 1.0 111.977 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -166.97 155.7 10.18 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -43.0 -59.7 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.904 0.383 . . . . 1.0 111.092 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' SER . 52.8 p-10 -143.29 60.47 1.4 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 119.235 -0.412 . . . . 1.0 111.869 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.45 ' HB3' ' H ' ' A' ' 58' ' ' LEU . 22.2 m-80 -23.08 83.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.392 0.615 . . . . 1.0 112.26 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 25' ' ' ASP . 13.9 m -93.31 -151.99 0.32 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.455 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -123.07 145.15 48.79 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.427 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 m -167.07 107.11 0.61 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.119 -0.697 . . . . 1.0 109.119 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.2 m -84.27 115.64 22.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.273 0.559 . . . . 1.0 110.331 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -141.41 167.16 22.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.651 -0.704 . . . . 1.0 110.198 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.556 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 98.1 m -170.21 112.66 0.45 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 1.0 109.96 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 32' ' ' THR . . . 167.57 137.15 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.309 . . . . 1.0 110.807 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -72.8 112.37 8.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.157 0.504 . . . . 1.0 110.659 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -150.77 147.51 27.39 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.71 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.49 143.97 53.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.71 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.84 -25.47 20.68 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -102.65 146.76 32.96 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 116.949 0.374 . . . . 1.0 110.493 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -41.98 123.95 2.64 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.08 1.853 . . . . 1.0 112.627 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -45.33 -23.7 0.22 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.769 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -56.4 -43.05 78.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.49 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.5 mm -62.29 -47.05 94.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.676 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -62.02 -39.64 92.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.746 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -57.52 -49.08 77.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.382 -0.599 . . . . 1.0 109.382 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mt -55.63 -39.1 70.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 73.6 t80 -77.37 16.18 0.65 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.84 0.352 . . . . 1.0 110.756 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -95.7 -35.95 11.38 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.567 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.1 pp -115.17 139.72 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.855 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -62.04 136.11 57.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.702 -0.681 . . . . 1.0 110.782 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.98 -42.85 0.98 Allowed Glycine 0 C--O 1.228 -0.256 0 N-CA-C 111.28 -0.728 . . . . 1.0 111.28 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 51' ' ' VAL . 13.2 p -66.02 113.18 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.136 0.493 . . . . 1.0 111.205 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -83.68 -49.38 9.2 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.487 -0.56 . . . . 1.0 109.487 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -158.81 153.74 25.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.411 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 51' ' ' VAL . 48.9 mm -121.12 136.43 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.673 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -112.49 142.93 44.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.02 -0.536 . . . . 1.0 109.826 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -135.41 117.0 14.88 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.859 -0.422 . . . . 1.0 109.859 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 60' ' ' PHE . 8.8 p -165.79 145.18 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.226 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.45 ' H ' ' HB3' ' A' ' 26' ' ' ASN . 0.4 OUTLIER 58.33 -156.17 0.33 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.195 0.522 . . . . 1.0 110.966 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 19' ' ' LEU . 82.8 m-20 -91.51 13.42 17.78 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.414 ' O ' ' O ' ' A' ' 57' ' ' VAL . 36.4 p90 -140.71 149.11 41.77 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.703 0.287 . . . . 1.0 110.235 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 pt -128.17 159.66 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.9 p -122.85 130.24 52.63 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.6 mt -115.36 110.47 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.524 -0.546 . . . . 1.0 109.524 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.54 109.75 21.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.331 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.655 ' NZ ' ' HE1' ' A' ' 71' ' ' TRP . 24.3 mtmm -122.14 153.66 38.44 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.222 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -67.31 164.91 17.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.203 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.595 ' N ' HD22 ' A' ' 13' ' ' ASN . 42.6 p-10 -58.48 -28.74 65.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.736 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 14.3 m120 -70.32 3.29 3.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.583 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.53 145.43 24.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.274 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.506 HD21 ' CD ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -140.88 123.4 15.98 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.26 -0.427 . . . . 1.0 109.991 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.655 ' HE1' ' NZ ' ' A' ' 65' ' ' LYS . 3.1 m0 -64.78 -27.23 68.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.39 -0.368 . . . . 1.0 111.237 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -57.57 -16.25 9.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.583 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.506 ' CD ' HD21 ' A' ' 70' ' ' ASN . 97.0 mt-10 -96.01 -33.5 12.11 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.588 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 74' ' ' LEU . 4.0 mm? -74.86 -31.3 61.59 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 121.042 -0.263 . . . . 1.0 111.066 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.3 mp -41.17 -61.94 1.19 Allowed Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 123.022 0.201 . . . . 1.0 110.876 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.97 -24.81 67.01 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.06 1.84 . . . . 1.0 112.718 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -79.06 -55.75 4.89 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.108 0.48 . . . . 1.0 111.56 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.461 ' O ' ' OG1' ' A' ' 81' ' ' THR . 2.3 pp -65.23 -39.01 84.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.044 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -49.11 -29.42 5.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.906 0.384 . . . . 1.0 110.606 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -70.69 -25.95 63.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.615 -0.266 . . . . 1.0 111.307 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 78' ' ' ILE . 81.9 p -60.62 -48.78 80.25 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.916 0.389 . . . . 1.0 111.921 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -35.65 58.29 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.097 -0.502 . . . . 1.0 110.221 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.85 -37.85 69.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.396 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -67.63 -1.62 5.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.49 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.3 p -60.78 -33.1 72.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.517 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.5 p30 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.545 179.761 . . . . . . . . 0 0 . 1 stop_ save_